CLDF Title
Home | Contact Us | Bookmark
HEPATITIS
HBV HCV HDV
CIRRHOSIS
HEPATIC ENCEPHALOPATHY (HE) HEPATORENAL SYNDROME (HRS) THROMBOCYTOPENIA
NASH
CHOLESTATIC
PRIMARY BILIARY CHOLANGITIS (PBC)
HCC ALCOHOL LIVER DISEASE PEDIATRIC LIVER DISEASE
About CLDF
Board of Trustees Board of Advisors/Faculty 2020 GI Fellow Board of Advisors CLDF Committees
Centers of Educational Expertise  
Slide Library Webcasts Annotations Abstract Library Committee Members Conference Highlights
 
HBV | Abstract Library
Abstract Library
 
The summaries are free for public use. The Chronic Liver Disease Foundation will continue to add and archive summaries of articles deemed relevant to CLDF by the Board of Trustees and its Advisors.
1.Antiviral Therapy Reduces Risk of Cirrhosis in Noncirrhotic HBV Patients Among 4 Urban Safety-Net Health Systems
 

Am J Gastroenterol. 2021 Jul 1;116(7):1465-1475. doi: 10.14309/ajg.0000000000001195.

Robert J Wong 1 2 3, Mamta K Jain 4 5, George Therapondos 6, Bolin Niu 7, Onkar Kshirsagar 8, Mae Thamer 8
 
2.Long-term safety of rituximab in rheumatic patients with previously resolved hepatitis B virus infection
 

Intern Emerg Med. 2021 Sep 2. doi: 10.1007/s11739-021-02836-3. Online ahead of print.

Michele Barone 1, Vincenzo Venerito 2, Rosa Paolillo 1, Giacomo Emmi 3, Marco Fornaro 2, Fabio Cacciapaglia 2, Luca Cantarini 4, Alfredo Di Leo 1, Florenzo Iannone 2, Giuseppe Lopalco 5
 
3.Risk of Reactivation of Hepatitis B Virus (HBV) and Tuberculosis (TB) and Complications of Hepatitis C Virus (HCV) Following Tocilizumab Therapy: A Systematic Review to Inform Risk Assessment in the COVID-19 Era
 

Front Med (Lausanne). 2021 Aug 20;8:706482. doi: 10.3389/fmed.2021.706482.eCollection 2021.

Cori Campbell 1, Monique I Andersson 2 3, M Azim Ansari 1 4, Olivia Moswela 5, Siraj A Misbah 6, Paul Klenerman 1 2, Philippa C Matthews 1 2
 
4.Towards eradication of HBV: Treatment approaches and status of clinical trials
 

Curr Opin Pharmacol. 2021 Aug 30;60:232-240. doi: 10.1016/j.coph.2021.07.008.Online ahead of print.

Lisa Sandmann 1, Markus Cornberg 2
 
5.Hepadnaviral Lymphotropism and Its Relevance to HBV Persistence and Pathogenesis
 

Front Microbiol. 2021 Aug 6;12:695384. doi: 10.3389/fmicb.2021.695384.eCollection 2021.

Carla S Coffin 1, Patricia M Mulrooney-Cousins 2, Tomasz I Michalak 2
 
6.Liver disease symptoms are associated with higher risk of adverse clinical outcomes: A longitudinal study of North American adults with chronic Hepatitis B
 

GastroHep. 2021 May;3(3):196-208. doi: 10.1002/ygh2.458. Epub 2021 May 5.

Donna M Evon 1, Hsing-Hua S Lin 2, Robert J Fontana 3, Mandana Khalili 4, Colina Yim 5, Abdus S Wahed 2, Jay H Hoofnagle 6
 
7.Treatment Algorithm for Managing Chronic Hepatitis B Virus Infection in the United States: 2021 Update
 

Clin Gastroenterol Hepatol. 2021 Jul 27;S1542-3565(21)00818-1. doi: 10.1016/j.cgh.2021.07.036.Online ahead of print.

Paul Martin 1, Mindie H Nguyen 2, Douglas T Dieterich 3, Daryl T-Y Lau 4, Harry L A Janssen 5, Marion G Peters 6, Ira Jacobson 7
 
8.Immunologic markers and risk of hepatocellular carcinoma in hepatitis B virus- and hepatitis C virus-infected individuals
 

Aliment Pharmacol Ther. 2021 Jul 19. doi: 10.1111/apt.16524. Online ahead of print.

Jill Koshiol 1, Ilona Argirion 1, Zhiwei Liu 1, Tram Kim Lam 2, Thomas R O'Brien 1, Kelly Yu 1, Katherine A McGlynn 1, Jessica L Petrick 1 3, Ligia Pinto 4, Chien-Jen Chen 5 6, Allan Hildesheim 1, Ruth M Pfeiffer 1, Mei-Hsuan Lee 7, Hwai-I Yang 5
 
9.The Inflammatory Cytokine Profile Associated with Liver Damage is Broader and Stronger in Chronic Hepatitis B Patients Compared to Acute Hepatitis B Patients
 

J Infect Dis. 2021 Jul 21;jiab373. doi: 10.1093/infdis/jiab373. Online ahead of print.

Alexandra Johnson Valiente 1 2, Kin Seng Liem 2 3, Kathleen B Schwarz 4 5, Philip Rosenthal 6, Karen F Murray 7, Douglas Mogul 5, Jeffery Teckman 8, Norberto Rodriguez-Baez 9, Sarah Jane Schwarzenberg 10, Jordan J Feld 2 11, David K Wong 2, Lia L Lewis-Ximenez 12, Georg Lauer 13, Bettina E Hansen 2 14, Simon C Ling 15 16, Harry L A Janssen 2 11, Adam J Gehring 1 2 11
 
10.Hepatitis B Virus (HBV) Genotype: A Significant Risk Factor in Determining which Patients with Chronic HBV Infection should Undergo Surveillance for Hepatocellular Carcinoma: The Hepatitis B Alaska (HEP-B-AK) Study
 

Hepatology. 2021 Jul 22. doi: 10.1002/hep.32065. Online ahead of print.

Brian J McMahon 1 2, Solu Nolen 2, Mary Snowball 1, Chriss Homan 1, Susan Negus 1, Elena Roik 1, Philip R Spradling 3, Dana Bruden 2
 
11.Hepatitis B vaccine and risk of acute myocardial infarction among individuals with diabetes mellitus
 

Pharmacoepidemiol Drug Saf. 2021 Jul 10. doi: 10.1002/pds.5327. Online ahead of print.

Katherine Wong 1, Katia Bruxvoort 1, Jeff Slezak 1, Jin-Wen Y Hsu 1, Kristi Reynolds 1, Lina S Sy 1, Steven J Jacobsen 1
 
12.Liver failure from delayed hepatitis B reactivation in anti-HBc-positive patient following rituximab for B-cell lymphoma
 

 

BMJ Case Rep. 2021 Jul 9;14(7):e243526. doi: 10.1136/bcr-2021-243526.

Branko Borojevic 1, Ayushi Chauhan 2, Scott Patterson 3
 
13.Hepatitis B Screening of At-Risk Immigrants Seen at Primary Care Clinics: A Quality Improvement Project
 

Mayo Clin Proc Innov Qual Outcomes. 2021 May 27;5(3):635-644.doi: 10.1016/j.mayocpiqo.2021.04.002. eCollection 2021 Jun.

Peace N Eneh 1, Mohamed Mady 1, Mikayla A Schmidt 1, Eneyew Tilahun 1, Fatima Hassan 1, Jane W Njeru 2, Sarah J Crane 2, Rajeev Chaudhry 2, Lewis R Roberts 1
 
14.Challenges in Phase 4 post-licensure safety studies using real world data in the United States: Hepatitis B vaccine example
 

Vaccine X. 2021 Jun 11;8:100101. doi: 10.1016/j.jvacx.2021.100101. eCollection 2021 Aug.

Katia Bruxvoort 1, Lina S Sy 1, Bradley K Ackerson 1, Jeff Slezak 1, Lei Qian 1, William Towner 1, Kristi Reynolds 1, Zendi Solano 1, Cheryl M Carlson 1, Steven J Jacobsen 1
 
15.A Deep Ravine Rather Than a Shallow Gap: Many More Bridges Needed to Improve Care of Chronic Hepatitis B in the United States
 

Am J Gastroenterol. 2021 Jun 30. doi: 10.14309/ajg.0000000000001364. Online ahead of print.

Esperance A K Schaefer 1
 
16.Estimated prevalence and number of persons with isolated antibody to hepatitis B core antigen and associated occult hepatitis B, United States, 2001-2018
 

J Infect Dis. 2021 Jul 12;jiab366. doi: 10.1093/infdis/jiab366. Online ahead of print.

Philip R Spradling 1, Jian Xing 1, Aaron M Harris 1, Kathleen N Ly 1
 
17.Moving Fast Toward Hepatitis B Virus Elimination
 

Adv Exp Med Biol. 2021;1322:115-138. doi: 10.1007/978-981-16-0267-2_5.

Leda Bassit # 1, Suzane Kioko Ono # 2, Raymond F Schinazi 3
 
18.Unexpected Hepatitis B Virus Infection After Liver Transplantation - United States, 2014-2019
 

MMWR Morb Mortal Wkly Rep. 2021 Jul 9;70(27):961-966. doi: 10.15585/mmwr.mm7027a1.

Danae Bixler, Pallavi Annambhotla, Martha P Montgomery, Tonya Mixon-Hayden, Ben Kupronis, Marian G Michaels, Ricardo M La Hoz, Sridhar V Basavaraju, Saleem Kamili, Anne Moorman
 
19.Epidemiology and Prevention of Tuberculosis and Chronic Hepatitis B Virus Infection in the United States
 

J Immigr Minor Health. 2021 Jun 23. doi: 10.1007/s10903-021-01231-6.Online ahead of print.

Amit S Chitnis 1, Ramsey Cheung 2 3, Robert G Gish 4, Robert J Wong 2 3
 
20.Family imaginaries in the disclosure of a blood-borne virus
 

Sociol Health Illn. 2021 Jun 23. doi: 10.1111/1467-9566.13316. Online ahead of print.

Anthony K J Smith 1, Asha Persson 1, Kerryn Drysdale 1 2, Joanne Bryant 1, Kylie Valentine 3, Jack Wallace 4, Myra Hamilton 5, Rebecca M Gray 1, Christy E Newman 1
 
21.Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated: a retrospective longitudinal UK cohort study
 

BMC Infect Dis. 2021 Jun 26;21(1):610. doi: 10.1186/s12879-021-06226-0.

Tingyan Wang 1 2, David A Smith 2 3, Cori Campbell 1 2, Jolynne Mokaya 1, Oliver Freeman 2 4, Hizni Salih 2 4, Anna L McNaughton 1, Sarah Cripps 5, Kinga A Várnai 2 3, Theresa Noble 2 3, Kerrie Woods 2 3, Jane Collier 6, Katie Jeffery 7, Jim Davies 2 8, Eleanor Barnes # 9 10, Philippa C Matthews # 11 12 13
 
22.Hepatitis B cure: How and when
 

Liver Int. 2021 Jun;41 Suppl 1:24-29.doi: 10.1111/liv.14837.

Geoffrey Dusheiko 1
 
23.Comparison of Novel Biomarkers with Conventional HBV Markers among Untreated Adults with Chronic Hepatitis B in North America
 

Hepatology. 2021 Jun 16. doi: 10.1002/hep.32018. Online ahead of print.

Marc G Ghany 1, Wendy C King 2, Mauricio Lisker-Melman 3, Anna Sf Lok 4, Norah Terrault 5, Harry L A Janssen 6, Mandana Khalili 7, Raymond T Chung 8, William M Lee 9, Daryl T Y Lau 10, Gavin A Cloherty 11, Richard K Sterling 12
 
24.Hepatitis B infections among blood donors in England between 2009 and 2018: Is an occult hepatitis B infection a risk for blood safety?
 

Transfusion. 2021 Jun 11. doi: 10.1111/trf.16543. Online ahead of print.

Heli Harvala 1 2, Claire Reynolds 3, Zoë Gibney 4, Jade Derrick 5, Samreen Ijaz 5, Katy L Davison 4, Su Brailsford 1 3
 
25.Hepatitis B and Hepatitis C among Adults on Probation or Parole in the United States: 2015-2018
 

J Health Care Poor Underserved. 2021;32(2):671-679. doi: 10.1353/hpu.2021.0096.

Greta Kilmer, Elizabeth Hughes
 
26.Prevalence of Hepatitis B Virus (HBV) Infection, Vaccine-Induced Immunity, and Susceptibility among At-Risk Populations: U.S. Households, 2013-2018
 

Hepatology. 2021 Jun 7. doi: 10.1002/hep.31991. Online ahead of print.

Henry Roberts 1, Kathleen N Ly 1, Shaoman Yin 1, Elizabeth Hughes 1, Eyasu Teshale 1, Ruth Jiles 1
 
27.Covalently closed circular DNA: the ultimate therapeutic target for curing Hepatitis B virus infections
 

J Hepatol. 2021 May 26;S0168-8278(21)00348-2. doi: 10.1016/j.jhep.2021.05.013.Online ahead of print.

Maria Guadalupe Martinez 1, Anders Boyd 2, Emmanuel Combe 1, Barbara Testoni 1, Fabien Zoulim 3
 
28.Safety and Effectiveness of Tenofovir Alafenamide in Usual Clinical Practice Confirms Results of Clinical Trials: TARGET-HBV
 

Dig Dis Sci. 2021 May 31. doi: 10.1007/s10620-021-07033-y. Online ahead of print.

David E Bernstein 1, Huy N Trinh 2, Eugene R Schiff 3, Coleman I Smith 4, Andrea R Mospan 5, Richard C Zink 5, Michael W Fried 5, Anna S Lok 6
 
29.Common concerns, barriers to care, and the lived experience of individuals with hepatitis B: a qualitative study
 

BMC Public Health. 2021 May 28;21(1):1004. doi: 10.1186/s12889-021-11093-0.

Catherine Freeland 1 2, Sean Farrell 3 4, Priyanka Kumar 3 5, Maureen Kamischke 6, Michaela Jackson 6, Sierra Bodor 6, Timothy M Block 6, Rosemary Frasso 3, Chari Cohen 6
 
30.An Updated Assessment of Chronic Hepatitis B Prevalence Among Foreign-Born Persons Living in the United States
 

Hepatology. 2021 Mar 3. doi: 10.1002/hep.31782. Online ahead of print.

Robert J Wong 1 2, Carol L Brosgart 3, Sue Welch 4, Tim Block 5 6, Mark Chen 4, Chari Cohen 5 6, W Ray Kim 1, Kris V Kowdley 7, Anna S Lok 8, Naoky Tsai 9, John Ward 10, Steven S Wong 4, Robert G Gish 5
 
31.Low Rates of Hepatitis B Virus Treatment Among Treatment-Eligible Patients in Safety-Net Health Systems
 

J Clin Gastroenterol. 2021 Mar 17. doi: 10.1097/MCG.0000000000001530. Online ahead of print.

Robert J Wong 1, Mamta K Jain, George Therapondos, Bolin Niu, Onkar Kshirsagar, Mae Thamer
 
32.Low Prevalence of Vaccination or Documented Immunity to Hepatitis A and Hepatitis B Viruses Among Individuals with Chronic Liver Disease
 

Am J Med. 2021 Mar 26;S0002-9343(21)00159-5. doi: 10.1016/j.amjmed.2021.02.008. Online ahead of print.

Robert J Wong 1, Robert G Gish 2, Ramsey Cheung 3, Amit S Chitnis 4
 
33.Antiviral Therapy Reduces Risk of Cirrhosis in Noncirrhotic HBV Patients Among 4 Urban Safety-Net Health Systems
 

Am J Gastroenterol. 2021 Mar 1. doi: 10.14309/ajg.0000000000001195. Online ahead of print.

Robert J Wong 1, Mamta K Jain, George Therapondos, Bolin Niu, Onkar Kshirsagar, Mae Thamer
 
34.Estimating Prevalence of Hepatitis B Virus Coinfection Among Adults With Tuberculosis: A Systematic Review With Meta-analysis
 

J Clin Gastroenterol. 2021 Apr 9. doi: 10.1097/MCG.0000000000001533. Online ahead of print.

Robert J Wong 1, Ashley Hubbard, Laurie Bagley, Rita Shiau, Amit S Chitnis
 
35.Estimating the attributable fraction of cirrhosis and hepatocellular carcinoma due to hepatitis B and C
 

J Viral Hepat. 2021 May 18. doi: 10.1111/jvh.13545. Online ahead of print.

Erika Duffell 1, Helena Cortez-Pinto 2, Marieta Simonova 3, Olav Dalgard 4, Elin Hoffmann Dahl 5, Catherine de Martel 6, Antons Mozalevskis 7, Maria Buti 8, Slava Pavlova 3, Tnaiq Hadzhilova 3, Carolina Simões 2, Krum Katzarov 3, Otilia Mardh 1
 
36.Haemodialysis patients show a highly diminished antibody response after COVID-19 mRNA vaccination compared to healthy controls
 

Nephrol Dial Transplant. 2021 May 17;gfab179. doi: 10.1093/ndt/gfab179. Online ahead of print.

Benedikt Simon 1, Harald Rubey 1, Andreas Treipl 2, Martin Gromann 2, Boris Hemedi 3, Sonja Zehetmayer 4, Bernhard Kirsch 2
 
37.Hepatitis B and C among patients with hidradenitis suppurativa: a population-based study
 

Int J Dermatol. 2021 May 17. doi: 10.1111/ijd.15578. Online ahead of print.

Jeffrey M Cohen 1, Khalaf K Kridin 2, Lourdes M Perez-Chada 3, Joseph F Merola 3 4, Arnon D Cohen 5 6
 
38.Therapeutic vaccination for treatment of Chronic Hepatitis B
 

Clin Exp Immunol. 2021 May 9. doi: 10.1111/cei.13614. Online ahead of print.

Tamsin Cargill 1 2, Eleanor Barnes 1 2 3
 
39.High Rates of Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Metabolic and Cardiovascular Comorbidities
 

Microorganisms. 2021 Apr 30;9(5):968. doi: 10.3390/microorganisms9050968.

Jan-Hendrik Bockmann 1 2, Matin Kohsar 1, John M Murray 3, Vanessa Hamed 1, Maura Dandri 1 2, Stefan Lüth 4, Ansgar W Lohse 1 2, Julian Schulze-Zur-Wiesch 1 2

 
 
40.Cost-Effectiveness of One-Time Universal Screening for Chronic Hepatitis B Infection in Adults in the United States
 

Clin Infect. 2021 May 6;ciab405.doi: 10.1093/cid/ciab405. Online ahead of print.

Mehlika Toy 1, David Hutton 2, Aaron M Harris 3, Noele Nelson 3, Joshua A Salomon 4, Samuel So 1
 
41.Characteristics Associated with Monitoring and Treatment of Chronic Hepatitis B in a Large Cohort of Australian Adults
 

Dig Dis Sci. 2021 May 4. doi: 10.1007/s10620-021-07008-z. Online ahead of print.

Wen-Qiang He 1, Gail V Matthews 2, Bette Liu 3
 
42.Challenges in Formulation and Implementation of Hepatitis B Elimination Programs
 

Cureus. 2021 Apr 24;13(4):e14657. doi: 10.7759/cureus.14657.

Zaigham Abbas 1, Minaam Abbas 2
 
43.Robust hepatitis B vaccine-reactive T cell responses in failed humoral immunity
 

Mol Ther Methods Clin Dev. 2021 Mar 23;21:288-298. doi:10.1016/j.omtm.2021.03.012.eCollection 2021 Jun 11.

Gounwa Awad 1, Toralf Roch 1 2, Ulrik Stervbo 1, Sviatlana Kaliszczyk 1 2, Anna Stittrich 2 3, Jan Hörstrup 4, Ocan Cinkilic 5, Heiner Appel 6, Larysa Natrus 7, Ludmila Gayova 7, Felix Seibert 1, Frederic Bauer 1, Timm Westhoff 1, Mikalai Nienen 2 3 8, Nina Babel 1 2
 
44.Trends in Prevalence and Characteristics of Resolved and Current Hepatitis B among US-Born Persons: National Health and Nutrition Examination Survey, 2001-2018
 

J Infect Dis. 2021 Apr 27;jiab224. doi: 10.1093/infdis/jiab224. Online ahead of print.

Kathleen N Ly 1, Jian Xing 1, Philip R Spradling 1
 
45.Clinical Significance of Quantitative e Antigen in a Cohort of Hepatitis B Virus Infected Children and Adults in North America
 

J Viral Hepat. 2021 Apr 24. doi: 10.1111/jvh.13520. Online ahead of print.

Stewart L Cooper 1, Wendy C King 2, Douglas B Mogul 3, Marc G Ghany 4, Kathleen B Schwarz 3, Hepatitis B Research Network (HBRN)

 

  • Hepatitis B Research Network (HBRN): 

Daryl T-Y Lau, Raymond T Chung, Lewis R Roberts, Mohamed A Hassan, Sarah Jane Schwarzenberg, Adrian M Di Bisceglie, Mauricio Lisker-Melman, Jeffrey Teckman, Harry L A Janssen, David K Wong, Joshua Juan, Jordan Feld, Colina Yim, Keyur Patel, Simon C Ling, William M Lee, Carol S Murakami, Robert Perrillo, Son Do, Norberto Rodriguez-Baez, Steven-Huy B Han, Tram T Tran, Norah A Terrault, Mandana Khalili, Philip Rosenthal, Anna Suk-Fong Lok, Robert J Fontana, Naoky Tsai, Barak Younoszai, Michael W Fried, Andrew Muir, Donna Evon, Jama M Darling, Robert C Carithers, Margaret Shuhart, Kris V Kowdley, Chia C Wang, Karen F Murray, Richard K Sterling, Velimir A Luketic, T Jake Liang, Jay H Hoofnagle, Edward Doo, Kyong-Mi Chang, Jang-June Park, Steven H Belle, Abdus Wahed, David Kleiner
 
46.Hepatitis B virus resistance to tenofovir: fact or fiction? A systematic literature review and structural analysis of drug resistance mechanisms
 

Wellcome Open Res. 2020 Jun 29;5:151. doi: 10.12688/wellcomeopenres.15992.1.eCollection 2020.

Jolynne Mokaya 1, Anna L McNaughton 1, Phillip A Bester 2, Dominique Goedhals 2, Eleanor Barnes 1 3 4, Brian D Marsden 5 6, Philippa C Matthews 1 4 7
 
47.Hepatitis B Reactivation: A Review of Clinical Guidelines
 

J Clin Gastroenterol. 2021 May-Jun 01;55(5):393-399. doi: 10.1097/MCG.0000000000001520.

Yun Wang 1, Steven-Huy B Han 2
 
48.Hepatitis D virus and liver transplantation: Indications and outcomes
 

World J Hepatol. 2021 Mar 27;13(3):291-299. doi: 10.4254/wjh.v13.i3.291.

Haris Muhammad 1, Aniqa Tehreem 2, Muhammad Baraa Hammami 3, Peng-Sheng Ting 3, Ramzan Idilman 4, Ahmet Gurakar 5
 
49.Hepatitis B Reactivation: A Review of Clinical Guidelines
 

J Clin Gastroenterol. 2021 May-Jun 01;55(5):393-399. doi: 10.1097/MCG.0000000000001520.

Yun Wang 1, Steven-Huy B Han 2
 
50.Low Prevalence of Vaccination or Documented Immunity to Hepatitis A and Hepatitis B Viruses Among Individuals with Chronic Liver Disease
 

Am J Med. 2021 Mar 25;S0002-9343(21)00159-5. doi: 10.1016/j.amjmed.2021.02.008.Online ahead of print.

Robert J Wong 1, Robert G Gish 2, Ramsey Cheung 3, Amit S Chitnis 4
 
51.Chronic Hepatitis B and HIV Coinfection: A Continuing Challenge in the Era of Antiretroviral Therapy
 

Curr Hepatol Rep. 2020 Dec;19(4):345-353. doi: 10.1007/s11901-020-00541-x.Epub 2020 Sep 16.

H Nina Kim 1 2
 
52.Clinical utility of quantifying hepatitis B surface antigen in African patients with chronic hepatitis B
 

J Viral Hepat. 2021 Mar 22. doi: 10.1111/jvh.13499. Online ahead of print.

Gerrit Post 1, Jess Howell 2, Amina Sow 3, Gibril Ndow 4, Isabelle Chemin 5, Gora Lo 3, Amie Cessay 4, Damien Cohen 5, Ramou Njie 6, Souleymane Toure 7, Madoky Diop 7, Roger Sombie 8, Jean Nana 9, Vincent Leroy 9, Karine Lacombe 10, Lamin Bojang 4, Frank Tacke 1, Coumba Toure-Kane 3, Mourtalla Ka 7, Maimuna Mendy 6, Souleymane Mboup 3, Mark Thursz 11, Yusuke Shimakawa 12, Patrick Ingiliz 1 13, Maud Lemoine 11
 
53.A Prospective Study Evaluating Changes in Histology, Clinical and Virologic Outcomes in HBV-HIV Co-infected Adults in North America
 

Hepatology. 2021 Mar 20. doi: 10.1002/hep.31823. Online ahead of print.

Richard K Sterling 1, Wendy C King 2, Mandana Khalili 3, Raymond T Chung 4, Mark Sulkowski 5, Mamta K Jain 6, Mauricio Lisker-Melman 7, Marc G Ghany 8, David K Wong 9, Amanda S Hinerman 2, Atul K Bhan 4, Abdus S Wahed 2, David E Kleiner 8, HIV-HBV Cohort Study of the Hepatitis B Research Network
 
54.Process and operations strategies to enable global access to antibody therapies
 

Biotechnol Prog. 2021 Mar 8;e3139. doi: 10.1002/btpr.3139. Online ahead of print.

Brian Kelley 1, Todd Renshaw 1, Michael Kamarck 1
 
55.Acceptability and Feasibility of Home-Based Hepatitis B Screening Among Haitian Immigrants
 

J Immigr Minor Health. 2021 Mar 9. doi: 10.1007/s10903-021-01165-z. Online ahead of print.

Patricia D Jones 1 2, Kristin Gmunder 3, Saradjine Batrony 3, Paul Martin 3 4, Erin Kobetz 3 5, Olveen Carrasquillo 3 6
 
56.Clinical and occupational health management of healthcare workers living with chronic hepatitis B: UK policy and international comparisons
 

J Viral Hepat. 2021 Mar 4. doi: 10.1111/jvh.13494. Online ahead of print.

Grace E Dolman 1, Apostolos Koffas 2, Emily Phipps 3, Patrick T F Kennedy 1
 
57.Multicenter Evaluation of the Cepheid Xpert ® HBV Viral Load Test
 

Diagnostics (Basel). 2021 Feb 12;11(2):297. doi: 10.3390/diagnostics11020297.

Fabbio Marcuccilli 1, Stephane Chevaliez 2, Thomas Muller 3, Luna Colagrossi 4, Giulia Abbondanza 1, Kurt Beyser 3, Mélanie Wlassow 2, Valérie Ortonne 2, Carlo Federico Perno 4, Marco Ciotti 1
 
58.Hepatitis B Virus DNA Integration and Clonal Expansion of Hepatocytes in the Chronically Infected Liver
 

Viruses. 2021 Jan 30;13(2):210.doi: 10.3390/v13020210.

William S Mason 1, Allison R Jilbert 2, Samuel Litwin 1
 
59.Human antiviral B cell responses: Emerging lessons from hepatitis B and COVID-19
 

Immunol Rev. 2021 Feb 8. doi: 10.1111/imr.12953. Online ahead of print.

Alice R Burton 1, Mala K Maini 1
 
60.Case Report: Application of hepatitis B virus (HBV) deep sequencing to distinguish between acute and chronic infection
 

Wellcome Open Res. 2021 Jan 25;5:240.doi: 10.12688/wellcomeopenres.16157.2. eCollection 2020.

Louise O Downs 1 2, Anna L McNaughton 2, Mariateresa de Cesare 3, M Azim Ansari 3, Jacqueline Martin 4, Charles Woodrow 1, Rory Bowden 3, Jane Collier 4, Eleanor Barnes 2 4 5, Philippa C Matthews 1 2 5
 
61.Urinary Polycyclic Aromatic Hydrocarbons Concentrations and Hepatitis B Antibody Serology in the United States (NHANES, 2003-2014)
 

Environ Res. 2021 Feb 1;110801. doi: 10.1016/j.envres.2021.110801. Online ahead of print.

Faye V Andrews 1, Ellen Smit 2, Barrett M Welch 3, Sharia M Ahmed 4, Molly L Kile 2
 
62.Hepatitis B Core-Related Antigen as Surrogate Biomarker of Intrahepatic Hepatitis B Virus Covalently-Closed-Circular DNA in Patients with Chronic Hepatitis B: A Meta-Analysis
 

Diagnostics (Basel). 2021 Jan 28;11(2):187. doi: 10.3390/diagnostics11020187.

Gian Paolo Caviglia 1, Angelo Armandi 1, Chiara Rosso 1, Davide Giuseppe Ribaldone 1, Rinaldo Pellicano 2, Sharmila Fagoonee 3
 
63.The Estimated Direct Lifetime Medical Costs of Sexually Transmitted Infections Acquired in the United States in 2018
 

Sex Transm Dis. 2021 Jan 23. doi: 10.1097/OLQ.0000000000001380. Online ahead of print.

Harrell W Chesson 1, Ian H Spicknall, Adrienna Bingham, Marc Brisson, Samuel T Eppink, Paul G Farnham, Kristen M Kreisel, Sagar Kumar, Jean-François Laprise, Thomas A Peterman, Henry Roberts, Thomas L Gift
 
64.Incidence and Prevalence of Sexually Transmitted Hepatitis B, United States, 2013 – 2018
 

Sex Transm Dis. 2021 Jan 23. doi: 10.1097/OLQ.0000000000001359. Online ahead of print.

Henry Roberts 1, Ruth Jiles, Aaron M Harris, Neil Gupta, Eyasu Teshale
 
65.Hepatitis B Virus Reactivation in Cancer Patients Treated With Immune Checkpoint Inhibitors
 

J Immunother. 2021 Jan 19. doi: 10.1097/CJI.0000000000000358. Online ahead of print.

Ethan A Burns 1, Ibrahim N Muhsen, Kartik Anand, Jiaqiong Xu, Godsfavour Umoru, Abeer N Arain, Maen Abdelrahim
 
66.Test to Protect Family and Self-A Hepatitis B Screening and Care-Linkage Initiative in the Coastal Mississippi Vietnamese Community
 

J Health Care Poor Underserved. 2020;31(3):1228-1247. doi: 10.1353/hpu.2020.0091.

Tanya T Funchess, Danielle Fastring, Victor Sutton, Victoria Walker, Daniel Le
 
67.Improving Hepatitis B Care in the US: A Case for a New "Ryan White" Program
 

J Health Care Poor Underserved. 2020;31(3):1037-1043. doi: 10.1353/hpu.2020.0077.

Jonathan D Alpern, Thomas M Leventhal, Nathan C Bahr
 
68.The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection
 

BMJ Glob Health. 2021 Jan;6(1):e004275. doi: 10.1136/bmjgh-2020-004275.

Caitlin M Pley 1, Anna L McNaughton 2, Philippa C Matthews 2 3, José Lourenço 4
 
69.Reduced immune responses to hepatitis B primary vaccination in obese individuals with nonalcoholic fatty liver disease (NAFLD)
 

NPJ Vaccines. 2021 Jan 11;6(1):9. doi: 10.1038/s41541-020-00266-4.

Shivali S Joshi 1, Rachelle P Davis 2, Mang M Ma 3, Edward Tam 4, Curtis L Cooper 5, Alnoor Ramji 6, Erin M Kelly 5, Saumya Jayakumar 1 7, Mark G Swain 1, Craig N Jenne 2, Carla S Coffin 8
 
70.Rapid and high seroprotection rates achieved with a tri-antigenic Hepatitis B vaccine in healthy young adults: Results from a Phase IV study
 

Vaccine. 2021 Jan 12;S0264-410X(20)31630-3. doi: 10.1016/j.vaccine.2020.12.050.Online ahead of print.

Jacob Atsmon 1, Nathalie Machluf 2, Vered Yagon-Gur 2, Cyril Sabbah 2, Johanna N Spaans 3, Bebi Yassin-Rajkumar 3, David E Anderson 3, Vlad Popovic 3, Francisco Diaz-Mitoma 4
 
71.The global burden of chronic hepatitis B virus infection: comparison of country-level prevalence estimates from four research groups
 

Int J Epidemiol. 2020 Dec 27;dyaa253. doi: 10.1093/ije/dyaa253. Online ahead of print.

Nora Schmit 1, Shevanthi Nayagam 1 2, Mark R Thursz 2, Timothy B Hallett 1
 
72.Adherence to pregnancy hepatitis B care guidelines in women and infants in the and evaluation of two interventions to improve care: a multi-center hospital-based study
 

J Viral Hepat. 2020 Dec 29. doi: 10.1111/jvh.13459. Online ahead of print.

Tatyana Kushner 1, Elianna Kaplowitz 2, Rena Mei 3, Chelsea Xu 4, Alex Acker 5, Emma Rosenbluth 1, Igbagbosanmi Oredein 4, Monika Sarkar 4, Norah Terrault 6, Meena Bansal 1, Kimberly A Forde 7 8
 
73.Screening for Hepatitis B Virus Infection in Nonpregnant Adolescents and Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
 

JAMA. 2020 Dec 15;324(23):2423-2436. doi: 10.1001/jama.2020.19750.

Roger Chou 1 2, Ian Blazina 1, Christina Bougatsos 1, Rebecca Holmes 1, Shelley Selph 1 3, Sara Grusing 1, Janice Jou 1 4
 
74.Screening for Hepatitis B Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement
 

JAMA. 2020 Dec 15;324(23):2415-2422. doi: 10.1001/jama.2020.22980.

US Preventive Services Task Force; Alex H Krist 1 2, Karina W Davidson 3, Carol M Mangione 4, Michael J Barry 5, Michael Cabana 6, Aaron B Caughey 7, Katrina Donahue 8, Chyke A Doubeni 9, John W Epling Jr 10, Martha Kubik 11, Gbenga Ogedegbe 12, Douglas K Owens 13, Lori Pbert 14, Michael Silverstein 15, Melissa A Simon 16, Chien-Wen Tseng 17 18, John B Wong 19
 
75.Development and validation of a hepatitis B-specific health-related quality of life instrument: CLDQ-HBV
 

J Viral Hepat. 2020 Dec 11. doi: 10.1111/jvh.13451. Online ahead of print.

Zobair M Younossi 1, Maria Stepanova 2, Issah Younossi 2, Andrei Racila 1
 
76.New Insights on Long-Term Hepatitis B Virus Responses in HIV-Hepatitis B virus Co-infected Patients: Implications for Antiretroviral Management in Hepatitis B virus-Endemic Settings
 

J Acquir Immune Defic Syndr. 2021 Jan 1;86(1):98-103. doi: 10.1097/QAI.0000000000002517.

David Dunn 1 2, Huw Price 1, Tobias Vudriko 3, Cissy Kityo 4, Godfrey Musoro 5, James Hakim 5, Charles Gilks 6, Pontiano Kaleebu 3, Deenan Pillay 7, Richard Gilson 1, DART Virology Group
 
77.Distinct Hepatitis B and HIV co-infected populations in Canada
 

J Viral Hepat. 2020 Dec 11. doi: 10.1111/jvh.13453. Online ahead of print.

Curtis Cooper 1, Matt Driedger 1, David Wong 2, Sarah Haylock-Jacobs 3, Abdel Aziz Shaheen 3, Carla Osiowy 4, Scott Fung 2, Karen Doucette 5, Alexander Wong 6, Lisa Barrett 7, Brian Conway 8, Alnoor Ramji 9, Gerald Minuk, Giada Sebastiani, Philip Wong, Carla S Coffin 3
 
78.Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta-analysis
 

J Viral Hepat. 2020 Dec 10. doi: 10.1111/jvh.13452. Online ahead of print.

Cori Campbell 1, Tingyan Wang 1, Anna L McNaughton 1, Eleanor Barnes 1, Philippa C Matthews 1 2 3
 
79.Global Occurrence of Clinically Relevant Hepatitis B Virus Variants as Found by Analysis of Publicly Available Sequencing Data
 

Viruses. 2020 Nov 23;12(11):1344. doi: 10.3390/v12111344.

Stoyan Velkov 1, Ulrike Protzer 1 2, Thomas Michler 1 2
 
80.Host RNA quality control as a hepatitis B antiviral target
 

Antiviral Res. 2020 Nov 23;104972. doi: 10.1016/j.antiviral.2020.104972.Online ahead of print.

Timothy M Block 1, John A T Young 2, Hassan Javanbakht 3, Michael J Sofia 4, Tianlun Zhou 5
 
81.Assessing the cost-utility of preferentially administering Heplisav-B vaccine to certain populations
 

Vaccine. 2020 Nov 4;S0264-410X(20)31387-6. doi: 10.1016/j.vaccine.2020.10.067.Online ahead of print.

Elizabeth M Rosenthal 1, Eric W Hall 2, Eli S Rosenberg 3, Aaron Harris 4, Noele P Nelson 4, Sarah Schillie 4
 
82.Real world application of the Xpert® HBV Viral Load assay on serum and dried blood spots
 

J Med Virol. 2020 Nov 11. doi: 10.1002/jmv.26662. Online ahead of print.

Kathy Jackson 1, Rosemary Tekoaua 2, Xin Li 1, Stephen Locarnini 1
 
83.Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Adults with Chronic Viral Hepatitis and Adults with Cirrhosis Secondary to Hepatitis B, C and Nonalcoholic Steatohepatitis
 

Drug Saf. 2020 Nov 3. doi: 10.1007/s40264-020-01014-2. Online ahead of print.

William R Treem 1, Melissa Palmer 2 3, Isabelle Lonjon-Domanec 4, Daniel Seekins 5, Lara Dimick-Santos 6, Mark I Avigan 6, John F Marcinak 7, Ajit Dash 8, Arie Regev 9, Eric Maller 10 11, Meenal Patwardhan 7, James H Lewis 12, Don C Rockey 13, Adrian M Di Bisceglie 14, James W Freston 15, Raul J Andrade 16, Naga Chalasani 17
 
84.Talking testing: Impact of a training intervention on midwives' antenatal HIV, hepatitis B and hepatitis C screening practice
 

Women Birth. 2020 Nov 3;S1871-5192(20)30358-9. doi: 10.1016/j.wombi.2020.10.001.Online ahead of print.

Jen Johnson 1, Caroline Carr 2, Susan J McDonald 3, Margaret M Flood 4
 
85.Hepatitis B Surface Antibody Titers and Hepatitis B Reactivation with Direct-Acting Antiviral Therapy for Hepatitis C
 

J Viral Hepat. 2020 Oct 12. doi: 10.1111/jvh.13421. Online ahead of print.

Shiva Poola 1, Sirish Sanaka 1, Kerry Sewell 2, Hans L Tillmann 1 3 4 5
 
86.We Are All Africans: A Highly Personal Migratory View of the History of Hepatitis B
 

Clin Liver Dis (Hoboken). 2020 Oct 7;16(Suppl 1):24-33. doi: 10.1002/cld.989.eCollection 2020 Oct.

Robert G Gish 1 2
 
87.Variations in Hepatitis B Vaccine Series Completion by Setting Among Adults at Risk in West Virginia
 

Am J Prev Med. 2020 Oct 1;S0749-3797(20)30272-5. doi: 10.1016/j.amepre.2020.05.022.Online ahead of print.

Stacy Tressler 1, Christa Lilly 2, Diane Gross 3, Thomas Hulsey 4, Judith Feinberg 5
 
88.Heplisav-B: A Hepatitis B Vaccine With a Novel Adjuvant
 

Ann Pharmacother. 2020 Sep 28;1060028020962050. doi: 10.1177/1060028020962050.Online ahead of print.

Caroline R Champion 1
 
89.Documentation of Hepatitis B Immunity in Nursing Students
 

Nurs Educ Perspect. 2020 Sep 22. doi: 10.1097/01.NEP.0000000000000736.Online ahead of print.

Julie Kientz Elting 1
 
90.Concurrent Hepatitis C and B Virus and Human Immunodeficiency Virus Infections Are Associated With Higher Mortality Risk Illustrating the Impact of Syndemics on Health Outcomes
 

Open Forum Infect Dis. 2020 Aug 13;7(9):ofaa347. doi: 10.1093/ofid/ofaa347.eCollection 2020 Sep.

Zahid A Butt 1 2 3, Stanley Wong 2, Carmine Rossi 2, Mawuena Binka 2, Jason Wong 2 3, Amanda Yu 2, Maryam Darvishian 4, Maria Alvarez 2, Nuria Chapinal 4, Geoff Mckee 2, Mark Gilbert 2 3, Mark W Tyndall 3, Mel Krajden 2 3 5, Naveed Z Janjua 2 3
 
91.Low risk of hepatitis b reactivation in patients with severe COVID-19 who receive immunosuppressive therapy
 

J Viral Hepat. 2020 Sep 24. doi: 10.1111/jvh.13410. Online ahead of print.

Sergio Rodríguez-Tajes 1 2, Anna Miralpeix 1 2, Josep Costa 2 3, Ester López-Suñé 4, Montserrat Laguno 5, Anna Pocurull 1, Sabela Lens 1 2, Zoe Mariño 1 2, Xavier Forns 1 2
 
92.A global investment framework for the elimination of hepatitis B
 

J Hepatol. 2020 Sep 21;S0168-8278(20)33625-4. doi: 10.1016/j.jhep.2020.09.013.Online ahead of print.

Jessica Howell 1, Alisa Pedrana 2, Sophia E Schroeder 2, Nick Scott 2, Lisa Aufegger 3, Rifat Atun 4, Ricardo Baptista-Leite 5, Gottfried Hirnschal 6, Ellen 't Hoen 7, Sharon J Hutchinson 8, Jeffrey V Lazarus 9, Lesi Olufunmilayo 10, Raquel Peck 11, Manik Sharma 12, Annette H Sohn 13, Alexander Thompson 14, Mark Thursz 15, David Wilson 2, Margaret Hellard 16
 
93.Human Papillomavirus, Herpes Zoster, and Hepatitis B Vaccinations in Immunocompromised Patients: An Update for Pharmacists
 

J Pharm Pract. 2020 Sep 17;897190020958261. doi: 10.1177/0897190020958261.Online ahead of print.

Michelle R Paulsen 1, Nikitha R Patel 2, Carol Sulis 3, Francis A Farraye 4, Shubha Bhat 2
 
94.medLow Incidence of Adverse Outcomes in Adults with Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy
 

Hepatology. 2020 Sep 16.doi: 10.1002/hep.31554. Online ahead of print.

Anna S Lok 1, Robert Perrillo 2, Christina M Lalama 3, Michael W Fried 4, Steven H Belle 5, Marc G Ghany 6, Mandana Khalili 7, Robert J Fontana 1, Richard K Sterling 8, Norah Terrault 9, Jordan J Feld 10, Adrian M Di Bisceglie 11, Daryl T Y Lau 12, Mohamed Hassan 13, Harry L A Janssen 14, Hepatitis B Research Network (HBRN)

Collaborators

  • Hepatitis B Research Network (HBRN): 

Raymond T Chung, Lewis R Roberts, Mauricio Lisker-Melman, David K Wong, Joshua Juan, Colina Yim, Keyur Patel, William M Lee, Carol S Murakami, Son Do, Steven-Huy B Han, Tram T Tran, Stewart L Cooper, Naoky Tsai, Barak Younoszai, Andrew Muir, Donna Evon, Jama M Darling, Robert C Carithers, Kris V Kowdley, Chia C Wang, Velimir A Luketic, T Jake Liang, Jay H Hoofnagle, Edward Doo, Kyong-Mi Chang, Jang-June Park, Abdus Wahed, Wendy C King, David Kleiner
 
95.Towards Genotype-Specific Care for Chronic Hepatitis B: The First 6 Years Follow Up From the CHARM Cohort Study
 

Open Forum Infect Dis. 2019 Nov 3;6(11):ofz469. doi: 10.1093/ofid/ofz469.eCollection 2019 Nov.

Jane Davies 1 2, Emma L Smith 2, Margaret Littlejohn 3, Rosalind Edwards 3, Vitina Sozzi 3, Kathy Jackson 3, Katie Mcguire 1, Paula Binks 1, Benjamin C Cowie 4 5, Stephen Locarnini 3, Joshua S Davis 1 6, Steven Y C Tong 1 7 8
 
96.Comparison of 48-week efficacy of tenofovir vs entecavir for patients with chronic hepatitis B: A network meta-analysis
 

J Viral Hepat. 2020 Sep 7. doi: 10.1111/jvh.13400. Online ahead of print.

Danny Con 1, Thomas Goodwin 2, Ammar Majeed 2 3, Stuart Roberts 2 3, William Kemp 2 3
 
97.HIV-, HBV-, and HCV-Related Information on U.S. Fertility Clinic Websites: A Content Analysis
 

Health Equity. 2020 Aug 14;4(1):345-352. doi: 10.1089/heq.2019.0100. eCollection 2020.

Margot Kelly-Hedrick 1, Marielle S Gross 2
 
98.Improving uptake of hepatitis B and hepatitis C testing in South Asian migrants in community and faith settings using educational interventions - a prospective descriptive study
 

Int J Infect Dis. 2020 Aug 27;S1201-9712(20)30689-5. doi: 10.1016/j.ijid.2020.08.059.Online ahead of print.

Claire Kelly 1, Marinos Pericleous 1, Ayesha Ahmed 2, Tushna Vandrevala 3, Jane Hendy 2, Shuja Shafi 4, Simon Skene 5, Sumita Verma 6, Chantal Edge 7, Margot Nicholls 8, Charles Gore 9, Simon de Lusignan 10, Aftab Ala 11
 
99.Very low probability of significant liver inflammation in chronic hepatitis B patients with low ALT levels in the absence of liver fibrosis
 

Aliment Pharmacol Ther. 2020 Sep 4. doi: 10.1111/apt.16067. Online ahead of print.

Milan J Sonneveld 1, Willem P Brouwer 1, Bettina E Hansen 2, Henry L-Y Chan 3, Teerha Piratvisuth 4, Ji-Dong Jia 5, Stefan Zeuzem 6, Rong-Nan Chien 7, Hannah Choi 2, Robert J de Knegt 1, Cynthia Wat 8, Vedran Pavlovic 8, Anuj Gaggar 9, Qing Xie 10, Maria Buti 11, Robert A de Man 1, Harry L A Janssen 1 2, SONIC-B Study Group
 
100.Fatty Liver Disease in a Prospective North American Cohort of Adults with HIV and Hepatitis B Coinfection
 

Clin Infect Dis. 2020 Sep 1;ciaa1303. doi: 10.1093/cid/ciaa1303. Online ahead of print.

Mandana Khalili 1, Wendy C King 2, David E Kleiner 3, Mamta K Jain 4, Raymond T Chung 5, Mark Sulkowski 6, Mauricio Lisker-Melman 7, David K Wong 8, Marc Ghany 3, Arun Sanyal 9, Richard K Sterling 9, HIV-HBV Cohort Study of the Hepatitis B Research Network
 
101.Prevalence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in United States blood donations, 2015 to 2019: The Transfusion-Transmissible Infections Monitoring System (TTIMS)
 

Transfusion. 2020 Aug 31. doi: 10.1111/trf.16005. Online ahead of print.

Whitney R Steele 1, Roger Y Dodd 1, Edward P Notari 1, Meng Xu 1, Diane Nelson 1, Debra A Kessler 2, Rita Reik 3, Alan E Williams 4, Brian Custer 5, Susan L Stramer 1, Transfusion-Transmissible Infections Monitoring System (TTIMS)
 
102.The Yin and the Yang of Treatment for Chronic Hepatitis B-When to Start, When to Stop Nucleos(t)ide Analogue Therapy
 

Viruses. 2020 Aug 25;12(9):E934. doi: 10.3390/v12090934.

Samuel Hall 1, Jessica Howell 1, Kumar Visvanathan 2, Alexander Thompson 1
 
103.The hepatitis B care cascade using administrative claims data, 2016
 

Am J Manag Care. 2020 Aug;26(8):331-338.doi: 10.37765/ajmc.2020.44069.

Aaron M Harris 1, Ademola Osinubi, Noele P Nelson, William W Thompson
 
104.Trends in Hepatitis B Surveillance Among Pregnant Women in New York City, 1998-2015
 

Public Health Re. 2020 Aug 14;33354920946793. doi: 10.1177/0033354920946793.Online ahead of print.

Robert J Arciuolo 1 2, Julie E Lazaroff 1, Jennifer B Rosen 1, Sungwoo Lim 3, Jane R Zucker 1 4
 
105.Susceptibility to Hepatitis A and B Virus Among Clients at a Syringe Services Program in Philadelphia, 2018
 

Public Health Rep. 2020 Aug 13;33354920943528. doi: 10.1177/0033354920943528.Online ahead of print.

Mary Figgatt 1, Jack Hildick-Smith 1, Eman Addish 1, Jennie Coleman 2, José Benitez 2, Catherine Freeland 3, Steven Alles 1, Kendra Viner 1, Caroline Johnson 1, Danica Kuncio 1
 
106.New blood borne virus infections among organ transplant recipients: an Australian data-linked cohort study examining donor-transmissions and other HIV, hepatitis C and hepatitis B notifications, 2000-2015
 

Transpl Infect Dis. 2020 Aug 7;e13437. doi: 10.1111/tid.13437. Online ahead of print.

Karen Mj Waller 1, Nicole L De La Mata 1, James A Hedley 1, Brenda M Rosales 1 2, Michael J O'Leary, Elena Cavazzoni 3, Vidiya Ramachandran 4, William D Rawlinson 4 5, Patrick J Kelly 1, Kate R Wyburn 2 6, Angela C Webster 1 7
 
107.Hepatitis A and B Vaccination in the United States
 

R I Med J (2013). 2020 Aug 3;103(6):44-46.

Martha C Sanchez 1
 
108.Clinical Research in Hepatology in the COVID-19 Pandemic and Post-Pandemic Era: Challenges and the Need for Innovation
 

Hepatology. 2020 Aug 2. doi: 10.1002/hep.31491. Online ahead of print.

Elizabeth C Verna 1, Marina Serper 2, Jaime Chu 3, Kathleen Corey 4, Oren K Fix 5, Karen Hoyt 6, Kimberly A Page 7, Rohit Loomba 8, Ming Li 9, Gregory T Everson 10, Michael W Fried 11, Guadalupe Garcia-Tsao 12, Norah Terrault 9, Anna S Lok 13, Raymond T Chung 4, K Rajender Reddy 2
 
109.Hepatitis B Virus Mutant Infections in Hemodialysis Patients: A Case Series
 

Kidney Med. 2019 Oct 1;1(6):347-353. doi: 10.1016/j.xkme.2019.07.011.eCollection Nov-Dec 2019.

Ibironke W Apata 1 2, Duc B Nguyen 1, Yury Khudyakov 1, Tonya Mixson-Hayden 1, Jon Rosenberg 3, Matt Zahn 4, Jane Greenko 5, Ernest Clement 6, Allison E Portney 7 8, Prathit A Kulkarni 1 7, Maura Comer 9, Eleanor Adams 10, Saleem Kamili 1, Priti R Patel 1, Anne C Moorman 1
 
110.Do the most heavily burdened countries have the right policies to eliminate viral hepatitis B and C?
 

Lancet Gastroenterol Hepatol. 2020 Jul 27;S2468-1253(20)30011-X.doi: 10.1016/S2468-1253(20)30011-X. Online ahead of print.

Adam Palayew 1, Homie Razavi 2, Sharon J Hutchinson 3, Graham S Cooke 4, Jeffrey V Lazarus 5
 
111.Progress towards elimination goals for viral hepatitis
 

Nat Rev Gastroenterol Hepatol. 2020 Jul 23;1-10. doi: 10.1038/s41575-020-0332-6.Online ahead of print.

Andrea L Cox 1, Manal H El-Sayed 2, Jia-Horng Kao 3 4, Jeffrey V Lazarus 5, Maud Lemoine 6, Anna S Lok 7, Fabien Zoulim 8 9 10
 
112.Application of EASL 2017 criteria for switching hepatitis B patients from tenofovir disoproxil to entecavir or tenofovir alafenamide
 

Dig Liver Dis. 2020 Jul 20;S1590-8658(20)30322-4. doi: 10.1016/j.dld.2020.06.037.Online ahead of print.

Luisa Roade 1, Alessandro Loglio 2, Marta Borghi 2, Mar Riveiro-Barciela 1, Roberta Soffredini 2, Floriana Facchetti 2, Dhanai di Paolo 2, David Tabernero 3, Giovanna Lunghi 4, Rafael Esteban 1, Maria Buti 5, Pietro Lampertico 6
 
113.A Predictive Model for Hepatitis B Infection Among High-Risk Adults Using a Community-Based Sample in Greater Philadelphia
 

J Viral Hepat. 2020 Jul 23. doi: 10.1111/jvh.13365. Online ahead of print.

Catherine Freeland 1, Daniel Vader 2, Chari Cohen 3, Brandon George 4
 
114.Circulating Pregenomic HBV RNA is Primarily Full-length in Chronic Hepatitis B Patients Undergoing Nucleos(t)ide Analogue Therapy
 

Clin Infect Dis. 2020 Jul 20;ciaa1015. doi: 10.1093/cid/ciaa1015. Online ahead of print.

Mark Anderson 1, Jeffery Gersch 1, Ka-Cheung Luk 1, George Dawson 1, Ivana Carey 2, Kosh Agarwal 3, Pir Shah 4, Geoffrey Dusheiko 3, Daryl Lau 5, Gavin Cloherty 1
 
115.Hepatitis B seroprevalence in the U.S. military and its impact on potential screening strategies
 

Mil Med. 2020 Jul 10;usaa131. doi: 10.1093/milmed/usaa131. Online ahead of print.

Paul T Scott 1, Robert L Cohen 2 3, David M Brett-Major 4, Shilpa Hakre 1 5, Jennifer A Malia 1, Jason F Okulicz 6, Charmagne G Beckett 7, Jason M Blaylock 8, Michael A Forgione 6, Stephen A Harrison 6, Clinton K Murray 6, Francisco J Rentas 9, Roland L Fahie 9, Adam W Armstrong 10, Aatif M Hayat 2, Laura A Pacha 2 11, Peter Dawson 12, Beth Blackwell 12, Angelia A Eick-Cost 13 14, Hala H Maktabi 13 15, Nelson L Michael 1, Linda L Jagodzinski 1, Steven B Cersovsky 2, Sheila A Peel 1
 
116.Immunity to Hepatitis B Is Undetectable in the Majority of Adolescents and Young Adults Seeking Outpatient Medication Treatment for Opioid Use Disorder
 

J Addict Med. 2020 Jun 12. doi: 10.1097/ADM.0000000000000689. Online ahead of print.

Samuel W Stull 1, Erin R McKnight, Steven C Matson, Andrea E Bonny
 
117.ATI-2173, A Novel Liver-Targeted Non-Chain Terminating Nucleotide for HBV Cure Regimens
 

Antimicrob Agents Chemother. 2020 Jun 15;AAC.00836-20. doi: 10.1128/AAC.00836-20.Online ahead of print.

Katherine E Squires 1, Douglas L Mayers 1, Gregory R Bluemling 2, Alexander A Kolykhalov 2, David B Guthrie 2, Prabhakar Reddy 2, Debbie G Mitchell 2, Manohar T Saindane 2, Zachary M Sticher 2, Vindhya Edpuganti 2, Abel De La Rosa 1
 
118.Assessing Solid Organ Donors and Monitoring Transplant Recipients for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infection - U.S. Public Health Service Guideline, 2020
 

MMWR Recomm Rep. 2020 Jun 26;69(4):1-16. doi: 10.15585/mmwr.rr6904a1.

Jefferson M Jones, Ian Kracalik, Marilyn E Levi, James S Bowman 3rd, James J Berger, Danae Bixler, Kate Buchacz, Anne Moorman, John T Brooks, Sridhar V Basavaraju
 
119.Acute Hepatitis B Surge: Opioid Epidemic Implication and Management Challenges
 

Open Forum Infect Dis. 2020 May 23;7(6):ofaa190. doi: 10.1093/ofid/ofaa190.eCollection 2020 Jun.

Erik D Johansson 1, Marina Nunez 2
 
120.Evaluation of a Program to Improve Linkage to and Retention in Care Among Refugees With Hepatitis B Virus Infection - Three U.S. Cities, 2006-2018
 

MMWR Morb Mortal Wkly Rep. 2020 May 29;69(21):647-650doi: 10.15585/mmwr.mm6921a2.

Janine Young, Colleen Payton, Patricia Walker, Daniel White, Megan Brandeland, Gayathri S Kumar, Emily S Jentes, Ann Settgast, Malini DeSilva

Free PMC article
 
121.Association Between Seroclearance of Hepatitis B Surface Antigen and Long-term Clinical Outcomes of Patients With Chronic HBV Infection: Systematic Review and Meta-analysis
 

Clin Gastroenterol Hepatol. 2020 May 27;S1542-3565(20)30748-5.doi: 10.1016/j.cgh.2020.05.041. Online ahead of print.

Ryan T Anderson 1, Hannah S J Choi 2, Oliver Lenz 3, Marion G Peters 4, Harry L A Janssen 5, Poonam Mishra 6, Eric Donaldson 7, Gabriel Westman 8, Stephanie Buchholz 9, Veronica Miller 10, Bettina E Hansen 11
 
122.Care Quality and Outcomes Among U.S. Veterans With Chronic Hepatitis B in the Hepatitis C Direct Acting Antiviral Era
 

Viral Hepat. 2020 Jun 2. doi: 10.1111/jvh.13340. Online ahead of print.

David E Kaplan 1 2, Elina Medvedeva 2, Marina Serper 1 3 2
 
123.Should Treatment Indications for Chronic Hepatitis B Be Expanded?
 

Clin Gastroenterol Hepatol. 2020 May 17;S1542-3565(20)30677-7.doi: 10.1016/j.cgh.2020.04.091. Online ahead of print.

Wen-Juei Jeng 1, Anna S Lok 2
 
124.A Best Practice Alert for Identifying Hepatitis B-Infected Patients
 

Am J Trop Med Hyg 2020 May 18.doi: 10.4269/ajtmh.20-0041. Online ahead of print.

Malini DeSilva 1 2, Amy Kodet 2, Patricia Walker 3 1 2
 
125.Hepatitis B core-specific memory B cell responses associate with clinical parameters in patients with chronic HBV
 

Vanwolleghem T1, Groothuismink ZMA2, Kreefft K2, Hung M3, Novikov N3, Boonstra A2. J Hepatol. 2020 Feb 12. pii: S0168-8278(20)30071-4. doi: 10.1016/j.jhep.2020.01.024. [Epub ahead of print]
 
126.Hepatitis B: Current Status of Therapy and Future Therapies
 

Gastroenterol Clin North Am. 2020 Jun;49(2):215-238.doi: 10.1016/j.gtc.2020.01.003. Epub 2020 Mar 29.

Elias Spyrou 1, Coleman I Smith 2, Marc G Ghany 3
 
127.Impact of a Vaccine Intervention on County-Level Rates of Acute Hepatitis B in West Virginia, 2011-2018
 

Prev Med. 2020 Aug;137:106121. doi: 10.1016/j.ypmed.2020.106121. Epub 2020 May 8.

Stacy R Tressler 1, Gordon S Smith 2, Brian M Hendricks 2
 
128.The Lived Experience of Chronic Hepatitis B: A Broader View of Its Impacts and Why We Need a Cure
 

Viruses. 2020 May 7;12(5):E515.oi: 10.3390/v12050515.

Thomas Tu 1, Joan M Block 2, Su Wang 3 4, Chari Cohen 2, Mark W Douglas 1 5
 
129.Global Epidemiology of Viral Hepatitis
 

Gastroenterol Clin North Am. 2020 Jun;49(2):179-189.doi: 10.1016/j.gtc.2020.01.001.

Homie Razavi 1
 
130.Vitamin D and the Hepatitis B Vaccine Response: A Prospective Cohort Study and a Randomized, Placebo-Controlled Oral Vitamin D 3 and Simulated Sunlight Supplementation Trial in Healthy Adults
 

Nutr. 2020 May 10.doi: 10.1007/s00394-020-02261-w. Online ahead of print

Daniel S Kashi 1 2, Samuel J Oliver 3, Laurel M Wentz 4, Ross Roberts 1, Alexander T Carswell 1, Jonathan C Y Tang 5, Sarah Jackson 6, Rachel M Izard 7, Donald Allan 8, Lesley E Rhodes 9, William D Fraser 5, Julie P Greeves 5 6, Neil P Walsh 2
 
131.Adherence in Chronic Hepatitis B: Associations Between Medication Possession Ratio and Adverse Viral Outcomes
 

C Gastroenterol. 2020 May 7;20(1):140.doi: 10.1186/s12876-020-01219-w.

Nicole L Allard 1 2, Jennifer H MacLachlan 3 4, Anouk Dev 5, James Dwyer 6, Geeta Srivatsa 7, Timothy Spelman 4 8, Alexander J Thompson 4 9, Benjamin C Cowie 3 4
 
132.Prevalence and Clinical Features of Patients With Concurrent HBsAg and Anti-HBs: Evaluation of the Hepatitis B Research Network Cohort
 

J Viral Hepat. 2020 May 4.doi: 10.1111/jvh.13312. Online ahead of print.

William M Lee 1, Wendy C King 2, Kathleen B Schwarz 3, Jody Rule 1, Anna Sf Lok 4, HBRN Investigators
 
133.Assay for Hepatitis B Core-related Antigen Identify Patients With High Viral Load: Systematic Review and Meta-analysis of Individual Participant Data
 

Clin Gastroenterol Hepatol. 2020 Apr 29;S1542-3565(20)30590-5.doi: 10.1016/j.cgh.2020.04.045. Online ahead of print.

Kyoko Yoshida 1, Alice Desbiolles 2, Sarah F Feldman 2, Sang Hoon Ahn 3, Enagnon K Alidjinou 4, Masanori Atsukawa 5, Laurence Bocket 4, Maurizia R Brunetto 6, Maria Buti 7, Ivana Carey 8, Gian Paolo Caviglia 9, En-Qiang Chen 10, Markus Cornberg 11, Masaru Enomoto 12, Masao Honda 13, Christoph Höner Zu Siederdissen 11, Masatoshi Ishigami 14, Harry LA Janssen 15, Benjamin Maasoumy 11, Takeshi Matsui 16, Akihiro Matsumoto 17, Shuhei Nishiguchi 18, Mar Riveiro-Barciela 7, Akinobu Takaki 19, Pisit Tangkijvanich 20, Hidenori Toyoda 21, Margo Jh van Campenhout 22, Bo Wang 8, Lai Wei 23, Hwai-I Yang 24, Yoshihiko Yano 25, Hiroshi Yatsuhashi 26, Man-Fung Yuen 27, Eiji Tanaka 28, Maud Lemoine 1, Yasuhito Tanaka 29, Yusuke Shimakawa 30
 
134.Incidence and Factors Associated With HBV Relapse After Cessation of Entecavir or Tenofovir in Patients With HBsAg Below 100 IU/mL
 

Clin Gastroenterol Hepatol. 2020 Apr 29;S1542-3565(20)30534-6.doi: 10.1016/j.cgh.2020.04.037. Online ahead of print.

Tzu-Ning Tseng 1, Tsung-Hui Hu 1, Jing-Houng Wang 1, Yuan-Hung Kuo 1, Chao-Hung Hung 2, Sheng-Nan Lu 2, Wen-Juei Jeng 3, Chien-Hung Chen 4
 
135.Improving Birth Dose Hepatitis B Vaccination Rates: A Quality Improvement Intervention
 

Hosp Pediatr. 2020 May;10(5):430-437. doi: 10.1542/hpeds.2019-0294.

Chanda Bradshaw 1, Eileen DiFrisco 2, William Schweizer 3, Joy Pavsic 4, Kathleen Demarco 4, Jane Weckesser 4, Gabrielle Gold-VonSimson 5, Rebecca E Rosenberg 5
 
136.Hepatitis B Surface Antigen Seroclearance: Immune Mechanisms, Clinical Impact, Importance for Drug Development
 

J Hepatol. 2020 Apr 22;S0168-8278(20)30225-7. doi: 10.1016/j.jhep.2020.04.013.Online ahead of print.

Issam Tout 1, Dimitri Loureiro 1, Abdellah Mansouri 1, Vassili Soumelis 2, Nathalie Boyer 1, Tarik Asselah 3
 
137.Hbsag Levels Can Be Used to Rule Out Cirrhosis in Hbeag Positive Chronic Hepatitis B: Results From the Sonic-B Study
 

J Infect Dis. 2020 Apr 21;jiaa192 doi: 10.1093/infdis/jiaa192. Online ahead of print.

Milan J Sonneveld 1, Bettina E Hansen 2 3, Willem P Brouwer 1, Henry L-Y Chan 4, Teerha Piratvisuth 5, Ji-Dong Jia 6, Stefan Zeuzem 7, R N Chien 8, R J de Knegt 1, Cynthia Wat 9, Vedran Pavlovic 9, Anuj Gaggar 10, Qing Xie 11, Maria Buti 12, R A de Man 1, Harry L A Janssen 1 2, SONIC-B Study group
 
138.Hepatitis B Virus Seroepidemiology Data for Africa: Modelling Intervention Strategies Based on a Systematic Review and Meta-Analysis
 

PLoS Med. 2020 Apr 21;17(4):e1003068. doi: 10.1371/journal.pmed.1003068.eCollection 2020 Apr.

Anna L McNaughton 1, José Lourenço 2, Phillip Armand Bester 3, Jolynne Mokaya 1, Sheila F Lumley 1 4, Uri Obolski 5 6, Donall Forde 7, Tongai G Maponga 8, Kenneth R Katumba 9, Dominique Goedhals 3, Sunetra Gupta 2, Janet Seeley 9 10, Robert Newton 9 11, Ponsiano Ocama 12, Philippa C Matthews 1 4
 
139.Comparative Effectiveness of Entecavir vs Tenofovir for Preventing Hepatocellular Carcinoma in Patients With Chronic Hepatitis B: A Systematic Review and Meta-analysis
 

Hepatology. 2020 Apr 10. doi: 10.1002/hep.31267. Online ahead of print.

Shravan Dave 1, Sooyoung Park 1 2, M Hassan Murad 3, Abbey Barnard 1, Larry Prokop 4, Leon A Adams 5, Siddharth Singh 1, Rohit Loomba 
 
140.Longitudinal Analysis of Serum MicroRNAs as Predictors of Cirrhosis Regression During Treatment of Hepatitis B Virus Infection
 

Liver Int. 2020 Apr 16. doi: 10.1111/liv.14474. Online ahead of print.

Cody Orr 1, Rob Myers 2, Biao Li 2, Zhaoshi Jiang 2, John Flaherty 2, Anuj Gaggar 2, Eric G Meissner 1
 
141.Final Analysis of the International Observational S-Collate Study of Peginterferon alfa-2a in Patients With Chronic Hepatitis B
 

PloS One. 2020 Apr 10;15(4):e0230893. doi: 10.1371/journal.pone.0230893. eCollection 2020.

Patrick Marcellin 1, Qing Xie 2, Seung Woon Paik 3, Robert Flisiak 4, Teerha Piratvisuth 5, Jörg Petersen 6, Tarik Asselah 1, Markus Cornberg 7, Denis Ouzan 8, Graham R Foster 9, Georgios Papatheodoridis 10, Diethelm Messinger 11, Loredana Regep 12, Georgios Bakalos 13, Ulrich Alshuth 14, Pietro Lampertico 15, Heiner Wedemeyer 7
 
142.Statin and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus or Hepatitis C Virus Infection: A Meta-Analysis
 

BMC Gastroenterol. 2020 Apr 9;20(1):98.doi: 10.1186/s12876-020-01222-1.

Xiaofei Li 1, Lina Sheng 2, Liwen Liu 2, Yongtao Hu 2, Yongxin Chen 2, Lianqing Lou 2
 
143.Diagnosis Rates of Chronic Hepatitis B in Privately Insured Patients in the United States
 

 JAMANetw Open. 2020 Apr 1;3(4):e201844. doi: 10.1001/jamanetworkopen.2020.1844.

Eiichi Ogawa 1 2, Yee Hui Yeo 1, Nolan Dang 1, Michael H Le 1, Donghak Jeong 1, Sally Tran 1, Linda Henry 1, Ramsey Cheung 1 3, Mindie H Nguyen 1
 
144.Preferences of Patients with Chronic Hepatitis B - A Discrete Choice Experiment on the Acceptability of Functional Cure
 

Hardtstock F#1, Sbarigia U#2, Kocaata Z1, Wilke T1, Sylvester SV3. Patient Prefer Adherence. 2020 Mar 19;14:613-624. doi: 10.2147/PPA.S238833. eCollection 2020.
 
145.Hepatic Histology in Treatment-naïve Children With Chronic Hepatitis B Infection Living in the United States and Canada
 

Rodriguez-Baez N1, Murray KF2, Kleiner DE3, Ling SC4, Rosenthal P5, Carlin K6, Cooper K6, Schwarz KB7, Schwarzenberg SJ8, Teckman JH9, Ghany MG10, Alawad A10. J Pediatr Gastroenterol Nutr. 2020 Apr 3. doi: 10.1097/MPG.0000000000002712. [Epub ahead of print]
 
146.Patient Knowledge, Beliefs and Barriers to Hepatitis B Care: Results of a Multicenter, Multiethnic Patient Survey
 

Mukhtar NA1, Evon DM2, Yim C3, Lok AS4, Lisha N5, Lisker-Melman M6, Hassan M7, Janssen HLA3, Khalili M8. Dig Dis Sci. 2020 Apr 1. doi: 10.1007/s10620-020-06224-3. [Epub ahead of print]
 
147.Chronic Hepatitis B infection and the risk of gestational diabetes: a cross sectional study
 

Giles M1,2, Davey MA1, Wallace E1. BJOG. 2020 Mar 16. doi: 10.1111/1471-0528.16217. [Epub ahead of print]
 
148.Present and future management of viral hepatitis B and C in children
 

Clemente MG1, Antonucci R2, Sotgiu G2, Dettori M2, Piana A2, Vajro P3. Clin Res Hepatol Gastroenterol. 2020 Mar 12. pii: S2210-7401(20)30043-7. doi: 10.1016/j.clinre.2020.02.010. [Epub ahead of print]
 
149.Current practice and contrasting views on discontinuation of nucleos(t)ide analog therapy in chronic hepatitis B
 

Hadziyannis E1, Hadziyannis S1. Expert Rev Gastroenterol Hepatol. 2020 Apr;14(4):243-251. doi: 10.1080/17474124.2020.1738219. Epub 2020 Mar 12.
 
150.Hepatitis B prophylaxis in adolescents who present for examination after alleged sexual assault
 

Jones ME1,2,3, Tully JM1,2,3. J Paediatr Child Health. 2020 Mar 12. doi: 10.1111/jpc.14860. [Epub ahead of print]
 
151.Universal Screening and Vaccination for Hepatitis B in Pregnancy: The Time Is Now
 

Prabhu M1, Riley LE. Obstet Gynecol. 2020 Apr;135(4):808-811. doi: 10.1097/AOG.0000000000003706.
 
152.Barriers to Hepatitis B Screening and Prevention for African Immigrant Populations in the United States: A Qualitative Study
 

Freeland C1, Bodor S1, Perera U2, Cohen C1. Viruses. 2020 Mar 11;12(3). pii: E305. doi: 10.3390/v12030305.
 
153.Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
 

Chan TT1, Chan WK2, Wong GL1,3, Chan AW4, Nik Mustapha NR5, Chan SL6, Chong CC7, Mahadeva S2, Shu SS1,3, Lai PB7, Chan HL1,3, Wong VW1,3. Am J Gastroenterol. 2020 Mar 9. doi: 10.14309/ajg.0000000000000588. [Epub ahead of print]
 
154.A nomogram for discrimination of non-alcoholic fatty liver disease in patients with chronic hepatitis B
 

Chen Y1,2, Cao D2, Li C1,2, Zhang P1,2, Wang X1, Li N1, Han Q1, Liu Z1. Eur J Gastroenterol Hepatol. 2020 Feb 27. doi: 10.1097/MEG.0000000000001691. [Epub ahead of print]
 
155.Alcohol, tobacco and coffee consumption and liver disease severity among individuals with Chronic Hepatitis B infection in North America
 

Brahmania M1, Liu S2, Wahed AS3, Yim C1, Hansen BE4, Khalili M5, Terrault NA5, Lok AS6, Ghany M7, Wang J2, Wong D1, Janssen HLA8; Hepatitis B Research Network. Ann Hepatol. 2020 Feb 8. pii: S1665-2681(20)30009-0. doi: 10.1016/j.aohep.2020.01.005. [Epub ahead of print]
 
156.No Difference in Incidence of Hepatocellular Carcinoma in Patients With Chronic HBV Infection Treated With Entecavir vs Tenofovir
 

Oh H1, Yoon EL2, Jun DW3, Ahn SB4, Lee HY4, Jeong JY5, Kim HS6, Jeong SW7, Kim SE8, Shim JJ9, Sohn JH10, Cho YK11; Long-term Safety of Entecavir and Tenofovir in Patients with Treatment-naive Chronic Hepatitis B virus (CHB) Infection (SAINT) study. Clin Gastroenterol Hepatol. 2020 Mar 2. pii: S1542-3565(20)30265-2. doi: 10.1016/j.cgh.2020.02.046. [Epub ahead of print]
 
157.Evaluation of hepatitis B virus in clinical trials of baricitinib in rheumatoid arthritis
 

Harigai M1, Winthrop K2, Takeuchi T3, Hsieh TY4, Chen YM4, Smolen JS5, Burmester G6, Walls C7, Wu WS7, Dickson C7, Liao R7, Genovese MC8. RMD Open. 2020 Feb;6(1). pii: e001095. doi: 10.1136/rmdopen-2019-001095
 
158.Antiviral therapy and hepatocellular carcinoma risk in hepatitis B patients with cirrhosis
 

Gao X1,2, Yang HI3, Trinh H4, Jeong D1, Li J5, Zhang J6, Le A1, Hoang J1, Nguyen P1, Henry L1, Nguyen MH1. Eur J Gastroenterol Hepatol. 2019 Dec 24. doi: 10.1097/MEG.0000000000001639.

 
159.Hepatitis B: Who to treat? A critical review of international guidelines
 

Huang DQ1,2, Lim SG1,2. Liver Int. 2020 Feb;40 Suppl 1:5-14. doi: 10.1111/liv.14365.
 
160.Approach to the patient with chronic hepatitis B and decompensated cirrhosis
 

Shiffman ML1. Liver Int. 2020 Feb;40 Suppl 1:22-26. doi: 10.1111/liv.14359.
 
161.Validation of a hierarchical algorithm to define chronic liver disease and cirrhosis etiology in administrative healthcare data
 

Philip G1, Djerboua M2, Carlone D3, Flemming JA1,2,3,4. PLoS One. 2020 Feb 18;15(2):e0229218. doi: 10.1371/journal.pone.0229218. eCollection 2020.
 
162.Validation of a hierarchical algorithm to define chronic liver disease and cirrhosis etiology in administrative healthcare data
 

Philip G1, Djerboua M2, Carlone D3, Flemming JA1,2,3,4. PLoS One. 2020 Feb 18;15(2):e0229218. doi: 10.1371/journal.pone.0229218. eCollection 2020.
 
163.Will we need novel combinations to cure HBV infection?
 

Dusheiko G1,2. Liver Int. 2020 Feb;40 Suppl 1:35-42. doi: 10.1111/liv.14371.
 
164.Management of hepatitis B in the era of checkpoint inhibition
 

Dutcher J1. J Immunother Cancer. 2020 Feb;8(1). pii: e000276. doi: 10.1136/jitc-2019-000276.
 
165.'Think Hep B' in primary care: A before-and-after evaluation of a self-guided learning package
 

Xiao Y1, van Gemert C2, Howell J3, Adamson E4, Towell V5, Cowie BC6, Thompson AJ7, Hellard M8. Aust J Gen Pract. 2020 Jan-Feb;49(1-2):66-69. doi: 10.31128/AJGP-10-18-4739.
 
166.Hepatitis B and Pregnancy: Virologic and Immunologic Characteristics
 

Joshi SS1,2, Coffin CS1,2. Hepatol Commun. 2020 Jan 2;4(2):157-171. doi: 10.1002/hep4.1460. eCollection 2020 Feb.
 
167.Comparing the Effects of Different Story Types and Speakers in Hepatitis B Storytelling Videos
 

Alber JM1, Cohen C2, Bleakley A3, Ghazvini SF1, Tolentino BT1, Almeida R1, Chance BL1. Health Promot Pract. 2020 Jan 19:1524839919894248. doi: 10.1177/1524839919894248. [Epub ahead of print]
 
168.Evaluating North Carolina's policy for healthcare personnel living with HIV and hepatitis B who perform invasive procedures after 25 years of implementation
 

Mitchell CL1, Lewis JW1,2, Maillard JM2, Moore ZS2, Weber DJ1. Infect Control Hosp Epidemiol. 2020 Jan 27:1-3. doi: 10.1017/ice.2019.372. [Epub ahead of print]
 
169.Toxicity and Survival of Hepatocellular Carcinoma Patients with Hepatitis B Infection Treated with Yttrium-90 Radioembolization: An Updated 15-Year Study
 

Gao R1, Gabr A1, Mouli S1, Riaz A1, Kulik L2, Lewandowski RJ1, Salem R3. J Vasc Interv Radiol. 2020 Jan 23. pii: S1051-0443(19)30808-5. doi: 10.1016/j.jvir.2019.08.033. [Epub ahead of print]
 
170.Hepatitis C virologic response in Hepatitis B and C coinfected persons treated with directly acting antiviral agents: Results from ERCHIVES
 

Butt AA1, Yan P2, Aslam S2, Sherman KE3, Siraj D4, Safdar N4, Hameed B5. Int J Infect Dis. 2020 Jan 21. pii: S1201-9712(20)30027-8. doi: 10.1016/j.ijid.2020.01.025. [Epub ahead of print]
 
171.Patient-reported outcomes in a large North American cohort living with chronic hepatitis B virus: a cross-sectional analysis
 

Evon DM1, Lin HS2, Khalili M3, Fontana RJ4, Yim C5, Wahed AS2, Fried MW1, Hoofnagle JH6; Hepatitis B Research Network (HBRN). Aliment Pharmacol Ther. 2020 Feb;51(4):457-468. doi: 10.1111/apt.15618. Epub 2020 Jan 14.
 
172.Direct comparison of three residual risk models for hepatitis B virus window period infections using updated input parameters
 

Lelie N1, Vermeulen M2, van Drimmelen H3, Coleman C2, Bruhn R4, Reddy R2, Busch M4, Kleinman S5. Vox Sang. 2020 Jan 20. doi: 10.1111/vox.12889. [Epub ahead of print]
 
173.Cross-sectional study of hepatitis B antibody status in health care workers immunized as children at an academic medical center in Wisconsin
 

Ritscher AM1, LeClair-Netzel M2, Friedlander NJ3, Howard Stewart DN1, Wagner M4, Kalscheur N5, Caldera F6, Hayney MS7. Vaccine. 2020 Jan 16. pii: S0264-410X(19)31678-0. doi: 10.1016/j.vaccine.2019.12.036. [Epub ahead of print]
 
174.Within-host mathematical models of hepatitis B virus infection: Past, present, and future
 

Goyal A1, Liao LE1, Perelson AS1. Curr Opin Syst Biol. 2019 Dec;18:27-35. doi: 10.1016/j.coisb.2019.10.003. Epub 2019 Nov 2.
 
175.Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis
 

de Martel C1, Georges D2, Bray F3, Ferlay J3, Clifford GM2. Lancet Glob Health. 2019 Dec 17. pii: S2214-109X(19)30488-7. doi: 10.1016/S2214-109X(19)30488-7. [Epub ahead of print]
 
176.Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis B
 

Lok AS1, Zoulim F2, Dusheiko G3, Chan HLY4, Buti M5, Ghany MG6, Gaggar A7, Yang JC7, Wu G7, Flaherty JF7, Subramanian GM7, Locarnini S8, Marcellin P9. Hepatol Commun. 2019 Oct 10;4(1):8-20. doi: 10.1002/hep4.1436. eCollection 2020 Jan.
 
177.Hepatitis B virus RNA as Early Predictor for Response to PEGylated Interferon Alfa in HBeAg Negative Chronic Hepatitis B
 

Farag MS1,2, van Campenhout MJH3, Pfefferkorn M4, Fischer J4, Deichsel D4, Boonstra A3, van Vuuren AJ3, Ferenci P5, Feld JJ1, Berg T4, Hansen BE1,6, van Bömmel F4, Janssen HLA1. Clin Infect Dis. 2020 Jan 8. pii: ciaa013. doi: 10.1093/cid/ciaa013. [Epub ahead of print]
 
178.Hepatitis B virus activity is not associated with degree of liver steatosis in patients with hepatitis B-related chronic liver disease
 

Worland T1, Apostolov R1, Asadi K1, Leung C1. Liver Int. 2019 Dec 28. doi: 10.1111/liv.14344. [Epub ahead of print]
 
179.Interventions to Increase Completion of Hepatitis B Vaccination in People who Inject Drugs: A Systematic Review and Meta-analysis
 

Tressler S1, Bhandari R1. Open Forum Infect Dis. 2019 Dec 6;6(12):ofz521. doi: 10.1093/ofid/ofz521. eCollection 2019 Dec.
 
180.Tenofovir versus entecavir in lowering the risk of hepatocellular carcinoma development in patients with chronic hepatitis B: a critical systematic review and meta-analysis
 

Li M1, Lv T2, Wu S1, Wei W1, Wu X3, Ou X2, Ma H2, Chow SC4, Kong Y5, You H6, Jia J7. Hepatol Int. 2020 Jan 3. doi: 10.1007/s12072-019-10005-0. [Epub ahead of print]
 
181.Enhancing the hepatitis B care cascade in Australia: A cost-effectiveness model
 

Xiao Y1,2,3, Howell J1,2,3,4, van Gemert C1,3, Thompson AJ2,3, Seaman CP1,4, McCulloch K3,5,6,7, Scott N1,4, Hellard ME1,3,4,7,8,9. J Viral Hepat. 2019 Dec 19. doi: 10.1111/jvh.13252. [Epub ahead of print]
 
182.Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission
 

Sarin SK1, Kumar M2, Eslam M3, George J3, Al Mahtab M4, Akbar SMF5, Jia J6, Tian Q6, Aggarwal R7, Muljono DH8, Omata M9, Ooka Y10, Han KH11, Lee HW11, Jafri W12, Butt AS12, Chong CH13, Lim SG14, Pwu RF15, Chen DS16. Lancet Gastroenterol Hepatol. 2019 Dec 13. pii: S2468-1253(19)30342-5. doi: 10.1016/S2468-1253(19)30342-5. [Epub ahead of print]
 
183.Liver Fibrosis Progression and Mortality in Hepatitis B- and C-Coinfected Persons Treated With Directly Acting Antiviral Agents: Results From ERCHIVES
 

Butt AA1,2,3, Yan P1, Aslam S1, Abou-Samra AB2,3, Sherman KE4, Shaikh OS1. Clin Infect Dis. 2019 Dec 16. pii: ciz1097. doi: 10.1093/cid/ciz1097. [Epub ahead of print]
 
184.Review article: clinical pharmacology of current and investigational hepatitis B virus therapies
 

Smolders EJ1,2,3, Burger DM3, Feld JJ4, Kiser JJ1. Aliment Pharmacol Ther. 2020 Jan;51(2):231-243. doi: 10.1111/apt.15581. Epub 2019 Dec 16.
 
185.Role of Biomarkers in Guiding Cure of Viral Hepatitis B
 

Buti M1,2, Riveiro-Barciela M1,2, Rodríguez-Frías F2,3,4, Tabernero D2,3, Esteban R1,2. Semin Liver Dis. 2019 Dec 5. doi: 10.1055/s-0039-3401031. [Epub ahead of print]
 
186.Role of Biomarkers in Guiding Cure of Viral Hepatitis B
 

Buti M1,2, Riveiro-Barciela M1,2, Rodríguez-Frías F2,3,4, Tabernero D2,3, Esteban R1,2. Semin Liver Dis. 2019 Dec 5. doi: 10.1055/s-0039-3401031. [Epub ahead of print]
 
187.Knowledge and Perceptions of Hepatitis B and Hepatocellular Carcinoma Screening Guidelines Among Trainees: A Tale of Three Centers
 

Mahfouz M1, Nguyen H2, Tu J3, Diaz CR4,5, Anjan S6, Brown S4, Bosire K7, Carrasquillo O4,8, Martin P8,9, Jones PD10,11. Dig Dis Sci. 2019 Dec 7. doi: 10.1007/s10620-019-05980-1. [Epub ahead of print]
 
188.Liver safety assessment in clinical trials of new agents for chronic hepatitis B
 

Fontana RJ1, Avigan MI2, Janssen HLA3, Regev A4, Mishra P5, Gaggar A6, Brown N7, Wat C8, Mendez P9, Anderson RT10, Given B11, Miller V10, Beumont M12. J Viral Hepat. 2019 Dec 11. doi: 10.1111/jvh.13223. [Epub ahead of print]
 
189.Quantification of Hepatitis B Surface Antigen: Is there a Role in HIV-Hepatitis B Virus Coinfection?
 

Jakharia N1, Kottilil S1, Chua JV1. AIDS Rev. 2019;21(4):175-183. doi: 10.24875/AIDSRev.19000077.
 
190.Long-term virological and adherence outcomes to antiviral treatment in a 4-year cohort chronic HBV study
 

Abreu RM1,2, Bassit LC3, Tao S3, Jiang Y3, Ferreira AS1, Hori PC2, Ganova-Raeva LM4, Khudyakov Y4, Schinazi RF3, Carrilho FJ1, Ono SK1. Antivir Ther. 2019 Dec 4. doi: 10.3851/IMP3338. [Epub ahead of print]
 
191.Incidence and Risk Factors of Postoperative Mortality and Morbidity After Elective Versus Emergent Abdominal Surgery in a National Sample of 8193 Patients With Cirrhosis
 

Johnson KM1,2, Newman KL3, Green PK4, Berry K4, Cornia PB1,2, Wu P5, Beste LA4,6,2, Itani K7, Harris AHS8,9, Kamath PS10, Ioannou GN4,11. Ann Surg. 2019 Oct 23. doi: 10.1097/SLA.0000000000003674. [Epub ahead of print]
 
192.Quantitative of serum hepatitis B core antibody is a potential predictor of recurrence after interferon-induced hepatitis B surface antigen clearance
 

Wu Y1, Wang X1, Lin X1, Shen C2, Chen X3. J Microbiol Immunol Infect. 2019 Sep 28. pii: S1684-1182(19)30145-8. doi: 10.1016/j.jmii.2019.09.004. [Epub ahead of print]
 
193.Point of care and oral fluid Hepatitis B testing in remote Indigenous communities of northern Australia
 

Sullivan RP1,2,3, Davies J1,2, Binks P1, Dhurrkay RG1, Gurruwiwi GG1, Bukulatjpi SM1, McKinnon M1, Hosking K1,4, Littlejohn M5, Jackson K5, Locarnini S5, Davis JS1,6, Tong SY1,7. J Viral Hepat. 2019 Nov 29. doi: 10.1111/jvh.13243. [Epub ahead of print]
 
194.Asian Consensus Recommendations on Optimizing the Diagnosis and Initiation of Treatment of Hepatitis B Virus Infection in Resource-Limited Settings
 

Gane EJ1, Charlton MR2, Mohamed R3, Sollano JD4, Tun KS5, Thuy PTT6, Payawal DA7, Gani RA8, Muljono DH9,10,11, Acharya SK12, Zhuang H13, Shukla A14, Madan K15, Saraf N16, Tyagi S17, Singh KR18, Cua IHY19, Jargalsaikhan G20,21, Duger D22, Sukeepaisarnjaroen W23, Purnomo HD24, Hasan I25, Lesmana LA26, Lesmana CRA27, Kyi KP28, Naing W29, Ac R30, Hadigal S30. J Viral Hepat. 2019 Nov 30. doi: 10.1111/jvh.13244. [Epub ahead of print]
 
195.Emerging tools in the changing landscape of chronic hepatitis B management
 

Gill US1, Battisti A1, Kennedy PT1. Expert Rev Anti Infect Ther. 2019 Nov 18. doi: 10.1080/14787210.2019.1694906. [Epub ahead of print]
 
196.Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference
 

Cornberg M1,2,3, Lok AS4, Terrault NA5, Zoulim F6; 2019 EASL-AASLD HBV Treatment Endpoints Conference Faculty. Hepatology. 2019 Nov 12. doi: 10.1002/hep.31030. [Epub ahead of print]
 
197.Hepatitis Flare In Hepatitis B Core Antibody Positive Kidney Recipients Treated With Rituximab
 

Raja M1, Natori Y1, Donato C1, De Lima D2, Centino A3, Mattiazzi A4, Morris M1. Transpl Infect Dis. 2019 Nov 12:e13211. doi: 10.1111/tid.13211. [Epub ahead of print]
 
198.Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference
 

Cornberg M1, Suk-Fong Lok A2, Terrault NA3, Zoulim F4; 2019 EASL-AASLD HBV Treatment Endpoints Conference Faculty. J Hepatol. 2019 Nov 9. pii: S0168-8278(19)30671-3. doi: 10.1016/j.jhep.2019.11.003. [Epub ahead of print]
 
199.RNA Interference Therapy with ARC-520 Results in Prolonged HBsAg Response in Patients with Chronic Hepatitis B Infection
 

Yuen MF1, Schiefke I2, Yoon JH3, Ahn SH4, Heo J5, Kim JH6, Chan HLY7, Yoon KT8, Klinker H9, Manns M10, Petersen J11, Schluep T12, Hamilton J12, Given BD12, Ferrari C13, Lai CL1, Locarnini SA14, Gish RG15. Hepatology. 2019 Oct 26. doi: 10.1002/hep.31008. [Epub ahead of print]
 
200.Occult HBV Infection: A Case Series at a Military Treatment Facility
 

Pak K1, Ordway S2, Torres D2. Mil Med. 2019 Nov 4. pii: usz379. doi: 10.1093/milmed/usz379. [Epub ahead of print]
 
201.A Patient-Centered Hepatitis B Virus (HBV) Educational Intervention Improves HBV Care Among Underserved Safety-Net Populations
 

Wong RJ1, Khalili M2. J Clin Gastroenterol. 2019 Oct 31. doi: 10.1097/MCG.0000000000001276. [Epub ahead of print]
 
202.'Teach-back' is a simple communication tool that improves disease knowledge in people with chronic hepatitis B - a pilot randomized controlled study
 

Tran S1,2, Bennett G3,4, Richmond J3,4,5, Nguyen T3,4, Ryan M3,4, Hong T3,4, Howell J3,4, Demediuk B3,4, Desmond P3,4, Bell S3,4, Thompson A6,7. BMC Public Health. 2019 Oct 23;19(1):1355. doi: 10.1186/s12889-019-7658-4.
 
203. Surveillance-Based Estimate of the Prevalence of Chronic Hepatitis B Virus Infection, New York City, 2016.
 

Moore MS1, Bocour A1, Winters A1. Public Health Rep. 2019 Oct 24:33354919882962. doi: 10.1177/0033354919882962. [Epub ahead of print]
 
204.Long-term Outcomes with Oral Therapy in Liver Transplant Recipients with Hepatitis B
 

Saab S1,2,3, Song D2, Challita YP1, Zhou TX1, Saab EG1, Viramontes MR1, Choi G1,2, Durazo FA1,2, Han SB1,2, El Kabany MM1,2, Jackson NJ4, Busuttil RW1. Clin Transplant. 2019 Oct 25:e13740. doi: 10.1111/ctr.13740. [Epub ahead of print]
 
205.National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2018
 

Walker TY, Elam-Evans LD, Yankey D, Markowitz LE, Williams CL, Fredua B, Singleton JA, Stokley S. MMWR Morb Mortal Wkly Rep. 2019 Aug 23;68(33):718-723. doi: 10.15585/mmwr.mm6833a2.
 
206.Factors Associated with Hepatitis B Exposure among People who Report Using Methamphetamine: NHANES 2009-2016
 

Tressler SR1, Kushner T2, Bhandari R1. J Infect Dis. 2019 Aug 30. pii: jiz445. doi: 10.1093/infdis/jiz445. [Epub ahead of print]
 
207.HIV and the liver
 

Sherman KE1, Peters MG2, Thomas DL3. Top Antivir Med. 2019 Sep/Oct;27(3):101-110.
 
208.Prevalence and burden of HBV co-infection among people living with HIV: a global systematic review and meta-analysis
 

Platt L1, French CE2, McGowan CR1,3, Sabin K4, Gower E5, Trickey A2, McDonald B6,7, Ong J7, Stone J2, Easterbrook P8, Vickerman P2. J Viral Hepat. 2019 Oct 11. doi: 10.1111/jvh.13217. [Epub ahead of print]
 
209.The role of iron in viral infections
 

Schmidt SM1. Front Biosci (Landmark Ed). 2020 Jan 1;25:893-911.
 
210.Hepatitis B virus reactivation: Risk factors and current management strategies
 

Smalls DJ1, Kiger RE1, Norris LB1,2, Bennett CL1,2,3,4,5, Love BL1,2,3. Pharmacotherapy. 2019 Oct 9. doi: 10.1002/phar.2340. [Epub ahead of print]
 
211.Practical Guide to Vaccination in All Stages of CKD, Including Patients Treated by Dialysis or Kidney Transplantation
 

Krueger KM1, Ison MG2, Ghossein C3. Am J Kidney Dis. 2019 Oct 1. pii: S0272-6386(19)30891-1. doi: 10.1053/j.ajkd.2019.06.014. [Epub ahead of print]
 
212.Trends in Hepatitis B Infection and Immunity among Women of Childbearing Age in the United States
 

Kushner T1, Chen Z2, Tressler S3, Kaufman H2, Feinberg J4, Terrault NA5. Clin Infect Dis. 2019 Aug 26. pii: ciz841. doi: 10.1093/cid/ciz841. [Epub ahead of print]
 
213.Hepatitis A and Hepatitis B Vaccination Coverage Among Persons Who Inject Drugs and Have Evidence of Hepatitis C Infection
 

Koepke R1,2, Sill DN1, Akhtar WZ2, Mitchell KP1, Guilfoyle SM1, Westergaard RP2, Schauer SL1, Vergeront JM1. Public Health Rep. 2019 Sep 20:33354919874088. doi: 10.1177/0033354919874088. [Epub ahead of print]
 
214.Factors Associated with Hepatitis B Exposure among People who Report Using Methamphetamine: NHANES 2009-2016
 

Tressler SR1, Kushner T2, Bhandari R1. J Infect Dis. 2019 Aug 30. pii: jiz445. doi: 10.1093/infdis/jiz445. [Epub ahead of print]
 
215.Insight into hepatitis B prevalence and risk factors among Vietnamese Americans: a cross-sectional analysis of data from a community-based screening program
 

Lee AW1, Jacobs W2, Chan E3, Nguyen B4, Hua DN4, Ho JN4, Yuen P3, Van Nguyen T4. BMJ Open. 2019 Aug 26;9(8):e029616. doi: 10.1136/bmjopen-2019-029616.
 
216.Phenotypes of Chronic Hepatitis B in Children from a Large North American Cohort
 

Schwarz KB1, Lombardero M2, Di Bisceglie AM3, Murray KF4, Rosenthal P5, Ling SC6, Cloonan YK2, Rodriguez-Baez N7, Schwarzenberg SJ8, Hoofnagle JH9, Teckman J3; Hepatitis B Research Network (HBRN). J Pediatr Gastroenterol Nutr. 2019 Aug 20. doi: 10.1097/MPG.0000000000002467. [Epub ahead of print]
 
217.Current perspectives into the evaluation and management of hepatitis B: a review
 

Manne V1, Gochanour E1, Kowdley KV1. Hepatobiliary Surg Nutr. 2019 Aug;8(4):361-369. doi: 10.21037/hbsn.2019.02.09.
 
218.Twitter As a Noninvasive Bio-Marker for Trends in Liver Disease
 

Da BL1, Surana P2, Schueler SA1, Jalaly NY2, Kamal N1, Taneja S1, Vittal A2, Gilman CL2, Heller T2, Koh C2. Hepatol Commun. 2019 Jul 13;3(9):1271-1280. doi: 10.1002/hep4.1394. eCollection 2019 Sep.
 
219.Infectious disease screening in patients prior to undergoing immunosuppressive therapy
 

Sullivan R1,2, Gaskell C3, R Lewis C4,5, Vollmer-Conna U6, Post JJ1,4. Int J Clin Pract. 2019 Aug 23. doi: 10.1111/ijcp.13406. [Epub ahead of print]
 
220.Hepatitis B Vaccination and Waning Hepatitis B Immunity in Persons Living with HIV
 

Farooq PD1, Sherman KE2. Curr HIV/AIDS Rep. 2019 Aug 29. doi: 10.1007/s11904-019-00461-6. [Epub ahead of print]
 
221.Hepatitis B virus infection as a risk factor for chronic kidney disease.
 

Fabrizi F1, Cerutti R1, Ridruejo E2,3,4. Expert Rev Clin Pharmacol. 2019 Sep;12(9):867-874. doi: 10.1080/17512433.2019.1657828. Epub 2019 Aug 28.
 
222.Hepatitis B Vaccination and Waning Hepatitis B Immunity in Persons Living with HIV
 

Farooq PD1, Sherman KE2. Curr HIV/AIDS Rep. 2019 Aug 29. doi: 10.1007/s11904-019-00461-6. [Epub ahead of print]
 
223.Phenotypes of Chronic Hepatitis B in Children from a Large North American Cohort
 

Schwarz KB1, Lombardero M2, Di Bisceglie AM3, Murray KF4, Rosenthal P5, Ling SC6, Cloonan YK2, Rodriguez-Baez N7, Schwarzenberg SJ8, Hoofnagle JH9, Teckman J3; Hepatitis B Research Network (HBRN). J Pediatr Gastroenterol Nutr. 2019 Aug 20. doi: 10.1097/MPG.0000000000002467. [Epub ahead of print]
 
224.Are Published Health Economic Models for Chronic Hepatitis B Appropriately Capturing the Benefits of HBsAg Loss? A Systematic Literature Review
 

Wigfield P1, Sbarigia U2, Hashim M3, Vincken T3, Heeg B3. Pharmacoecon Open. 2019 Aug 19. doi: 10.1007/s41669-019-00175-w. [Epub ahead of print]
 
225.The effects of message framing and healthcare provider recommendation on adult hepatitis Bvaccination: A randomized controlled trial
 

Kasting ML1, Head KJ2, Cox D3, Cox AD4, Zimet GD5. Prev Med. 2019 Aug 9:105798. doi: 10.1016/j.ypmed.2019.105798. [Epub ahead of print]
 
226.Screening for Hepatitis B Virus Infection in Pregnant Women: An Updated Systematic Review for the U.S. Preventive Services Task Force
 

Henderson JT, Webber EM, Bean SI. 
 
227.Modelling progress towards elimination of hepatitis B in Australia
 

McCulloch K1,2, Romero N1,3, MacLachlan J1,3, Allard N1,3, Cowie B1,3,4. Hepatology. 2019 Aug 16. doi: 10.1002/hep.30899. [Epub ahead of print]
 
228.Presence of Precore (C)/C Promoter Mutants in Peripheral Blood Mononuclear Cells of Chronic Hepatitis B (CHB) Carriers During Pregnancy Does Not Correlate with Increased Risk of Liver Disease in 4 Years of Follow-Up
 

Joshi SS1,2, Gao S1,2, Castillo E3, Coffin CS4,5. Dig Dis Sci. 2019 Aug 2. doi: 10.1007/s10620-019-05745-w. [Epub ahead of print]
 
229.Reactivation of hepatitis B virus infection in patients with hemo-lymphoproliferative diseases, and its prevention
 

Sagnelli C1, Pisaturo M2, Calò F2, Martini S2, Sagnelli E2, Coppola N2. World J Gastroenterol. 2019 Jul 14;25(26):3299-3312. doi: 10.3748/wjg.v25.i26.3299.
 
230.Predicting HBsAg clearance in genotype A chronic hepatitis B using HBsAg epitope profiling: a biomarker for functional cure
 

Walsh R1, Hammond R1, Yuen L1, Deerain J1, O'Donnell T1, Leary T2, Cloherty G2, Gaggar A3, Kitrinos K3, Subramanian M3, Wong D4, Locarnini S1.

Liver Int. 2019 Aug 4. doi: 10.1111/liv.14207. [Epub ahead of print]
 
231.Prevalence of Hepatitis B Virus Exposure in the Veterans Health Administration and Association With Military-related Risk Factors
 

Beste LA1, Ioannou GN2, Chang MF3, Forsberg CW4, Korpak AM4, Boyko EJ5, Sporleder JL6, Smith NL7, Maynard C8, Chartier M9, Dominitz JA10; VA Cooperative Study Group #488. Clin Gastroenterol Hepatol. 2019 Aug 5. pii: S1542-3565(19)30845-6. doi: 10.1016/j.cgh.2019.07.056. [Epub ahead of print]
 
232.Hepatitis B and C prevalence and incidence in key population groups with multiple risk factors in the EU/EEA: a systematic review
 

Mason LM1, Duffell E2, Veldhuijzen IK3, Petriti U1, Bunge EM1, Tavoschi L4,2. Euro Surveill. 2019 Jul;24(30). doi: 10.2807/1560-7917.ES.2019.24.30.1800614.
 
233.Review article: immune checkpoint inhibitors and the liver, from therapeutic efficacy to side effects
 

Lombardi A1,2, Mondelli MU1,2. Aliment Pharmacol Ther. 2019 Aug 4. doi: 10.1111/apt.15449. [Epub ahead of print]
 
234.Association Between Negative Results From Tests for HBV DNA and RNA and Durability of Response After Discontinuation of Nucles(t)ide Analogue Therapy
 

Fan R1, Zhou B1, Xu M2, Tan D3, Niu J4, Wang H5, Ren H6, Chen X7, Wang M8, Ning Q9, Shi G10, Sheng J11, Tang H12, Bai X13, Liu S1, Lu F14, Peng J1, Sun J15, Xie Q16, Hou J17; Chronic Hepatitis B Study Consortium.Collaborators (9) Clin Gastroenterol Hepatol. 2019 Jul 27. pii: S1542-3565(19)30790-6. doi: 10.1016/j.cgh.2019.07.046. [Epub ahead of print]
 
235.Hepatitis B and C testing strategies in healthcare and community settings in the EU/EEA: a systematic review
 

Mason LMK1, Veldhuijzen IK2, Duffell E3, van Ahee A1, Bunge EM1, Amato-Gauci AJ3, Tavoschi L3. J Viral Hepat. 2019 Jul 22. doi: 10.1111/jvh.13182. [Epub ahead of print]
 
236.Screening for Hepatitis B Virus Infection in Pregnant Women: US Preventive Services Task Force Reaffirmation Recommendation Statement
 

US Preventive Services Task Force, Owens DK1,2, Davidson KW3, Krist AH4,5, Barry MJ6, Cabana M7, Caughey AB8, Doubeni CA9, Epling JW Jr10, Kemper AR11, Kubik M12, Landefeld CS13, Mangione CM14, Pbert L15, Silverstein M16, Simon MA17, Tseng CW18,19, Wong JB20. JAMA. 2019 Jul 23;322(4):349-354. doi: 10.1001/jama.2019.9365.
 
237.Evaluation of Rapid Diagnostic Tests for Assessment of Hepatitis B in Resource-Limited Settings
 

Leathers JS1, Pisano MB2, Re V2, Van Oord G3, Sultan A4, Boonstra A3, Debes JD3,5. Ann Glob Health. 2019 Jul 4;85(1). pii: 98. doi: 10.5334/aogh.2562.
 
238.Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers
 

Chang KC1, Chang MH1, Lee CN1, Chang CH1, Wu JF1, Ni YH1, Wen WH2, Shyu MK1, Lai MW3, Chen SM1, Hu JJ1, Lin HH2, Hsu JJ1, Mu SC1, Lin YC2, Liu CJ1, Chen DS1, Lin LH1, Chen HL1; Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT study). Aliment Pharmacol Ther. 2019 Aug;50(3):306-316. doi: 10.1111/apt.15321. Epub 2019 Jul 4.
 
239.Challenges with hepatitis B vaccination of high risk adults - A pilot program
 

Bridges CB1, Watson TL2, Nelson NP3, Chavez-Torres M4, Fineis P5, Ntiri-Reid B6, Wake E7, Leahy JM8, Kurian AK9, Hall MAK10, Kennedy ED11. Vaccine. 2019 Jul 11. pii: S0264-410X(19)30746-7. doi: 10.1016/j.vaccine.2019.05.089. [Epub ahead of print]
 
240.Hepatitis B testing practices at a tertiary care centre and their associated costs: A retrospective analysis
 

Lawandi A1, Cheng MP1, Lee TC1,2. PLoS One. 2019 Jul 8;14(7):e0219347. doi: 10.1371/journal.pone.0219347. eCollection 2019.
 
241.Hepatitis B and C virus infection and risk of hematological malignancies
 

Marrone A1, Ciotti M2, Rinaldi L1, Adinolfi LE1, Ghany M3. J Viral Hepat. 2019 Jul 20. doi: 10.1111/jvh.13183. [Epub ahead of print]
 
242.Non-invasive biomarkers for chronic hepatitis B virus infection management
 

Charre C1, Levrero M2, Zoulim F2, Scholtès C3. Antiviral Res. 2019 Jul 6;169:104553. doi: 10.1016/j.antiviral.2019.104553. [Epub ahead of print]
 
243.The Effects of Hepatic Steatosis on the Natural History of HBV Infection
 

Suliman I1, Abdelgelil N2, Kassamali F3, Hassanein TI4. Clin Liver Dis. 2019 Aug;23(3):433-450. doi: 10.1016/j.cld.2019.05.001.
 
244.Drugs in the Pipeline for HBV
 

Lopatin U1. Clin Liver Dis. 2019 Aug;23(3):535-555. doi: 10.1016/j.cld.2019.04.006. Epub 2019 May 29.
 
245.Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Other Populations and Newer Agents
 

Sasadeusz J1, Grigg A2, Hughes PD3, Lee Lim S4, Lucas M5, McColl G6, McLachlan SA7, Peters MG8, Shackel N9, Slavin M10, Sundararajan V11, Thompson A12, Doyle J13, Rickard J2, De Cruz P14, Gish RG15, Visvanathan K12. Clin Liver Dis. 2019 Aug;23(3):521-534. doi: 10.1016/j.cld.2019.04.012. Epub 2019 Jun 5.
 
246.HBV/HDV Coinfection: A Challenge for Therapeutics
 

Koh C1, Da BL2, Glenn JS3. Clin Liver Dis. 2019 Aug;23(3):557-572. doi: 10.1016/j.cld.2019.04.005. Epub 2019 May 24.
 
247.Managing Psoriasis in Patients with HBV or HCV Infection: Practical Considerations
 

Piaserico S1, Messina F2, Russo FP3. Am J Clin Dermatol. 2019 Jun 20. doi: 10.1007/s40257-019-00457-3. [Epub ahead of print]
 
248.Hepatitis B in Pregnant Women and their Infants
 

Cryer AM1, Imperial JC2. Clin Liver Dis. 2019 Aug;23(3):451-462. doi: 10.1016/j.cld.2019.04.007. Epub 2019 Jun 4.
 
249.Antiretroviral Effects on HBV/HIV Co-infection and the Natural History of Liver Disease
 

Wyles DL1. Clin Liver Dis. 2019 Aug;23(3):473-486. doi: 10.1016/j.cld.2019.04.004. Epub 2019 May 24.
 
250.HBV/HCV Coinfection in the Era of HCV-DAAs
 

Abdelaal R1, Yanny B2, El Kabany M3. Clin Liver Dis. 2019 Aug;23(3):463-472. doi: 10.1016/j.cld.2019.04.003. Epub 2019 May 27.
 
251.Global Perspective on Hepatitis B Virus Infections in the Era of Effective Vaccines
 

Gomes C1, Wong RJ2, Gish RG3. Clin Liver Dis. 2019 Aug;23(3):383-399. doi: 10.1016/j.cld.2019.04.001. Epub 2019 May 23.
 
252.Will Infant Hepatitis B Immunization Protect Adults?
 

Scheifele DW1. Pediatr Infect Dis J. 2019 Jun;38(6S Suppl 1):S64-S66. doi: 10.1097/INF.0000000000002326.
 
253.Evaluating non-invasive markers to identify advanced fibrosis by liver biopsy in HBV/HIV coinfected adults
 

Sterling RK1, King WC2, Wahed AS2, Kleiner DE3, Khalili M4, Sulkowski M5, Chung RT6, Jain MK7, Lisker-Melman M8, Wong DK9, Ghany MG3; HIV-HBV Cohort Study of the Hepatitis B Research Network. Hepatology. 2019 Jun 20. doi: 10.1002/hep.30825. [Epub ahead of print]
 
254.Exploration of long-acting implant formulations of hepatitis B drug entecavir
 

Henry SJ1, Barrett SE2, Forster SP1, Teller RS1, Yang Z1, Li L1, Mackey MA1, Doto GJ3, Ruth MP3, Tsuchiya T3, Klein LJ1, Gindy ME1. Eur J Pharm Sci. 2019 Jun 15;136:104958. doi: 10.1016/j.ejps.2019.104958. [Epub ahead of print]
 
255.Underreporting of Hepatitis B and C virus infections - Pennsylvania, 2001-2015
 

Roberts H1, Boktor SW2, Waller K2, Daar ZS3, Boscarino JA3, Dubin PH1,4, Suryaprasad A1,5, Moorman AC1. PLoS One. 2019 Jun 6;14(6):e0217455. doi: 10.1371/journal.pone.0217455. eCollection 2019.
 
256.Patient-Reported Outcomes in Patients Chronic Viral Hepatitis without Cirrhosis: The Impact of Hepatitis B and C Viral Replication
 

Younossi ZM1,2, Stepanova M3, Younossi I3, Papatheodoridis G4, Janssen HLA5, Agarwal K6, Nguyen MH7, Gane E8, Tsai N9, Nader F3. Liver Int. 2019 Jun 7. doi: 10.1111/liv.14171. [Epub ahead of print]
 
257.Management of Fulminant Hepatitis B
 

Ichai P1,2,3, Samuel D4,5,6. Curr Infect Dis Rep. 2019 Jun 4;21(7):25. doi: 10.1007/s11908-019-0682-9.
 
258.Hepatorenal Syndrome or Hepatocardiorenal Syndrome: Revisiting Basic Concepts in View of Emerging Data
 

Kazory A1, Ronco C2,3. Cardiorenal Med. 2019;9(1):1-7. doi: 10.1159/000492791. Epub 2018 Sep 17.
 
259.Associations Between Hepatitis B Virus Infection and Risk of All Cancer Types
 

Song C1, Lv J2, Liu Y3, Chen JG4, Ge Z1, Zhu J4, Dai J1, Du LB5, Yu C2, Guo Y6, Bian Z6, Yang L6,7, Chen Y6,7, Chen Z6,7, Liu J8, Jiang J9, Zhu L9, Zhai X9, Jiang Y1, Ma H1, Jin G1, Shen H1, Li L2, Hu Z1; China Kadoorie Biobank Collaborative Group. JAMA Netw Open. 2019 Jun 5;2(6):e195718. doi: 10.1001/jamanetworkopen.2019.5718.
 
260.Ten-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis Bvirus infection
 

Marcellin P1, Wong D2, Sievert W3, Buggisch P4, Petersen J4, Flisiak R5, Manns M6,7, Kaita K8, Krastev Z9, Lee SS10, Cathcart AL11, Crans G11, Op den Brouw M12, Jump B11, Gaggar A11, Flaherty J11, Buti-Ferret M13. Liver Int. 2019 May 28. doi: 10.1111/liv.14155. [Epub ahead of print]
 
261.High risk of clinical events in untreated HBeAg-negative chronic hepatitis B patients with high viral load and no significant ALT elevation
 

Choi GH1, Kim GA2, Choi J3, Han S4, Lim YS3. Aliment Pharmacol Ther. 2019 May 28. doi: 10.1111/apt.15311. [Epub ahead of print]
 
262.Metabolic Syndrome and Liver Steatosis occur at lower body mass index in US Asian patients with Chronic Hepatitis B
 

Clarke WT1, Miranda J1, Neidich E1, Hudock R1, Peters MG1, Kelly EM2. J Viral Hepat. 2019 May 28. doi: 10.1111/jvh.13147. [Epub ahead of print]
 
263.Determinants of Liver Complications Among HIV/Hepatitis B Virus-Coinfected Patients
 

Lo Re V 3rd1, Newcomb CW1, Carbonari DM1, Roy JA1, Althoff KN2, Kitahata MM3, Reddy KR1, Lim JK4, Silverberg MJ5, Mayor AM6, Horberg MA7, Cachay ER8, Kirk GD2, Hull M9, Gill J10, Sterling TR11, Kostman JR12, Peters MG13, Moore RD2, Klein MB14, Kim HN3; North American AIDS Cohort Collaboration on Research and Design of IeDEA. J Acquir Immune Defic Syndr. 2019 Apr 29. doi: 10.1097/QAI.0000000000002094. [Epub ahead of print]
 
264.Updates on Chronic HBV: Current Challenges and Future Goals
 

Lee HM1, Banini BA2. Curr Treat Options Gastroenterol. 2019 May 10. doi: 10.1007/s11938-019-00236-3. [Epub ahead of print]
 
265.Chronic hepatitis delta virus infection leads to functional impairment and severe loss of MAIT cells
 

Dias J1, Hengst J2, Parrot T1, Leeansyah E3, Lunemann S4, Malone DFG1, Hardtke S5, Strauss O1, Zimmer CL1, Berglin L1, Schirdewahn T5, Ciesek S6, Marquardt N1, von Hahn T5, Manns MP5, Cornberg M5, Ljunggren HG1, Wedemeyer H7, Sandberg JK1, Björkström NK8. J Hepatol. 2019 May 6. pii: S0168-8278(19)30270-3. doi: 10.1016/j.jhep.2019.04.009. [Epub ahead of print]
 
266.Long-Term Follow-up and Quantitative Hepatitis B Surface Antigen Monitoring in North American Chronic HBV Carriers
 

O'Neil CR1, Congly SE2, Rose MS3, Lee SS2, Borman MA2, Charlton CL4, Osiowy C5, Swain MG2, Burak KW2, Coffin CS6. Ann Hepatol. 2018 Mar - Apr;17(2):232-241. doi: 10.5604/01.3001.0010.8640.
 
267.Total Alanine Aminotransferase (ALT) Flares in Pregnant North American Women With Chronic Hepatitis B Infection: Results From a Prospective Observational Study
 

Bzowej NH1, Tran TT2, Li R3, Belle SH4, Smith CI5, Khalili M6, Chung R7, Tsai N8, Terrault N9; Hepatitis B Research Network (HBRN). Am J Gastroenterol. 2019 May 1. doi: 10.14309/ajg.0000000000000221. [Epub ahead of print]
 
268.Management Approaches to Hepatitis B Virus Vaccination Nonresponse
 

Yanny B1,2, Konyn P1,2, Najarian LM1,2, Mitry A1,2, Saab S1,2. Gastroenterol Hepatol (N Y). 2019 Feb;15(2):93-99.
 
269.Treatment of Viral Infections During Pregnancy
 

Rogan SC1, Beigi RH2. Clin Perinatol. 2019 Jun;46(2):235-256. doi: 10.1016/j.clp.2019.02.009. Epub 2019 Mar 28.
 
270.Hepatitis B Virus and HIV Coinfection: Fibrosis, Fat, and Future Directions
 

Kim AY1. Am J Gastroenterol. 2019 Apr 12. doi: 10.14309/ajg.0000000000000231. [Epub ahead of print]
 
271.A global scientific strategy to cure hepatitis B
 

Revill PA1, Chisari FV2, Block JM3, Dandri M4, Gehring AJ5, Guo H6, Hu J7, Kramvis A8, Lampertico P9, Janssen HLA10, Levrero M11, Li W12, Liang TJ13, Lim SG14, Lu F15, Penicaud MC16, Tavis JE17, Thimme R18; Members of the ICE-HBV Working Groups; ICE-HBV Stakeholders Group Chairs; ICE-HBV Senior Advisors, Zoulim F19. Lancet Gastroenterol Hepatol. 2019 Apr 10. pii: S2468-1253(19)30119-0. doi: 10.1016/S2468-1253(19)30119-0. [Epub ahead of print]
 
272.Countdown to 2030: eliminating hepatitis B disease, China
 

Liu J1, Liang W2, Jing W1, Liu M1. Bull World Health Organ. 2019 Mar 1;97(3):230-238. doi: 10.2471/BLT.18.219469. Epub 2019 Jan 28.
 
273.Indication for treatment and severity of disease in treatment-naive patients with chronic hepatitis B virus infection
 

Post G1,2, Shalev N3, Baumgarten A2, Shimakawa Y4, Lemoine M5, Krznaric I2, Dupke S2, Carganico A2, Arastéh K6, Ingiliz P2. Eur J Gastroenterol Hepatol. 2019 Apr 5. doi: 10.1097/MEG.0000000000001409. [Epub ahead of print]
 
274.Evidence for Use of Tenofovir in Pregnancy to Prevent Perinatal Transmission of Hepatitis B Infection
 

Sylvester-Armstrong KR1, Duff WP. Clin Obstet Gynecol. 2019 Mar 27. doi: 10.1097/GRF.0000000000000438. [Epub ahead of print]
 
275.Maternal and Infant Bone Mineral Density 1 Year After Delivery in a Randomized, Controlled Trial of Maternal Tenofovir Disoproxil Fumarate to Prevent Mother-to-child Transmission of Hepatitis B Virus
 

Salvadori N1,2, Fan B3, Teeyasoontranon W4, Ngo-Giang-Huong N1,2,5, Phanomcheong S6, Luvira A7, Puangsombat A8, Suwannarat A9, Srirompotong U10, Putiyanun C11, Cressey TR1,2,5,12, Decker L1,2, Khamduang W2, Harrison L13, Tierney C13, Shepherd JA3,14, Kourtis AP15, Bulterys M15,16, Siberry GK17, Jourdain G1,2,5. Clin Infect Dis. 2019 Mar 29. pii: ciy982. doi: 10.1093/cid/ciy982. [Epub ahead of print]
 
276.Immunetolerant Hepatitis B: Maybe a misnomer but still hard to treat
 

Martin P1. Hepatology. 2019 Apr 9. doi: 10.1002/hep.30654. [Epub ahead of print]
 
277.Sociodemographic, clinical and birth hospitalization characteristics and infant Hepatitis B vaccination in Washington State
 

Oster NV1, Williams EC2, Unger JM3, Newcomb PA4, Jacobson EN5, deHart MP6, Englund JA7, Hofstetter AM7. Vaccine. 2019 Mar 28. pii: S0264-410X(19)30384-6. doi: 10.1016/j.vaccine.2019.03.050. [Epub ahead of print]
 
278.Age, race and viral genotype are associated with the prevalence of Hepatitis B e antigen in children and adults with chronic Hepatitis B
 

Di Bisceglie AM1, King WC2, Lisker-Melman M3, Khalili M4, Belle SH2, Feld JJ5, Ghany MG6, Janssen HLA5, Lau D7, Lee WM8, Ling SC5, Cooper S9, Rosenthal P4, Schwarz KB10, Sterling RK11, Teckman JH1, Terrault N4; Hepatitis B Research Network (HBRN). J Viral Hepat. 2019 Apr 11. doi: 10.1111/jvh.13104. [Epub ahead of print]

Collaborators (37)
 
279.Hepatitis B testing, care linkage, and vaccination coverage within a registry of hepatitis C infected patients
 

Harris AM1, Millman AJ2, Lora M3, Osinubi A4, Lom J5, Miller LS6. Vaccine. 2019 Apr 10;37(16):2188-2193. doi: 10.1016/j.vaccine.2019.03.012. Epub 2019 Mar 19.
 
280.Screening of Donor and Candidate Prior to Solid Organ Transplantation - Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice
 

Malinis M1, Boucher HW2; AST Infectious Diseases Community of Practice. Clin Transplant. 2019 Mar 21:e13548. doi: 10.1111/ctr.13548. [Epub ahead of print]
 
281.Recent advances in the development of HBV capsid assembly modulators
 

Nijampatnam B1, Liotta DC2. Curr Opin Chem Biol. 2019 Apr 2;50:73-79. doi: 10.1016/j.cbpa.2019.02.009. [Epub ahead of print]
 
282.Hepatitis B testing, care linkage, and vaccination coverage within a registry of hepatitis C infected patients
 

Harris AM1, Millman AJ2, Lora M3, Osinubi A4, Lom J5, Miller LS6. Vaccine. 2019 Apr 10;37(16):2188-2193. doi: 10.1016/j.vaccine.2019.03.012. Epub 2019 Mar 19.
 
283.Association of Daily Aspirin Therapy With Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
 

Lee TY1,2, Hsu YC3,4,5,6, Tseng HC7, Yu SH1, Lin JT4,8, Wu MS9, Wu CY7,10,11,12. JAMA Intern Med. 2019 Mar 18. doi: 10.1001/jamainternmed.2018.8342. [Epub ahead of print]
 
284.Sexual Behaviors and Health Practices Among Student Service Members and Veterans
 

Albright DL1, Landor AA2, McDaniel JT3, Godfrey K4, Fletcher KL5, Thomas KH6, Bertram J4. Arch Sex Behav. 2019 Mar 11. doi: 10.1007/s10508-018-1331-3. [Epub ahead of print]
 
285.Pathophysiology and Treatment of Hepatitis B and C Infections in Patients With End-Stage Renal Disease
 

Soi V1, Daifi C2, Yee J2, Adams E2. Adv Chronic Kidney Dis. 2019 Jan;26(1):41-50. doi: 10.1053/j.ackd.2018.10.004.
 
286.Current state-of-the-art pharmacotherapy for the management of hepatitis B infection
 

Tillmann HL1,2, Samuel G1. Expert Opin Pharmacother. 2019 Mar 11:1-13. doi: 10.1080/14656566.2019.1583744. [Epub ahead of print]
 
287.Maintaining complete virological suppression by reduced doses of nucleos(t)ide analogue in patients with chronic hepatitis B
 

Hsu CW1,2, Yeh C3, Yeh CT1,2. J Med Virol. 2019 Feb 28. doi: 10.1002/jmv.25443. [Epub ahead of print]
 
288.Predictive Factors for Successful Vaccination Against Hepatitis B Surface Antigen in Patients Who Have Undergone Orthotopic Liver Transplantation
 

Ikeda A1, Takaki A, Yasunaka T, Oyama A, Adachi T, Wada N, Onishi H, Ikeda F, Shiraha H, Yoshida K, Kuise T, Nobuoka D, Yoshida R, Umeda Y, Yagi T, Fujiwara T, Okada H. Acta Med Okayama. 2019 Feb;73(1):41-50. doi: 10.18926/AMO/56457.
 
289.The necessity of education and hepatitis B vaccination for young people: A study of high risk behaviour for blood borne viruses in the United Kingdom
 

Sira J1, Brown M1, Ambegaokar S2, Modin L1, Kelly DA1. J Child Health Care. 2019 Feb 28:1367493519831499. doi: 10.1177/1367493519831499. [Epub ahead of print]
 
290.Safety and efficacy of stopping tenofovir disoproxil fumarate in patients with chronic hepatitis B following at least 8 years of therapy: a prespecified follow-up analysis of two randomised trials
 

Buti M1, Wong DK2, Gane E3, Flisiak R4, Manns M5, Kaita K6, Janssen HLA2, Op den Brouw M7, Jump B8, Kitrinos K8, Crans G8, Flaherty J8, Gaggar A8, Marcellin P9. Lancet Gastroenterol Hepatol. 2019 Apr;4(4):296-304. doi: 10.1016/S2468-1253(19)30015-9. Epub 2019 Feb 20.
 
291.The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals
 

Popping S1, Bade D2, Boucher C1,2, van der Valk M3, El-Sayed M4, Sigurour O5, Sypsa V6, Morgan T7, Gamkrelidze A8, Mukabatsinda C9, Deuffic-Burban S10, Ninburg M11, Feld J12, Hellard M13, Ward J14,15. J Virus Erad. 2019 Jan 1;5(1):60-66.
 
292.Achieving Excellence in Hepatitis B Virus Care for Veterans in the Veterans Health Administration
 

Chartier M1, Maier MM1, Morgan TR1, Lowy E1, Hoffman-Högg L1, Ross D1, Beste LA1. Fed Pract. 2018 Mar;35(Suppl 2):S49-S53.
 
293.Hepatitis B: Screening, Prevention, Diagnosis, and Treatment
 

Wilkins T1, Sams R1, Carpenter M1.Author informationAm Fam Physician. 2019 Mar 1;99(5):314-323.
 
294.Progress Toward Hepatitis B Control and Elimination of Mother-to-Child Transmission of Hepatitis B Virus - Western Pacific Region, 2005-2017
 

Woodring J, Pastore R, Brink A, Ishikawa N, Takashima Y, Tohme RA. MMWR Morb Mortal Wkly Rep. 2019 Mar 1;68(8):195-200. doi: 10.15585/mmwr.mm6808a2.
 
295.Antiviral therapy and the development of osteopenia/osteoporosis among Asians with chronic hepatitis B
 

Wei MT1, Le AK1, Chang MS2, Hsu H3, Nguyen P1, Zhang JQ4, Wong C5, Wong C6, Cheung R7, Nguyen MH1. J Med Virol. 2019 Feb 18. doi: 10.1002/jmv.25433. [Epub ahead of print]
 
296.A global meta-analysis on HIV, hepatitis C and hepatitis B among people who inject drugs - do gender differences vary by country-level indicators?
  Leung J1, Peacock A1, Colledge S2, Grebely J3, Cunningham EB3, Hickman M4, Vickerman P4, Stone J4, Trickey A4, Dumchev K5, Lynskey M6, Hines L4, Griffiths P7, Mattick RP1, Degenhardt L1, Larney S1. J Infect Dis. 2019 Feb 6. doi: 10.1093/infdis/jiz058. [Epub ahead of print]
 
297.Spontaneous loss of surface antigen among adults living with chronic hepatitis B virus infection: a systematic review and pooled meta-analyses
  Zhou K1, Contag C2, Whitaker E3, Terrault N4. Lancet Gastroenterol Hepatol. 2019 Jan 21. pii: S2468-1253(18)30308-X. doi: 10.1016/S2468-1253(18)30308-X. [Epub ahead of print]
 
298.Bridging the access gap: Medicare ineligibility in people living with chronic hepatitis B
  MacLachlan JH1,2, Cowie BC1,2,3. Intern Med J. 2019 Jan;49(1):122-125. doi: 10.1111/imj.14175.
 
299.Primary Care for Persons Who Inject Drugs
  Visconti AJ1, Sell J2, Greenblatt AD3. Am Fam Physician. 2019 Jan 15;99(2):109-116.
 
300.Characteristics of Deceased Solid Organ Donors and Screening Results for Hepatitis B, C, and Human Immunodeficiency Viruses - United States, 2010-2017
  Abara WE, Collier MG, Moorman A, Bixler D, Jones J, Annambhotla P, Bowman J, Levi ME, Brooks JT, Basavaraju SV. MMWR Morb Mortal Wkly Rep. 2019 Jan 25;68(3):61-66. doi: 10.15585/mmwr.mm6803a2.
 
301.Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection Among Patients With Newly Diagnosed Cancer From Academic and Community Oncology Practices
  Ramsey SD1, Unger JM2,3, Baker LH4, Little RF5, Loomba R6, Hwang JP7, Chugh R4, Konerman MA4, Arnold K2,3, Menter AR8, Thomas E9, Michels RM10, Jorgensen CW10, Burton GV11, Bhadkamkar NA7, Hershman DL12. JAMA Oncol. 2019 Jan 17. doi: 10.1001/jamaoncol.2018.6437. [Epub ahead of print]
 
302.Hepatitis B Virus Infection: What Is Current and New
  Peters MG1. Top Antivir Med. 2019 Jan;26(4):112-116.
 
303.Hepatitis B Treatment: What We Know Now and What Remains to Be Researched
  Suk-Fong Lok A1. Hepatol Commun. 2018 Nov 15;3(1):8-19. doi: 10.1002/hep4.1281. eCollection 2019 Jan.
 
304.Early steep decline of liver stiffness predicts histological reversal of fibrosis in chronic hepatitis B patients treated with entecavir
  Kong Y1, Sun Y1, Zhou J1, Wu X1, Chen Y2, Piao H3, Lu L4, Ding H5, Nan Y6, Jiang W7, Xu Y8, Xie W9, Li H10, Feng B11, Shi G12, Chen G13, Li H14, Zheng H15, Cheng J16, Wang T17, Liu H18, Fudong L18, Chen S17, Mao Y19, Sun J20, Chen T21, Han T22, Han Y23, Wang L1, Ou X1, Zhang H24, Jia J1, You H1. J Viral Hepat. 2019 Jan 9. doi: 10.1111/jvh.13058. [Epub ahead of print]
 
305.Prevalence of Hepatitis B and Hepatitis D Virus Infections in the United States, 2011-2016
  Patel EU1, Thio CL2, Boon D3, Thomas DL2, Tobian AAR1. Clin Infect Dis. 2019 Jan 3. doi: 10.1093/cid/ciz001. [Epub ahead of print]
 
306.Discovery of half-life of circulating HBsAg in patients with chronic hepatitis B infection using heavy water labeling
  Loomba R1, Decaris M2, Li KW2,3, Shankaran M3, Mohammed H2,3, Matthews M2,3, Richards LM1, Nguyen P1, Rizo E1, Andrews B1, Soto R1, Angel T3, Suri V4, Kitrinos KM4, Barnes D4, Czerwieniec G4, Brendza K4, Subramanian GM4, Gaggar A4, Hellerstein MK2,3. Clin Infect Dis. 2018 Dec 24. doi: 10.1093/cid/ciy1100. [Epub ahead of print]
 
307.New and Old Biomarkers for Diagnosis and Management of Chronic Hepatitis B Virus Infection
  Coffin CS1, Zhou K2, Terrault NA3. Gastroenterology. 2018 Nov 22. pii: S0016-5085(18)35285-5. doi: 10.1053/j.gastro.2018.11.037. [Epub ahead of print]
 
308.The push is on to cure hepatitis B, a long-overlooked scourge of millions
  Jon Cohen
 
309.Defining the therapeutic range for adalimumab and predicting response in psoriasis: a multicenter prospective observational cohort study
  Wilkinson N1, Tsakok T2, Dand N2, Bloem K3, Duckworth M4, Baudry D4, Pushpa-Rajah A4, Griffiths CE5, Reynolds N6, Barker J2, Warren RB5, Burden AD7, Rispens T3, Stocken D8, Smith C9; BSTOP study group and PSORT consortium. J Invest Dermatol. 2018 Aug 18. pii: S0022-202X(18)32482-5. doi: 10.1016/j.jid.2018.07.028. [Epub ahead of print]
 
310.Ustekinumab use in patients with severe psoriasis co-infected with hepatitis B and/or C
  Siegel S1, Winthrop K2, Ehst B3, Ortega Loayza A4. Br J Dermatol. 2018 Nov 20. doi: 10.1111/bjd.17444. [Epub ahead of print]
 
311.Prevalent misconceptions about opioid use disorders in the United States produce failed policy and public health responses
  Heimer R1,2, Hawk K3, Vermund SH1,4. Clin Infect Dis. 2018 Nov 17. doi: 10.1093/cid/ciy977. [Epub ahead of print]
 
312.Efficacy and safety of antiviral treatment on blocking the mother-to-child transmission of hepatitis B virus: a meta-analysis
  Song J1, Yang F1, Wang S1, Tikande S1, Deng Y1, Tang W1, Cao G1. J Viral Hepat. 2018 Nov 11. doi: 10.1111/jvh.13036. [Epub ahead of print]
 
313.Assessing the Impact of Electronic Health Record Interventions on Hepatitis B Screening and Vaccination
  Weir RC, Toyoji M, McKee M, Li V, Wang CC. J Health Care Poor Underserved. 2018;29(4):1587-1605. doi: 10.1353/hpu.2018.0114.
 
314.Acute Hepatitis B with Pancreatitis and Cholecystitis Leading to Acute Liver Failure and Death
  Albert AR1, Valencia R2, Smereck JA2. Clin Pract Cases Emerg Med. 2018 Aug 15;2(4):304-308. doi: 10.5811/cpcem.2018.7.38344. eCollection 2018 Nov.
 
315.Primary resistance of hepatitis B virus to nucleoside and nucleotide analogues
  Chevaliez S1,2, Rodriguez C1,2, Poiteau L1,2, Soulier A1,2, Donati F1,2, Darty-Mercier M1,2, Pioche C3, Leroy V4,5, Brodard V6, Zoulim F7,8, Brouard C3, Larsen C3, Semaille C3, Roudot-Thoraval F9, Pawlotsky JM1,2; Hepatology Reference Centers Laboratories Network for Chronic Hepatitis BSurveillance. J Viral Hepat. 2018 Oct 19. doi: 10.1111/jvh.13025. [Epub ahead of print]
 
316.Combination of entecavir/ peginterferon alfa-2a in children with HBeAg-positive immune tolerant chronic hepatitis B virus infection
  Rosenthal P1, Ling SC2, Belle SH3, Murray KF4, Rodriguez-Baez N5, Schwarzenberg SJ6, Teckman J7, Lin HS3, Schwarz KB8; Hepatitis B Research Network (HBRN). Hepatology. 2018 Oct 15. doi: 10.1002/hep.30312. [Epub ahead of print]
 
317.Serum HBV RNA: a New Potential Biomarker for Chronic Hepatitis B Virus Infection
  Liu S1, Zhou B1,2, Valdes JD2, Sun J1, Guo H2. Hepatology. 2018 Oct 25. doi: 10.1002/hep.30325. [Epub ahead of print]
 
318.Management of chronic hepatitis B during pregnancy
  Aslam A1, Campoverde Reyes KJ1,2, Malladi VR1, Ishtiaq R1, Lau DTY1. Gastroenterol Rep (Oxf). 2018 Nov;6(4):257-262. doi: 10.1093/gastro/goy025. Epub 2018 Jul 24.
 
319.Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type b vaccine: a randomized trial in the United States
  Klein NP1, Abu-Elyazeed R2, Cheuvart B3, Janssens W3, Mesaros N3. Hum Vaccin Immunother. 2018 Nov 16. doi: 10.1080/21645515.2018.1549449. [Epub ahead of print]
 
320.What is Needed to Eliminate Hepatitis B Virus and Hepatitis C Virus as Global Health Threats
  Ward JW1, Hinman AR2. Gastroenterology. 2018 Nov 1. pii: S0016-5085(18)35205-3. doi: 10.1053/j.gastro.2018.10.048. [Epub ahead of print]
 
321.Post-infection viral superinfection technology could treat HBV and HCV patients with unmet needs
  Bakacs T1, Safadi R2, Kovesdi I3. Hepatol Med Policy. 2018 Jan 5;3:2. doi: 10.1186/s41124-017-0028-x. eCollection 2018.
 
322.Lichen striatus-like eruption in an adult following hepatitis B vaccination: a case report and review of the literature
  Jones J1, Marquart JD, Logemann NF, DiBlasi DR. Dermatol Online J. 2018 Jul 15;24(7). pii: 13030/qt1hr764kv.
 
323.The impact of currently licensed therapies on viral and immune responses in Chronic Hepatitis B: considerations for future novel therapeutics
  Gill US1,2, Kennedy PTF1,2. J Viral Hepat. 2018 Nov 11. doi: 10.1111/jvh.13040. [Epub ahead of print]
 
324.A randomized trial of serological and cellular responses to hepatitis B vaccination in chronic kidney disease
  da Silva EN1,2,3, Baker A4, Alshekaili J1,2, Karpe K5, Cook MC1,2,3. PLoS One. 2018 Oct 10;13(10):e0204477. doi: 10.1371/journal.pone.0204477. eCollection 2018.
 
325.Racial/ethnic- and county-specific prevalence of chronic hepatitis B and its burden in California
  Toy M1, Wei B1, Virdi TS1, Le A2, Trinh H3, Li J4, Zhang J5, Hsing AW6, So SK1, Nguyen MH2. Hepatol Med Policy. 2018 Jun 5;3:6. doi: 10.1186/s41124-018-0034-7. eCollection 2018.
 
326.Hepatitis B Prevalence and Risk Factors in a Foreign-Born Asian and Pacific Islander Population at a Community Health Center in Hawai'i
  Ferrer A1, Katz AR1, Hurwitz EL1, Pham T2. Asia Pac J Public Health. 2018 Sep 22:1010539518800359. doi: 10.1177/1010539518800359. [Epub ahead of print]
 
327.Risk factors for liver disease among adults of Mexican descent in the United States and Mexico
  Flores YN1, Zhang ZF2, Bastani R3, Leng M4, Crespi CM5, Ramírez-Palacios P1, Stevens H6, Salmerón J1. World J Gastroenterol. 2018 Oct 7;24(37):4281-4290. doi: 10.3748/wjg.v24.i37.4281.
 
328.B in IT - a community-based model for the management of hepatitis B patients in primary care clinics using a novel web-based clinical tool
  O'Leary DA1, Cropp E1, Isaac D2,3, Desmond PV1, Bell S1, Nguyen T1, Wong D1, Howell J1, Richmond J4,5,6, O'Neill J7, Thompson AJ1. Hepatol Med Policy. 2018 Jan 4;3:1. doi: 10.1186/s41124-017-0031-2. eCollection 2018.
 
329.Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis
  Chen HY#1, Shen DT#1, Ji DZ#2, Han PC1, Zhang WM2, Ma JF1, Chen WS3, Goyal H4, Pan S1, Xu HG1. Gut. 2018 Sep 18. pii: gutjnl-2018-316601. doi: 10.1136/gutjnl-2018-316601. [Epub ahead of print]
 
330.Declining in liver stiffness can not indicate fibrosis regression in patients with chronic hepatitis B: A 78-week prospective study
  Dong XQ1, Wu Z1, Li J1,2, Wang GQ1,3,2, Zhao H1,2; China HepB-Related Fibrosis Assessment Research Group. J Gastroenterol Hepatol. 2018 Oct 5. doi: 10.1111/jgh.14498. [Epub ahead of print]
 
331.Adherence to Nucleos(t)ide Analogue Therapies for Chronic Hepatitis B Infection: A Systematic Review and Meta-Analysis
  Ford N1, Scourse R2, Lemoine M3, Hutin Y1, Bulterys M1, Shubber Z4, Donchuk D5, Wandeler G6. Hepatol Commun. 2018 Sep 25;2(10):1160-1167. doi: 10.1002/hep4.1247. eCollection 2018 Oct.
 
332.Healthcare Resource Utilization and Costs by Disease Severity in an Insured National Sample of US Patients with Chronic Hepatitis B
  Nguyen MH1, Ozbay AB2, Liou I3, Meyer N4, Gordon SC5, Dusheiko G6, Lim JK7. J Hepatol. 2018 Oct 1. pii: S0168-8278(18)32440-1. doi: 10.1016/j.jhep.2018.09.021. [Epub ahead of print]
 
333.Insights From Deep Sequencing of the HBV Genome-Unique, Tiny, and Misunderstood
  McNaughton AL1, D'Arienzo V2, Ansari MA1, Lumley SF3, Littlejohn M4, Revill P4, McKeating JA2, Matthews PC3. Gastroenterology. 2018 Sep 27. pii: S0016-5085(18)35076-5. doi: 10.1053/j.gastro.2018.07.058. [Epub ahead of print]
 
334.Hepatitis B and C
  Mysore KR1, Leung DH2. Clin Liver Dis. 2018 Nov;22(4):703-722. doi: 10.1016/j.cld.2018.06.002. Epub 2018 Aug 22.
 
335.Hepatocellular carcinoma among US and non-US-born patients with chronic hepatitis B: Risk factors and age at diagnosis
  Kennedy K1, Graham SM1,2, Arora N3, Shuhart MC4, Kim HN1,2. PLoS One. 2018 Sep 25;13(9):e0204031. doi: 10.1371/journal.pone.0204031. eCollection 2018.
 
336.The prevalence of undetectable vaccine-induced immunity against hepatitis B virus in US adults at high risk for infection
  Yeo YH1, Le MH1, Chang ET2, Henry L1, Nguyen MH1. Hepatology. 2018 Sep 23. doi: 10.1002/hep.30285. [Epub ahead of print]
 
337.Uptake and safety of Hepatitis B vaccination during pregnancy: A Vaccine Safety Datalink study
  Groom HC1, Irving SA2, Koppolu P2, Smith N2, Vazquez-Benitez G3, Kharbanda EO3, Daley MF4, Donahue JG5, Getahun D6, Jackson LA7, Tse Kawai A8, Klein NP9, McCarthy NL10, Nordin JD3, Sukumaran L10, Naleway AL2. Vaccine. 2018 Oct 1;36(41):6111-6116. doi: 10.1016/j.vaccine.2018.08.074. Epub 2018 Sep 5.
 
338.Blood donor testing for hepatitis B virus in the United States: is there a case for continuation of hepatitis B surface antigen detection?
  Dodd RY1, Nguyen ML2, Krysztof DE2, Notari EP1, Stramer SL2. Transfusion. 2018 Sep;58(9):2166-2170. doi: 10.1111/trf.14784. Epub 2018 Aug 24.
 
339.Advancing age and comorbidity in a United States insured population-based cohort of patients with chronic hepatitis B
  Nguyen MH1, Lim JK2, Ozbay AB3, Fraysse J3, Liou I4, Meyer N5, Dusheiko G6,7, Gordon SC8. Hepatology. 2018 Sep 2. doi: 10.1002/hep.30246. [Epub ahead of print]
 
340.HBV core variants, liver fibrosis and hepatocellular carcinoma
  Ligat G1,2, Schuster C1,2, Baumert TF1,2,3,4. Hepatology. 2018 Aug 23. doi: 10.1002/hep.30231. [Epub ahead of print]
 
341.Towards the elimination of hepatitis B and hepatocellular carcinoma
  Spearman CW1. S Afr Med J. 2018 Aug 8;108(8b):13-16. doi: 10.7196/SAMJ.2018.v108i8b.13496.
 
342.A Review of the Hepatitis B Foundation Website
  Spratt S1, Stewart M1, Paige SR2, Stellefson M1. Health Promot Pract. 2018 Aug 15:1524839918790938. doi: 10.1177/1524839918790938. [Epub ahead of print]
 
343.Resource Utilization and Outcomes of Medicare Recipients With Chronic Hepatitis B in the United States
  Kim M1, Paik J2, Golabi P1,2, Jeffers T2, Mishra A1, Younossi ZM1,2. J Clin Gastroenterol. 2018 Aug 13. doi: 10.1097/MCG.0000000000001110. [Epub ahead of print]
 
344.Preventing Perinatal Transmission of Hepatitis B Necessitates Consideration of Antiviral Treatment in Pregnancy
  Terrault N1, Brown R Jr2, Lok A3, Wong J4, Chang KM5, Jonas M6, McMahon B7. Hepatology. 2018 Aug 2. doi: 10.1002/hep.30137. [Epub ahead of print]
 
345.The efficacy of Tenofivir to prevent perinatal transmission in chronic hepatitis B mothers'. a clinical perspective
  Mubarak G1, Ferstenberg R2. Hepatology. 2018 Aug 2. doi: 10.1002/hep.30138. [Epub ahead of print]
 
346.Mortality among Patients with Chronic Hepatitis B (CHB) Infection: the Chronic Hepatitis Cohort Study (CHeCS)
  Bixler D1, Zhong Y1, Ly KN1, Moorman AC1, Spradling PR1, Teshale EH1, Rupp L LB2, Gordon SC2, Boscarino JA3, Schmidt MA4, Daida YG5, Holmberg SD1; CHeCS Investigators. Clin Infect Dis. 2018 Jul 28. doi: 10.1093/cid/ciy598. [Epub ahead of print]
 
347.Global HBV burden: guesstimates and facts
  Ginzberg D1,2, Wong RJ3, Gish R1,2. Hepatol Int. 2018 Jul;12(4):315-329. doi: 10.1007/s12072-018-9884-8. Epub 2018 Jul 27.
 
348.Commentary: A review of risk of hepatitis B and C transmission through biting or spitting
  Pintilie H1, Brook G2. J Viral Hepat. 2018 Jul 26. doi: 10.1111/jvh.12976. [Epub ahead of print]
 
349.Effect of Hepatocellular Carcinoma on Mortality Among Individuals With Hepatitis B or Hepatitis C Infection in New York City, 2001-2012
  Moore MS1, Bocour A1, Tran OC2, Qiao B3, Schymura MJ3, Laraque F4, Winters A4. Open Forum Infect Dis. 2018 Jun 16;5(7):ofy144. doi: 10.1093/ofid/ofy144. eCollection 2018 Jul.
 
350.Access to Treatment for Hepatitis B Virus Infection - Worldwide, 2016
  Hutin Y, Nasrullah M, Easterbrook P, Nguimfack BD, Burrone E, Averhoff F, Bulterys M. MMWR Morb Mortal Wkly Rep. 2018 Jul 20;67(28):773-777. doi: 10.15585/mmwr.mm6728a2.
 
351.Maternal Hepatitis B Infection and Pregnancy Outcomes in the United States: A Population-Based Cohort Study
  Bajema KL1, Stankiewicz Karita HC1, Tenforde MW1, Hawes SE2, Heffron R2,3. Open Forum Infect Dis. 2018 Jun 9;5(6):ofy134. doi: 10.1093/ofid/ofy134. eCollection 2018 Jun.
 
352.Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices
  Schillie S1, Vellozzi C1, Reingold A2, Harris A1, Haber P3, Ward JW1, Nelson NP1. MMWR Recomm Rep. 2018 Jan 12;67(1):1-31. doi: 10.15585/mmwr.rr6701a1.
 
353.Association Between Hepatitis B Infection and Pancreatic Cancer: A Population-Based Analysis in the United States
  Desai R, Patel U1, Sharma S2, Singh S3, Doshi S4, Shaheen S5, Shamim S6, Korlapati LS7, Balan S8, Bray C4, Williams R9, Shah N10. Pancreas. 2018 Aug;47(7):849-855. doi: 10.1097/MPA.0000000000001095.
 
354.Exploring the feasibility of targeted chronic hepatitis B screening in the emergency department: A pilot study
  Brock C1, Yi Y1, Papaluca T2, Lucas B3, Angus PW1,2, Taylor D1,4, Leung C1,2. Emerg Med Australas. 2018 Jun 9. doi: 10.1111/1742-6723.13118. [Epub ahead of print]
 
355.Safety and Efficacy of Vesatolimod (GS-9620) in Patients with Chronic Hepatitis B Who Are Not Currently on Antiviral Treatment
  Agarwal K1, Ahn SH2, Elkhashab M3, Lau AH4, Gaggar A4, Bulusu A4, Tian X4, Cathcart AL4, Woo J4, Subramanian GM4, Andreone P5, Kim HJ6, Chuang WL7, Nguyen MH8. J Viral Hepat. 2018 May 31. doi: 10.1111/jvh.12942. [Epub ahead of print]
 
356.Strategies for the treatment of HBV/HDV
  Krause A1, Haberkorn U1, Mier W1. Eur J Pharmacol. 2018 Jun 20. pii: S0014-2999(18)30360-1. doi: 10.1016/j.ejphar.2018.06.030. [Epub ahead of print]
 
357.Defective T-cell immunity in hepatitis B virus infection: why therapeutic vaccination needs a helping hand
  Maini MK1, Pallett LJ2. Lancet Gastroenterol Hepatol. 2018 Mar;3(3):192-202. doi: 10.1016/S2468-1253(18)30007-4.
 
358.Hepatitis B vaccination and screening among foreign-born women of reproductive age in the United States: 2013-2015
  Kilmer GA1, Barker LK1, Ly KN1, Jiles RB1. Clin Infect Dis. 2018 Jun 1. doi: 10.1093/cid/ciy479. [Epub ahead of print]
 
359.Hepatitis B virus reactivation in patients treated with immunosuppressive drugs: a practical guide for clinicians
  Koffas A1, Dolman GE2, Kennedy PT3. Clin Med (Lond). 2018 Jun;18(3):212-218. doi: 10.7861/clinmedicine.18-3-212.
 
360.Clinical epidemiology of chronic viral hepatitis B: A Tuscany real-word large-scale cohort study
  Stasi C1, Silvestri C1, Berni R2, Brunetto MR3, Zignego AL4, Orsini C2, Milani S5, Ricciardi L6, De Luca A7, Blanc P8, Nencioni C9, Aquilini D10, Bartoloni A11, Bresci G12, Marchi S13, Filipponi F14, Colombatto P3, Forte P5, Galli A5, Luchi S6, Chigiotti S9, Nerli A10, Corti G11, Sacco R12, Carrai P14, Ricchiuti A13, Giusti M15, Almi P16, Cozzi A5, Carloppi S17, Laffi G18, Voller F1, Cipriani F19. World J Hepatol. 2018 May 27;10(5):409-416. doi: 10.4254/wjh.v10.i5.409.
 
361.An ultra-sensitive Abbott ARCHITECT® assay for the detection of hepatitis Bvirus surface antigen (HBsAg)
  Lou S1, Taylor R2, Pearce S3, Kuhns M4, Leary T5. J Clin Virol. 2018 May 21;105:18-25. doi: 10.1016/j.jcv.2018.05.009. [Epub ahead of print]
 
362.Switching to tenofovir vs continuing entecavir for hepatitis B virus with partial virologic response to entecavir: a randomized controlled trial
  Yim HJ1, Kim IH2, Suh SJ1, Jung YK1,3, Kim JH4, Seo YS5, Yeon JE4, Kim CW6, Kwon SY7, Park SH8, Lee MS8, Um SH5, Byun KS4. J Viral Hepat. 2018 May 17. doi: 10.1111/jvh.12934. [Epub ahead of print]
 
363.Hepatitis B Virus Testing and Care among Pregnant Women Using Commercial Claims Data, United States, 2011-2014
  Harris AM1, Isenhour C1, Schillie S1, Vellozzi C1. Infect Dis Obstet Gynecol. 2018 Apr 1;2018:4107329. doi: 10.1155/2018/4107329. eCollection 2018.
 
364.Hepatitis D Viremia Among Injection Drug Users in San Francisco
  Mahale P1, Aka PV1,2, Chen X3,4, Liu P3, Fram BJ5, Wang AS1, Simenel S5, Tseng FC1, Chen S6, Edlin BR7,8, Glenn JS3,5, O'Brien TR1. J Infect Dis. 2018 May 25;217(12):1902-1906. doi: 10.1093/infdis/jiy157.
 
365.Examining Hepatitis, A and B Vaccination, and HBV Reactivation Monitoring During Direct-Acting Antiviral Therapy for Hepatitis C
  Davison J1, O'Shea A2,3, Waterbury N4,5, Villalvazo Y2,6. J Community Health. 2018 May 30. doi: 10.1007/s10900-018-0530-0. [Epub ahead of print]
 
366.Hepatitis B virus (HBV) reactivation-The potential role of direct-acting agents for hepatitis C virus (HCV)
  Blackard JT1, Sherman KE1. Rev Med Virol. 2018 May 15:e1984. doi: 10.1002/rmv.1984. [Epub ahead of print]
 
367.Entecavir or tenofovir monotherapy prevents HBV recurrence in liver transplant recipients: A 5-year follow-up study after hepatitis B immunoglobulin withdrawal
  Manini MA1, Whitehouse G2, Bruce M2, Passerini M3, Lim TY2, Carey I2, Considine A2, Lampertico P3, Suddle A2, Heaton N2, Heneghan M2, Agarwal K2. Dig Liver Dis. 2018 Apr 13. pii: S1590-8658(18)30673-X. doi: 10.1016/j.dld.2018.03.032. [Epub ahead of print]
 
368.Community-Based Services to Improve Testing and Linkage to Care Among Non-U.S.-Born Persons with Chronic Hepatitis B Virus Infection - Three U.S. Programs, October 2014-September 2017
  Harris AM, Link-Gelles R, Kim K, Chandrasekar E, Wang S, Bannister N, Pong P, Chak E, Chen MS Jr, Bowlus C, Nelson NP. MMWR Morb Mortal Wkly Rep. 2018 May 18;67(19):541-546. doi: 10.15585/mmwr.mm6719a2.
 
369.Incidence of Hepatitis B Virus Reactivation and Hepatotoxicity in Patients Receiving Long-term Treatment With Tumor Necrosis Factor Antagonists
  Pauly MP1, Tucker LY2, Szpakowski JL2, Ready JB2, Baer D2, Hwang JP3, Lok AS4. Clin Gastroenterol Hepatol. 2018 Apr 24. pii: S1542-3565(18)30394-X. doi: 10.1016/j.cgh.2018.04.033. [Epub ahead of print]
 
370.Why, who and when to start treatment for chronic hepatitis B infection
  Dolman GE1, Koffas A2, Mason WS3, Kennedy PT4. Curr Opin Virol. 2018 Apr 11;30:39-47. doi: 10.1016/j.coviro.2018.03.006. [Epub ahead of print]
 
371.Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety?
  Hill A1, Hughes SL2, Gotham D2, Pozniak AL3. J Virus Erad. 2018 Apr 1;4(2):72-79.
 
372.Efficacy and Safety of Peginterferon Alfa-2a (40KD) in Children with Chronic Hepatitis B: The PEG-B-ACTIVE Study
  Wirth S1, Zhang H2, Hardikar W3, Schwarz KB4, Sokal E5, Yang W6, Fan H7, Morozov V8, Mao Q9, Deng H10, Yang Huang11, Yang L11, Frey N12, Nasmyth-Miller C13, Pavlovic V13, Wat C13. Hepatology. 2018 Apr 24. doi: 10.1002/hep.30050. [Epub ahead of print]
 
373.When do co-infections matter?
  McArdle AJ1, Turkova A2, Cunnington AJ3. Curr Opin Infect Dis. 2018 Jun;31(3):209-215. doi: 10.1097/QCO.0000000000000447.
 
374.Recommendations of the Advisory Committee on Immunization Practices for Use of a Hepatitis B Vaccine with a Novel Adjuvant
  Schillie S, Harris A, Link-Gelles R, Romero J, Ward J, Nelson N. MMWR Morb Mortal Wkly Rep. 2018 Apr 20;67(15):455-458. doi: 10.15585/mmwr.mm6715a5.
 
375.Cost Analysis of Single-Dose Hepatitis B Revaccination Among Infants Born to Hepatitis B Surface Antigen-Positive Mothers and Not Responding to the Initial Vaccine Series
  Hall EW1, Rosenberg ES2, Trigg M1, Nelson N3, Schillie S3. Public Health Rep. 2018 Jan 1:33354918768224. doi: 10.1177/0033354918768224. [Epub ahead of print]
 
376.From Infancy and Beyond… Ensuring a lifetime of hepatitis B virus (HBV) vaccine-induced immunity
  Osiowy C1. Hum Vaccin Immunother. 2018 Apr 11:1-21. doi: 10.1080/21645515.2018.1462428. [Epub ahead of print]
 
377.Gene Therapy for Chronic HBV-Can We Eliminate cccDNA?
  Bloom K1, Maepa MB2, Ely A3, Arbuthnot P4. Genes (Basel). 2018 Apr 12;9(4). pii: E207. doi: 10.3390/genes9040207.
 
378.Chronic hepatitis B virus and liver fibrosis: A mathematical model
  Friedman A1, Siewe N2. PLoS One. 2018 Apr 10;13(4):e0195037. doi: 10.1371/journal.pone.0195037. eCollection 2018.
 
379.Dolutegravir-based maintenance monotherapy versus dual therapy with lamivudine: a planned 24 week analysis of the DOLAM randomized clinical trial
  Blanco JL1, Rojas J1, Paredes R2, Negredo E2, Mallolas J1, Casadella M2, Clotet B2, Gatell JM1, de Lazzari E1, Martinez E1; DOLAM Study Team. J Antimicrob Chemother. 2018 Mar 28. doi: 10.1093/jac/dky093. [Epub ahead of print]
 
380.Social Media for Hepatitis B Awareness: Young Adult and Community Leader Perspectives
  Cohen C1, Alber JM2, Bleakley A3, Grossman S4, Freeland C1, Alarcon K1, Merchant RM3. Health Promot Pract. 2018 Mar 1:1524839918765438. doi: 10.1177/1524839918765438. [Epub ahead of print]
 
381.Hepatitis B Reactivation in the Treatment of Non-Hodgkin Lymphoma
  Kelling M1, Sokol L2, Dalia S3. Cancer Control. 2018 Jan-Mar;25(1):1073274818767879. doi: 10.1177/1073274818767879.
 
382.Relationship Between Metabolic Syndrome, Alanine Aminotransferase Levels, and Liver Disease Severity in a Multiethnic North American Cohort With Chronic Hepatitis B
  Khalili M1, Shuhart MC2, Lombardero M3, Feld JJ4, Kleiner DE5, Chung RT6, Terrault NA7, Lisker-Melman M8, Sanyal A9, Lok AS10; Hepatitis B Research Network (HBRN). Collaborators (36) Diabetes Care. 2018 Mar 29. pii: dc180040. doi: 10.2337/dc18-0040. [Epub ahead of print]
 
383.Mathematical model of immune response to hepatitis B
  Fatehi Chenar F1, Kyrychko YN1, Blyuss KB2. J Theor Biol. 2018 Mar 21;447:98-110. doi: 10.1016/j.jtbi.2018.03.025. [Epub ahead of print]
 
384.A Public Health Analysis on Gaps in Disease Monitoring and Opportunities for Improved Care for the Management of Hepatitis B and C
  Akhtar F1, Rehman S2. Cureus. 2018 Jan 16;10(1):e2077. doi: 10.7759/cureus.2077.
 
385.Long-term immunity to hepatitis B following vaccination in infancy: Real-world data analysis
  Klinger G1, Chodick G2, Levy I3. Vaccine. 2018 Mar 21. pii: S0264-410X(18)30373-6. doi: 10.1016/j.vaccine.2018.03.028. [Epub ahead of print]
 
386.Hepatitis B vaccine non-responders: possible mechanisms and solutions
  Saco TV1, Strauss AT1, Ledford DK1. Ann Allergy Asthma Immunol. 2018 Mar 19. pii: S1081-1206(18)30215-1. doi: 10.1016/j.anai.2018.03.017. [Epub ahead of print]
 
387.When do coinfections matter?
  McArdle AJ1, Turkova A2, Cunnington AJ3. Curr Opin Infect Dis. 2018 Mar 22. doi: 10.1097/QCO.0000000000000447. [Epub ahead of print]
 
388.Hepatitis B Virus Blood Screening: Need for Reappraisal of Blood Safety Measures?
  Candotti D1, Laperche S1. Front Med (Lausanne). 2018 Feb 21;5:29. doi: 10.3389/fmed.2018.00029. eCollection 2018.
 
389.Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B
  Jourdain G1, Ngo-Giang-Huong N1, Harrison L1, Decker L1, Khamduang W1, Tierney C1, Salvadori N1, Cressey TR1, Sirirungsi W1, Achalapong J1, Yuthavisuthi P1, Kanjanavikai P1, Na Ayudhaya OP1, Siriwachirachai T1, Prommas S1, Sabsanong P1, Limtrakul A1, Varadisai S1, Putiyanun C1, Suriyachai P1, Liampongsabuddhi P1, Sangsawang S1, Matanasarawut W1, Buranabanjasatean S1, Puernngooluerm P1, Bowonwatanuwong C1, Puthanakit T1, Klinbuayaem V1, Thongsawat S1, Thanprasertsuk S1, Siberry GK1, Watts DH1, Chakhtoura N1, Murphy TV1, Nelson NP1, Chung RT1, Pol S1, Chotivanich N1. N Engl J Med. 2018 Mar 8;378(10):911-923. doi: 10.1056/NEJMoa1708131.
 
390.Effect of Hepatitis B virus on Steatosis in Hepatitis C virus co-infected subjects: a multi-center study and systematic review
  Goossens N1, de Vito C2, Mangia A3, Clément S2, Cenderello G4, Barrera F5, D'Ambrosio R6, Coppola N7, Zampino R8, Stanzione M9, Adinolfi LE8, Wedemeyer H10, Semmo N11, Müllhaupt B12, Semela D13, Malinverni R14, Moradpour D15, Heim M16, Trincucci G17, Rubbia-Brandt L2, Negro F1,2; BOSTIC Study Group. J Viral Hepat. 2018 Mar 13. doi: 10.1111/jvh.12891. [Epub ahead of print]
 
391.Hepatitis B virus and risk of non-Hodgkin lymphoma: an updated meta-analysis of 58 studies
  Li M1, Gan Y1, Fan C2, Yuan H1, Zhang X3, Shen Y4, Wang Q1, Meng Z1, Xu D1, Tu H1. J Viral Hepat. 2018 Mar 13. doi: 10.1111/jvh.12892. [Epub ahead of print]
 
392.Vaccination coverage among foreign-born and U.S.-born adolescents in the United States: Successes and gaps - National Immunization Survey-Teen, 2012-2014
  Healy J1, Rodriguez-Lainz A2, Elam-Evans LD3, Hill HA3, Reagan-Steiner S4, Yankey D3. Vaccine. 2018 Mar 20;36(13):1743-1750. doi: 10.1016/j.vaccine.2018.02.052. Epub 2018 Feb 23.
 
393.HIV/HCV/HBV testing in the emergency department: a feasibility and seroprevalence study
  Bradshaw D1, Rae C1, Rayment M1, Turner N1, Turner R1, Pickard G2, Pillay K1, Roberts P1, Foxton M1, Sullivan AK1. HIV Med. 2018 Feb;19 Suppl 1:52-57. doi: 10.1111/hiv.12590.
 
394.Effects of Treatment of Chronic HBV Infection on Patient-reported Outcomes
  Younossi ZM1, Stepanova M2, Janssen HLA3, Agarwal K4, Nguyen MH5, Gane E6, Tsai N7, Younossi I2, Racila A2. Clin Gastroenterol Hepatol. 2018 Mar 2. pii: S1542-3565(18)30225-8. doi: 10.1016/j.cgh.2018.02.037. [Epub ahead of print]
 
395.Long-Term Follow-up and Quantitative Hepatitis B Surface Antigen Monitoring in North American Chronic HBV Carriers
  O'Neil CR1, Congly SE2, Rose MS3, Lee SS2, Borman MA2, Charlton CL4, Osiowy C5, Swain MG2, Burak KW2, Coffin CS6. Ann Hepatol. 2018 Mar 1;17(2):232-241. doi: 10.5604/01.3001.0010.8640.
 
396.Epidemiology and Treatment of Hepatitis B in Prisoners
  Smith JM1, Uvin AZ1,2, Macmadu A3,4, Rich JD1,3,5. Curr Hepatol Rep. 2017 Sep;16(3):178-183. doi: 10.1007/s11901-017-0364-8. Epub 2017 Aug 7.
 
397.Age-Specific Global Prevalence of Hepatitis B, Hepatitis C, HIV, and Tuberculosis Among Incarcerated People: A Systematic Review
  Kinner SA1, Snow K2, Wirtz AL3, Altice FL4, Beyrer C3, Dolan K5. J Adolesc Health. 2018 Mar;62(3S):S18-S26. doi: 10.1016/j.jadohealth.2017.09.030.
 
398.Phase IV randomized clinical study: Peginterferon alfa-2a with adefovir or entecavir pre-therapy for HBeAg-positive chronic hepatitis B
  Hsu CW1, Su WW2, Lee CM3, Peng CY4, Chuang WL5, Kao JH6, Chu HC7, Huang YH8, Chien RN9, Liaw YF10. J Formos Med Assoc. 2018 Feb 15. pii: S0929-6646(17)30716-7. doi: 10.1016/j.jfma.2017.12.007. [Epub ahead of print]
 
399.Improving a process to obtain hepatitis B serology among patients treated with infliximab at a large urban children's hospital
  Jean MR1, Weaver A1, Mastin-Diebold T1, Kissinger K1, Smitherman EA2, Favier L2, Danziger-Isakov L3, Williams E1, Brady RC3, Huggins J2, Denson LA1, Saeed SA1, Morgan P1, Dykes DMH1. BMJ Open Qual. 2017 Oct 18;6(2):e000092. doi: 10.1136/bmjoq-2017-000092. eCollection 2017.
 
400.Role of HBx in hepatitis B virus persistence and its therapeutic implications
  Slagle BL1, Bouchard MJ2. Curr Opin Virol. 2018 Feb 15;30:32-38. doi: 10.1016/j.coviro.2018.01.007. [Epub ahead of print]
 
401.8-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population
  Papatheodoridis GV1, Sypsa V2, Dalekos G3, Yurdaydin C4, Van Boemmel F5, Buti M6, Goulis J7, Luis Calleja J8, Chi H9, Manolakopoulos S10, Loglio A11, Siakavellas S12, Gatselis N3, Kesk?n O4, Lehretz M5, Savvidou S7, de la Revilla J8, Hansen BE9, Kourikou A10, Vlachogiannakos I12, Galanis K3, Idilman R4, Colombo M13, Esteban R6, Janssen HLA14, Berg T5, Lampertico P11. J Hepatol. 2018 Feb 7. pii: S0168-8278(18)30081-3. doi: 10.1016/j.jhep.2018.01.031. [Epub ahead of print]
 
402.Long-term safety and efficacy of nucleo(t)side analogue therapy in hepatitis B
  Buti M1,2, Riveiro-Barciela M1,2, Esteban R1,2. Liver Int. 2018 Feb;38 Suppl 1:84-89. doi: 10.1111/liv.13641.
 
403.Treatment of hepatitis B: Is there still a role for interferon?
  Viganò M1, Grossi G2, Loglio A2, Lampertico P2. Liver Int. 2018 Feb;38 Suppl 1:79-83. doi: 10.1111/liv.13635.
 
404.Management of chronic hepatitis B patients in immunetolerant phase: what latest guidelines recommend
  Wong GL1,2,3. Clin Mol Hepatol. 2018 Jan 22. doi: 10.3350/cmh.2017.0068. [Epub ahead of print]
 
405.Influence of antiviral therapy on the liver stiffness in chronic HBV hepatitis
  Rinaldi L1, Ascione A2, Messina V3, Rosato V4, Valente G5, Sangiovanni V6, Zampino R4, Marrone A4, Fontanella L4, de Rosa N7, Orabona P8, Buonomo C8, Chirianni A6, Adinolfi LE4, Piai G5. Infection. 2018 Jan 15. doi: 10.1007/s15010-017-1113-1. [Epub ahead of print]
 
406.Liver sampling: a vital window into HBV pathogenesis on the path to functional cure
  Gill US1, Pallett LJ2, Kennedy PTF1, Maini MK2. Gut. 2018 Jan 13. pii: gutjnl-2017-314873. doi: 10.1136/gutjnl-2017-314873. [Epub ahead of print]
 
407.Factors associated with non-adherence to HBV antiviral therapy
  Sheppard-Law S1,2,3, Zablotska-Manos I3, Kermeen M4, Holdaway S5, Lee A4, George J5,6, Zekry A7,8, Maher L3. Antivir Ther. 2017 Jan 22. doi: 10.3851/IMP3219. [Epub ahead of print]
 
408.Using Population Based Hospitalization Data to Monitor Increases in Conditions Causing Morbidity Among Persons Who Inject Drugs
  Collier MG1, Doshani M2, Asher A2. J Community Health. 2018 Jan 5. doi: 10.1007/s10900-017-0458-9. [Epub ahead of print]
 
409.Brief report: Prevalence of hepatitis B and C virus infections in U.S. Air Force basic military trainees who donated blood, 2013-2016
  Taylor DF, Cho RS, Okulicz JF, Webber BJ, Gancayco JG. MSMR. 2017 Dec;24(12):20-22.
 
410.Influence of birth origin and risk factor profile on hepatitis B mortality: Philadelphia, PA 2003-2013
  Higgins DC1, Kuncio DE2, Johnson CC2, Viner KM2. Ann Epidemiol. 2017 Dec 22. pii: S1047-2797(17)30891-8. doi: 10.1016/j.annepidem.2017.12.006. [Epub ahead of print]
 
411.Low Prevalence of Hepatitis B Vaccination Among Patients Receiving Medical Care for HIV Infection in the United States, 2009 to 2012
  Weiser J1, Perez A1, Bradley H1, King H1, Shouse RL1. Ann Intern Med. 2017 Dec 26. doi: 10.7326/M17-1689. [Epub ahead of print]
 
412.Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis Bvaccine in adults
  Jackson S1, Lentino J2, Kopp J3, Murray L4, Ellison W5, Rhee M6, Shockey G7, Akella L8, Erby K9, Heyward WL10, Janssen RS11; HBV-23 Study Group. Vaccine. 2017 Dec 27. pii: S0264-410X(17)31791-7. doi: 10.1016/j.vaccine.2017.12.038. [Epub ahead of print]
 
413.Impact of Enhanced Health Interventions for United States-Bound Refugees: Evaluating Best Practices in Migration Health
  Mitchell T1, Lee D1, Weinberg M1, Phares C1, James N2, Amornpaisarnloet K2, Aumpipat L2, Cooley G3, Davies A2, Tin Shwe VD2, Gajdadziev V2, Gorbacheva O2, Khwan-Niam C2, Klosovsky A4, Madilokkowit W2, Martin D3, Htun Myint NZ2, Yen Nguyen TN2, Nutman TB5, O'Connell EM5, Ortega L1, Prayadsab S2, Srimanee C2, Supakunatom W2, Vesessmith V2, Stauffer WM6,1. Am J Trop Med Hyg. 2017 Dec 18. doi: 10.4269/ajtmh.17-0725. [Epub ahead of print]
 
414.Association between virus exposure and depression in US adults
  Gale SD1, Berrett AN2, Erickson LD3, Brown BL2, Hedges DW4. Psychiatry Res. 2017 Dec 20;261:73-79. doi: 10.1016/j.psychres.2017.12.037. [Epub ahead of print]
 
415.Upcoming pharmacological developments in chronic hepatitis B: can we glimpse a cure on the horizon?
  Alonso S1, Guerra AR1, Carreira L1, Ferrer JÁ1, Gutiérrez ML1, Fernandez-Rodriguez CM2. BMC Gastroenterol. 2017 Dec 21;17(1):168. doi: 10.1186/s12876-017-0726-2.
 
416.Management of Hepatitis B Infection in Pregnancy
  Bartholomew ML1, Lee MJ. Clin Obstet Gynecol. 2017 Dec 15. doi: 10.1097/GRF.0000000000000331. [Epub ahead of print]
 
417.Research priorities for the discovery of a cure for chronic hepatitis B: Report of a workshop
  Block TM1, Alter H2, Brown N3, Brownstein A4, Brosgart C5, Chang KM6, Chen PJ7, Cohen C3, El-Serag H8, Feld J9, Gish R10, Glenn J11, Greten TF12, Guo JT4, Hoshida Y13, Kowdley KV14, Li W15, Lok AS16, McMahon B17, Mehta A18, Perrillo R19, Rice CM20, Rinaudo J12, Schinazi RF21, Shetty K22.Author informationAntiviral Res. 2017 Dec 14;150:93-100. doi: 10.1016/j.antiviral.2017.12.006. [Epub ahead of print]
 
418.A Pilot Program Integrating Hepatitis B Virus (HBV) Screening into an Outpatient Endoscopy Unit Improves HBV Screening Among an Ethnically Diverse Safety-Net Hospital
  Campbell B1, Lopez A2, Liu B3, Bhuket T3, Wong RJ4. Dig Dis Sci. 2017 Dec 5. doi: 10.1007/s10620-017-4870-x. [Epub ahead of print]
 
419.Unmet Needs in Clinical and Basic Hepatitis B Virus Research
  Su TH1,2, Kao JH1,2,3,4. J Infect Dis. 2017 Nov 16;216(suppl_8):S750-S756. doi: 10.1093/infdis/jix382.
 
420.Practice Patterns in Hepatitis B Virus Screening Before Cancer Chemotherapy in a Major US Hospital Network
  Kwak YE1, Stein SM2, Lim JK3. Dig Dis Sci. 2017 Nov 24. doi: 10.1007/s10620-017-4850-1. [Epub ahead of print]
 
421.Assessing the safety of hepatitis B vaccination during pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 1990-2016
  Moro PL1, Zheteyeva Y2, Barash F3, Lewis P4, Cano M4. Vaccine. 2017 Nov 23. pii: S0264-410X(17)31603-1. doi: 10.1016/j.vaccine.2017.11.039. [Epub ahead of print]
 
422.Antiviral Drugs in Newborn and Children
  Poole CL1, Kimberlin DW2. Pediatr Clin North Am. 2017 Dec;64(6):1403-1415. doi: 10.1016/j.pcl.2017.08.014.
 
423.Hepatitis B reactivation and outcomes in persons treated with directly acting antiviral agents against hepatitis C virus: results from ERCHIVES
  Butt AA1,2,3, Yan P1, Shaikh OS1,4, Abou-Samra AB2. Aliment Pharmacol Ther. 2017 Nov 27. doi: 10.1111/apt.14426. [Epub ahead of print]
 
424.The HepTestContest: a global innovation contest to identify approaches to hepatitis B and C testing
  Tucker JD1,2,3, Meyers K4,5, Best J4,6,7, Kaplan K7, Pendse R8, Fenton KA4,9, Andrieux-Meyer I10, Figueroa C11, Goicochea P12, Gore C13,14, Ishizaki A14, Khwairakpam G15, Miller V12, Mozalevskis A16, Ninburg M17, Ocama P18, Peeling R19, Walsh N20, Colombo MG21,22, Easterbrook P11. BMC Infect Dis. 2017 Nov 1;17(Suppl 1):701. doi: 10.1186/s12879-017-2771-4.
 
425.Diagnostic accuracy of tests to detect hepatitis B surface antigen: a systematic review of the literature and meta-analysis
  Amini A1, Varsaneux O1, Kelly H1, Tang W2,3, Chen W4, Boeras DI1, Falconer J1, Tucker JD2,3, Chou R5, Ishizaki A6, Easterbrook P6, Peeling RW7. BMC Infect Dis. 2017 Nov 1;17(Suppl 1):698. doi: 10.1186/s12879-017-2772-3.
 
426.Diagnostic accuracy of serological diagnosis of hepatitis C and B using dried blood spot samples (DBS): two systematic reviews and meta-analyses
  Lange B1,2, Cohn J3, Roberts T4, Camp J5, Chauffour J6, Gummadi N7, Ishizaki A8, Nagarathnam A9, Tuaillon E10,11, van de Perre P10,11, Pichler C12, Easterbrook P8, Denkinger CM4. BMC Infect Dis. 2017 Nov 1;17(Suppl 1):700. doi: 10.1186/s12879-017-2777-y.
 
427.Vaccinations in Older Adults
  Burke M1, Rowe T2. Clin Geriatr Med. 2018 Feb;34(1):131-143. doi: 10.1016/j.cger.2017.08.006. Epub 2017 Oct 14.
 
428.Hepatitis B and liver transplantation
  Ferrarese A1, Zanetto A1, Russo FP2. Minerva Gastroenterol Dietol. 2017 Nov 10. doi: 10.23736/S1121-421X.17.02453-9. [Epub ahead of print]
 
429.Safety, Efficacy and Pharmacodynamics of Vesatolimod (GS-9620) in Virally-Suppressed Patients with Chronic Hepatitis B
  Janssen HLA1, Brunetto MR2, Kim YJ3, Ferrari C4, Massetto B5, Nguyen AH5, Joshi A5, Woo J5, Lau AH5, Gaggar A5, Subramanian GM5, Yoshida EM6, Ahn SH7, Tsai NCS8, Fung S9, Gane EJ10. J Hepatol. 2017 Nov 2. pii: S0168-8278(17)32408-X. doi: 10.1016/j.jhep.2017.10.027. [Epub ahead of print]
 
430.Immunotherapy for Hepatitis B in the Direct Acting Anti-viral Era: Reevaluating the Thymosin ?1 Efficacy Trials in Light of a Combination Therapy Approach
  Naylor PH1, Mutchnick MG1. J Viral Hepat. 2017 Oct 20. doi: 10.1111/jvh.12807. [Epub ahead of print]
 
431.Assessment of Adherence to Baseline Quality Measures for Cirrhosis and the Impact of Performance Feedback in a Regional VA Medical Center
  Cahill JA1, Rizvi S1, Saeian K1. Am J Med Qual. 2017 Oct 1:1062860617736805. doi: 10.1177/1062860617736805. [Epub ahead of print]
 
432.Viral factors for HBV mother-to-child transmission
  Park JS1, Pan CQ2. Hepatol Int. 2017 Oct 12. doi: 10.1007/s12072-017-9825-y. [Epub ahead of print]
 
433.Social Determinants of Health Associated with HBV Testing and Access to Care among Foreign-born Persons Residing in the United States: 2009 - 2012
  Greene KM1, Duffus WA1, Xing J1, King H1. J Health Dispar Res Pract. 2017 Spring;10(2):1-20.
 
434.The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015
  Global Burden of Disease Liver Cancer Collaboration, Akinyemiju T1, Abera S2,3, Ahmed M4, Alam N5,6, Alemayohu MA7, Allen C8, Al-Raddadi R9, Alvis-Guzman N10, Amoako Y11, Artaman A12, Ayele TA13, Barac A14, Bensenor I15, Berhane A16, Bhutta Z17,18, Castillo-Rivas J19, Chitheer A20, Choi JY21, Cowie B22, Dandona L8,23, Dandona R8,23, Dey S24, Dicker D8, Phuc H25, Ekwueme DU26, Zaki MES27, Fischer F28, Fürst T29,30,31, Hancock J8, Hay SI8, Hotez P32,33, Jee SH34, Kasaeian A35, Khader Y36, Khang YH37, Kumar GA38, Kutz M8, Larson H39, Lopez A8,40, Lunevicius R41,42, Malekzadeh R43, McAlinden C44, Meier T45, Mendoza W46, Mokdad A8, Moradi-Lakeh M47,48, Nagel G49, Nguyen Q25, Nguyen G8, Ogbo F50,51, Patton G52, Pereira DM53, Pourmalek F54, Qorbani M55, Radfar A56, Roshandel G57, Salomon JA58, Sanabria J59,60, Sartorius B61, Satpathy M62,63, Sawhney M64, Sepanlou S43, Shackelford K8, Shore H65, Sun J66, Mengistu DT67, Topór-Madry R68,69, Tran B70,71, Ukwaja KN72, Vlassov V73, Vollset SE74,75, Vos T8, Wakayo T76, Weiderpass E77,78,79, Werdecker A80, Yonemoto N81, Younis M82,83, Yu C84, Zaidi Z85,86, Zhu L87, Murray CJL8, Naghavi M8, Fitzmaurice C8,88. JAMA Oncol. 2017 Oct 5. doi: 10.1001/jamaoncol.2017.3055. [Epub ahead of print]
 
435.Association Between Hepatic Steatosis, Measured by Controlled Attenuation Parameter, and Fibrosis Burden in Chronic Hepatitis B
  Seto WK1, Hui RW2, Mak LY2, Fung J3, Cheung KS2, Liu KS2, Wong DK3, Lai CL3, Yuen MF4. Clin Gastroenterol Hepatol. 2017 Sep 29. pii: S1542-3565(17)31186-2. doi: 10.1016/j.cgh.2017.09.044. [Epub ahead of print]
 
436.Black Box Warning for Possible HBV Reactivation During DAA Therapy for Chronic HCV Infection
  Pockros PJ1. Gastroenterol Hepatol (N Y). 2017 Sep;13(9):536-540.
 
437.Emerging Trends in Epidemiology of Hepatitis B Virus Infection
  Stasi C1,2, Silvestri C1, Voller F1. J Clin Transl Hepatol. 2017 Sep 28;5(3):272-276. doi: 10.14218/JCTH.2017.00010. Epub 2017 May 30.
 
438.Incidence, determinants and outcomes of pregnancy-associated hepatitis Bflares: A regional hospital-based cohort study
  Kushner T1,2,3, Shaw PA3, Kalra A4, Magaldi L5, Monpara P5, Bedi G6, Krok K6, Centkowski S2, Dalldorf K2, D'souza J2, Halegoua-De Marzio D4, Goldberg DS2,3, Trooskin S5, Levine LD7, Srinivas SK7, Lewis JD2,3, Forde KA2,3, Lo Re V 3rd3,8. Liver Int. 2017 Sep 20. doi: 10.1111/liv.13594. [Epub ahead of print]
 
439.Hepatitis B, hepatitis C and mortality among HIV-positive individuals
  Thornton AC, Jose S, Bhagani S, Chadwick D, Dunn D, Gilson R, Main J, Nelson M, Rodger A, Taylor C, Youssef E, Leen C, Gompels M, Kegg S, Schwenk A, Sabin C; UK Collaborative HIV cohort (UK CHIC) steering committee. AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001646. [Epub ahead of print]
 
440.Update From the Advisory Committee on Immunization Practices
  O'Leary ST1, Maldonado YA2, Byington CL3. J Pediatric Infect Dis Soc. 2017 Sep 1;6(3):215-218. doi: 10.1093/jpids/pix040.
 
441.Elimination of Perinatal Hepatitis B: Providing the First Vaccine Dose Within 24 Hours of Birth
  COMMITTEE ON INFECTIOUS DISEASES; COMMITTEE ON FETUS AND NEWBORN.
 
442.Perinatal transmission in infants of mothers with chronic hepatitis B in California
  Burgis JC1, Kong D1, Salibay C1, Zipprich J1, Harriman K1, So S1. World J Gastroenterol. 2017 Jul 21;23(27):4942-4949. doi: 10.3748/wjg.v23.i27.4942.
 
443.Predictors of positive test results in patients with cancer undergoing hepatitis Bscreening before chemotherapy
  Lok AS1, Cantor SB2, Fisch M2, Barbo AG2, Lin HY2, Suarez-Almazor ME2. J Clin Oncol. 2014 Oct 20;32(30_suppl):143. doi: 10.1200/jco.2014.32.30_suppl.143.
 
444.Evaluation of the Relationship between Alopecia Areata and Viral Antigen Exposure
  Richardson CT1, Hayden MS2, Gilmore ES3, Poligone B4,5. Am J Clin Dermatol. 2017 Aug 11. doi: 10.1007/s40257-017-0312-y. [Epub ahead of print]
 
445.Pregnancy outcome in more than 5000 births to women with viral hepatitis: a population-based cohort study in Sweden
  Stokkeland K1,2, Ludvigsson JF3,4,5, Hultcrantz R6,7, Ekbom A8, Höijer J9, Bottai M9, Stephansson O8,10. Eur J Epidemiol. 2017 May 26. doi: 10.1007/s10654-017-0261-z. [Epub ahead of print]
 
446.Treatment of chronic hepatitis B infection-2017
  Chen GF1,2, Wang C1,3,4, Lau G1,3,5. Liver Int. 2017 Jan;37 Suppl 1:59-66. doi: 10.1111/liv.13309.
 
447.Efficacy and safety of tenofovir in chronic hepatitis B: Australian real world experience
  Lovett GC1, Nguyen T1, Iser DM1, Holmes JA1, Chen R1, Demediuk B1, Shaw G1, Bell SJ1, Desmond PV1, Thompson AJ1. World J Hepatol. 2017 Jan 8;9(1):48-56. doi: 10.4254/wjh.v9.i1.48.
 
448.Occupational Health Update: Focus on Preventing the Acquisition of Infections with Pre-exposure Prophylaxis and Postexposure Prophylaxis
  Weber DJ1, Rutala WA2. Infect Dis Clin North Am. 2016 Sep;30(3):729-57. doi: 10.1016/j.idc.2016.04.008.
 
449.Infrequent clinical assessment of chronic hepatitis B patients in United States general healthcare settings
  Spradling PR1, Xing J1, Rupp LB1, Moorman AC1, Gordon SC1, Teshale ET1, Lu M1, Boscarino JA1, Trinacty CM1, Schmidt MA1, Holmberg SD1; Chronic Hepatitis Cohort Study (CHeCS) Investigators. Clin Infect Dis. 2016 Aug 2. pii: ciw516. [Epub ahead of print]
 
450.Factors associated with poor adherence to antiviral treatment for hepatitis B
  Allard N1,2, Dev A2,3,4, Dwyer J5, Srivatsa G6, Thompson A2,7, Cowie B1,2. J Viral Hepat. 2016 Aug 9. doi: 10.1111/jvh.12582. [Epub ahead of print]
 
451.Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load
  Pan CQ1, Duan Z1, Dai E1, Zhang S1, Han G1, Wang Y1, Zhang H1, Zou H1, Zhu B1, Zhao W1, Jiang H1; China Study Group for the Mother-to-Child Transmission of Hepatitis B. N Engl J Med. 2016 Jun 16;374(24):2324-34. doi: 10.1056/NEJMoa1508660.
 
452.Purification and enzymatic characterization of the hepatitis B virus ribonuclease H, a new target for antiviral inhibitors
  Villa JA1, Pike DP1, Patel KB1, Lomonosova E1, Lu G2, Abdulqader R1, Tavis JE3. Antiviral Res. 2016 Jun 17;132:186-195. doi: 10.1016/j.antiviral.2016.06.005. [Epub ahead of print]
 
453.Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study
  Ahn J1, Lim JK2, Lee HM3, Lok AS4, Nguyen M5, Pan CQ6, Mannalithara A5, Te H7, Reddy KR8, Trinh H9, Chu D10, Tran T11, Lau D12, Leduc TS13, Min A14, Trong Le L15, Bae H16, Van Tran S17, Do S18, Hann HL19, Wong C20, Han S21, Pillai A22, Park JS23, Tong M22, Scaglione S24, Woog J25, Kim WR5. Am J Gastroenterol. 2016 Jun 21. doi: 10.1038/ajg.2016.257. [Epub ahead of print]
 
454.Noninvasive Tests for Fibrosis Predict 5-Year Mortality and Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
  Kim JH1, Kim JW, Seo JW, Choe WH, Kwon SY. J Clin Gastroenterol. 2016 Jun 17. [Epub ahead of print]
 
455.International collaborative study on the 3rd WHO International Standard for hepatitis B surface antigen
  Wilkinson DE1, Seiz PL2, Schüttler CG2, Gerlich WH2, Glebe D2, Scheiblauer H3, Nick S3, Chudy M3, Dougall T4, Stone L5, Heath AB4; Collaborative Study Group. J Clin Virol. 2016 Jun 6. pii: S1386-6532(16)30135-4. doi: 10.1016/j.jcv.2016.06.003. [Epub ahead of print]
 
456.Transmission of blood-borne pathogens in US dental health care settings: 2016 Update
  Cleveland JL, Gray SK, Harte JA, Robison VA, Moorman AC, Gooch BF. J Am Dent Assoc. 2016 May 24. pii: S0002-8177(16)30307-5. doi: 10.1016/j.adaj.2016.03.020. [Epub ahead of print]
 
457.Overview of hepatitis B viral replication and genetic variability
  Tong S1, Revill P2. J Hepatol. 2016 Apr;64(1 Suppl):S4-S16. doi: 10.1016/j.jhep.2016.01.027.
 
458.Gastroenterologists Have Suboptimal Hepatitis B Virus Screening Rates in Patients Receiving Immunosuppressive Therapy
  Paul S1, Shuja A2, Tam I3, Kim EM3, Kang S4, Kapulsky L4, Viveiros K3, Lee H5. Dig Dis Sci. 2016 Mar 18. [Epub ahead of print]
 
459.Are current screening protocols for chronic hepatitis B virus infection adequate?
  Mortensen E1, Kamali A1, Schirmer PL2, Lucero-Obusan C2, Winston CA3, Oda G2, Winters MA1, Durfee J2, Martinello RA4, Davey VJ2, Holodniy M5. Diagn Microbiol Infect Dis. 2015 Dec 17. pii: S0732-8893(15)00442-3. doi: 10.1016/j.diagmicrobio.2015.12.005. [Epub ahead of print]
 
460.Development and validation of an oligonucleotide ligation assay to detect lamivudine resistance in hepatitis B virus
  Beck IA1, Payant R1, Ngo-Giang-Huong N2, Khamduang W3, Laomanit L4, Jourdain G2, Frenkel LM5. J Virol Methods. 2016 Mar 26. pii: S0166-0934(16)30049-0. doi: 10.1016/j.jviromet.2016.03.014. [Epub ahead of print]
 
461.Hepatitis B virus and hepatitis C virus infection in healthcare workers
  Coppola N1, De Pascalis S1, Onorato L1, Calò F1, Sagnelli C1, Sagnelli E1. World J Hepatol. 2016 Feb 18;8(5):273-81. doi: 10.4254/wjh.v8.i5.273.
 
462.Progress with Developing Use of Gene Editing to Cure Chronic Infection with Hepatitis B Virus
  Ely A, Moyo B, Arbuthnot P. Mol Ther. 2016 Feb 26. doi: 10.1038/mt.2016.43. [Epub ahead of print]
 
463.Surveillance of Vaccination Coverage Among Adult Populations - United States, 2014
  Williams WW1, Lu PJ, O'Halloran A, Kim DK, Grohskopf LA, Pilishvili T, Skoff TH, Nelson NP, Harpaz R, Markowitz LE, Rodriguez-Lainz A, Bridges CB. MMWR Surveill Summ. 2016 Feb 5;65(1):1-36. doi: 10.15585/mmwr.ss6501a1.
 
464.Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France
  Marcellin P1, Zoulim F2, Hézode C3, Causse X4, Roche B5, Truchi R6, Pauwels A7, Ouzan D8, Dumortier J9, Pageaux GP10, Bourlière M11, Riachi G12, Zarski JP13, Cadranel JF14, Tilliet V15, Stern C15, Pétour P16, Libert O15, Consoli SM17, Larrey D18. Dig Dis Sci. 2016 Jan 28. [Epub ahead of print]
 
465.Insomnia in Adults With Chronic Hepatitis B, Liver Failure, and Cirrhosis: A Case-
  Guo HM1, Liu M1, Xiang YT2, Zhao J1, Ungvari GS3, Correll CU4, Ng CH5, Chiu HF6, Duan ZP1. Perspect Psychiatr Care. 2015 Dec 3. doi: 10.1111/ppc.12138. [Epub ahead of print]
 
466.Antiviral therapy in management of chronic hepatitis B viral infection in children: A systematic review and meta-analysis
  Jonas MM1, Lok AS2, McMahon BJ3, Brown RS Jr4, Wong JB5, Ahmed AT6,7, Farah W6,7, Mouchli MA8, Singh S9, Prokop LJ10, Murad MH6,7,11, Mohammed K6,7,11. Hepatology. 2015 Nov 13. doi: 10.1002/hep.28278. [Epub ahead of print]
 
467.Role of occult hepatitis B virus infection in chronic hepatitis C
  Coppola N1, Onorato L1, Pisaturo M1, Macera M1, Sagnelli C1, Martini S1, Sagnelli E1. World J Gastroenterol. 2015 Nov 14;21(42):11931-40. doi: 10.3748/wjg.v21.i42.11931.
 
468.Hepatitis B Virus Reactivation and Prophylaxis During Solid Tumor Chemotherapy: A Systematic Review and Meta-analysis
  Paul S, Saxena A, Terrin N, Viveiros K, Balk EM, Wong JB. Ann Intern Med. 2015 Nov 24. doi: 10.7326/M15-1121. [Epub ahead of print]
 
469.Hepatitis delta virus: Making the point from virus isolation up to 2014
  Romeo R1, Perbellini R1. World J Hepatol. 2015 Oct 8;7(22):2389-95. doi: 10.4254/wjh.v7.i22.2389.
 
470.Entecavir safety and effectiveness in a national cohort of treatment-naïve chronic hepatitis B patients in the US - the ENUMERATE study
  Ahn J1, Lee HM2, Lim JK3, Pan CQ4, Nguyen MH5, Ray Kim W5, Mannalithara A5, Trinh H6, Chu D7, Tran T8, Min A9, Do S10, Te H11, Reddy KR12, Lok AS13. Aliment Pharmacol Ther. 2015 Oct 28. doi: 10.1111/apt.13440. [Epub ahead of print]
 
471.Diagnosing and treating hepatic encephalopathy
  Tiberi O1, Tognarelli JM2, Cook NA3, Crossey MM4, Dhanjal NS5, Taylor-Robinson SD6. Br J Hosp Med (Lond). 2015 Nov 2;76(11):646-54. doi: 10.12968/hmed.2015.76.11.646.
 
472.Mediation Analysis of Hepatitis B and C in Relation to Hepatocellular Carcinoma Risk
  Huang YT1, Yang HI, Liu J, Lee MH, Freeman JR, Chen CJ. Epidemiology. 2015 Oct 6. [Epub ahead of print]
 
473.Society for Maternal-Fetal Medicine (SMFM) Consult Series #38: Hepatitis B in Pregnancy- Screening, Treatment and Prevention of Vertical Transmission
  Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfm.org, Dionne-Odom J, Tita AT, Silverman NS. Am J Obstet Gynecol. 2015 Oct 7. pii: S0002-9378(15)01214-4. doi: 10.1016/j.ajog.2015.09.100. [Epub ahead of print]
 
474.Combination of Tenofovir Disoproxil Fumarate and Peginterferon alfa-2a Increases Loss of Hepatitis B Surface Antigen in Patients with Chronic Hepatitis B
  Marcellin P1, Ahn SH2, Ma X3, Caruntu FA4, Tak WY5, Elkashab M6, Chuang WL7, Lim SG8, Tabak F9, Mehta R10, Petersen J11, Foster GR12, Lou L13, Martins EB14, Dinh P14, Lin L14, Corsa A14, Charuworn P14, Subramanian GM14, Reiser H14, Reesink HW15, Fung S16, Strasser SI17, Trinh H18, Buti M19, Gaeta GB20, Hui AJ21, Papatheodoridis G22, Flisiak R23, Chan HL24; study 149 investigators. Gastroenterology. 2015 Oct 7. pii: S0016-5085(15)01429-8. doi: 10.1053/j.gastro.2015.09.043. [Epub ahead of print]
 
475.Invited Commentary: Screening for hepatitis B in the immigrant population and individuals who are in need of immunosuppressive drug therapy
  Perrillo R1. Proc (Bayl Univ Med Cent). 2015 Oct;28(4):443-4.
 
476.Determinants of Outcome Among Patients with Acute Liver Failure Listed for Liver Transplantation in the US
  Reddy KR1, Ellerbe C2, Schilsky M3, Stravitz RT4, Fontana RJ5, Durkalski V2, Lee WM6; Acute Liver Failure Study Group. Liver Transpl. 2015 Sep 30. doi: 10.1002/lt.24347. [Epub ahead of print]
 
477.A systematic review and meta-analysis of management options for adults who respond poorly to hepatitis B vaccination
  David MC1, Ha SH2, Paynter S3, Lau C4. Vaccine. 2015 Sep 27. pii: S0264-410X(15)01327-4. doi: 10.1016/j.vaccine.2015.09.051. [Epub ahead of print]
 
478.Estimated Annual Perinatal Hepatitis B Virus Infections in the United States, 2000-2009
  Ko SC1, Fan L2, Smith EA3, Fenlon N4, Koneru AK2, Murphy TV2. J Pediatric Infect Dis Soc. 2014 Dec 18. pii: piu115. [Epub ahead of print]
 
479.Screening for hepatitis B in patients with lymphoma
  Ramirez J1, Duddempudi AT1, Sana MM1, Hasan SS1, de Los Santos M1, Song J1, Fang-Hollingsworth Y1, Gupta SS1, Sears DM1. Proc (Bayl Univ Med Cent). 2015 Oct;28(4):438-42.
 
480.Hepatitis B virus reverse transcriptase - Target of current antiviral therapy and future drug development
  Clark DN1, Hu J2. Antiviral Res. 2015 Sep 23. pii: S0166-3542(15)00222-3. doi: 10.1016/j.antiviral.2015.09.011. [Epub ahead of print]
 
481.Current Management of Chronic Hepatitis B and C in Chronic Kidney Disease
  Mikolajczyk AE1, Aronsohn AI2. Adv Chronic Kidney Dis. 2015 Sep;22(5):352-60. doi: 10.1053/j.ackd.2015.06.008.
 
482.Glomerular Diseases Associated With Hepatitis B and C
  Gupta A1, Quigg RJ2. Adv Chronic Kidney Dis. 2015 Sep;22(5):343-51. doi: 10.1053/j.ackd.2015.06.003.
 
483.Feasibility, acceptability and safety of a nurse led hepatitis B clinic based in the community
  Pritchard-Jones J, Stevens C, McCaughan G, Strasser S. Collegian. 2015;22(2):233-40.
 
484.Hepatocellular Carcinoma in the Setting of Chronic Hepatitis B Virus Infection: Tumor Recurrence and Survival Rates After Liver Transplantation
  Dugum M1, Hanouneh I2, Lopez R3, Aucejo F4, Eghtesad B4, Zein N2. Transplant Proc. 2015 Jul-Aug;47(6):1939-44. doi: 10.1016/j.transproceed.2015.02.021.
 
485.Hepatitis B: Working Towards a Cure
  Chang BW1, Kaung A, Robbins L, Tran TT. Curr Gastroenterol Rep. 2015 Sep;17(9):460. doi: 10.1007/s11894-015-0460-2.
 
486.Present and future therapies of hepatitis B: From discovery to cure
  Liang TJ1, Block TM2, McMahon BJ3, Ghany MG1, Urban S4, Guo JT2, Locarnini S5, Zoulim F6, Chang KM7, Lok AS8. Hepatology. 2015 Aug 3. doi: 10.1002/hep.28025. [Epub ahead of print]
 
487.Randomized Controlled Trial of Entecavir Versus Placebo in Children with HBeAg-positive Chronic Hepatitis B
  Jonas MM1, Chang MH2, Sokal E3, Schwarz KB4, Kelly D5, Mo Kim K6, Ling SC7, Rosenthal P8, Oraseanu D9, Reynolds L10, Thiry A10, Ackerman P10. Hepatology. 2015 Jul 29. doi: 10.1002/hep.28015. [Epub ahead of print]
 
488.Comparison of Accelerated and Standard Hepatitis B Vaccination Schedules in High-Risk Healthy Adults: A Meta-Analysis of Randomized Controlled Trials
  Jin H1, Tan Z2, Zhang X2, Wang B1, Zhao Y1, Liu P1. PLoS One. 2015 Jul 21;10(7):e0133464. doi: 10.1371/journal.pone.0133464. eCollection 2015.
 
489.A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 Update
  Martin P1, Lau DT2, Nguyen MH3, Janssen HL4, Dieterich DT5, Peters MG6, Jacobson IM7. Clin Gastroenterol Hepatol. 2015 Jul 15. pii: S1542-3565(15)00963-5. doi: 10.1016/j.cgh.2015.07.007. [Epub ahead of print]
 
490.Effects of long-term entecavir treatment on the incidence of hepatocellular carcinoma in chronic hepatitis B patients
  Watanabe T1, Tokumoto Y, Joko K, Michitaka K, Mashiba T, Hiraoka A, Ochi H, Koizumi Y, Tada F, Hirooka M, Yoshida O, Imai Y, Abe M, Hiasa Y. Hepatol Int. 2015 Jul 22. [Epub ahead of print]
 
491.Comparative Meta-Analysis of Tenofovir Disoproxil Fumarate versus Emtricitabine and Tenofovir Disoproxil Fumarate as Treatments for Patients with Chronic Hepatitis B
  Cui G1, Xu X2, Diao H1. Sci Rep. 2015 Jul 13;5:11854. doi: 10.1038/srep11854.
 
492.Noninvasive Assessment of Liver Fibrosis
  Castera L1. Dig Dis. 2015;33(4):498-503. doi: 10.1159/000374097. Epub 2015 Jul 6.
 
493.The Severity of Liver Fibrosis Influences the Prognostic Value of Inflammation-Based Scores in Hepatitis B-Associated Hepatocellular Carcinoma
  Wang Q1, Blank S, Fiel MI, Kadri H, Luan W, Warren L, Zhu A, Deaderick PA, Sarpel U, Labow DM, Hiotis SP. Ann Surg Oncol. 2015 Jul 10. [Epub ahead of print]
 
494.Optimal Management of Hepatitis B Virus Infection - EASL Special Conference
  Lampertico P1, Maini M2, Papatheodoridis G3. J Hepatol. 2015 Jul 3. pii: S0168-8278(15)00453-5. doi: 10.1016/j.jhep.2015.06.026. [Epub ahead of print]
 
495.Hepatitis B and C virus infection and risk of lymphoid malignancies: A population-based cohort study (JPHC Study)
  Abe SK1, Inoue M2, Sawada N3, Iwasaki M3, Shimazu T3, Yamaji T3, Sasazuki S3, Tanaka Y4, Mizokami M5, Tsugane S6; JPHC Study Group. Cancer Epidemiol. 2015 Jul 3. pii: S1877-7821(15)00130-7. doi: 10.1016/j.canep.2015.06.002. [Epub ahead of print]
 
496.Outcomes of Infants Born to Women Infected With Hepatitis B
  Schillie S1, Walker T2, Veselsky S3, Crowley S4, Dusek C5, Lazaroff J6, Morris SA7, Onye K8, Ko S3, Fenlon N9, Nelson NP3, Murphy TV3. Pediatrics. 2015 Apr 20. pii: peds.2014-3213. [Epub ahead of print]
 
497.The Epidemiology of Acute Hepatitis B in the United States from Population-Based Surveillance, 2006-2011
  Iqbal K1, Klevens RM1, Kainer MA2, Baumgartner J3, Gerard K4, Poissant T5, Sweet K6, Vonderwahl C7, Knickerbocker T8, Khudyakov Y1, Xia GL1, Roberts H1, Teshale E1. Clin Infect Dis. 2015 Apr 22. pii: civ332. [Epub ahead of print]
 
498.Chronic hepatitis B: a wave of new therapies on the horizon
  Block TM1, Rawat S2, Brosgart CL3. Antiviral Res. 2015 Jun 22. pii: S0166-3542(15)00145-X. doi: 10.1016/j.antiviral.2015.06.014. [Epub ahead of print]
 
499.Cluster-Randomized Trial to Increase Hepatitis B Testing among Koreans in Los Angeles
  Bastani R1, Glenn BA2, Maxwell AE2, Jo AM3, Herrmann AK2, Crespi CM2, Wong WK2, Chang LC2, Stewart SL4, Nguyen TT5, Chen MS Jr6, Taylor VM7. Cancer Epidemiol Biomarkers Prev. 2015 Jun 23. pii: cebp.1396.2014. [Epub ahead of print]
 
500.Role of T-regulatory cells in the response to hepatitis B vaccine in hemodialysis patients
  Mathew RO1,2, Mason DL1,3, Song R4, Tryniszewski T5, Kennedy JS5. Hemodial Int. 2015 Jun 23. doi: 10.1111/hdi.12326. [Epub ahead of print]
 
501.A Comparison of Entecavir and Lamivudine for the Prophylaxis of Hepatitis B Virus Reactivation in Solid Tumor Patients Undergoing Systemic Cytotoxic Chemotherapy
  Chen WC1, Cheng JS2, Chiang PH2, Tsay FW3, Chan HH4, Chang HW5, Yu HC2, Tsai WL4, Lai KH4, Hsu PI4. PLoS One. 2015 Jun 29;10(6):e0131545. doi: 10.1371/journal.pone.0131545. eCollection 2015.
 
502.Hepatitis B Reactivation During Successful Treatment of Hepatitis C with Sofosbuvir and Simeprevir
  Collins JM1, Raphael KL2, Terry C2, Cartwright EJ3, Pillai A4, Anania FA5, Farley MM6. Clin Infect Dis. 2015 Jun 16. pii: civ474. [Epub ahead of print]
 
503.Chronic hepatitis B: virology, natural history, current management and a glimpse at future opportunities
  Gish RG1, Given BD2, Lai CL3, Locarnini SA4, Lau JY5, Lewis DL2, Schluep T2. Antiviral Res. 2015 Jun 16. pii: S0166-3542(15)00139-4. doi: 10.1016/j.antiviral.2015.06.008. [Epub ahead of print]
 
504.Improvement of liver function and non-invasive fibrosis markers in hepatitis B virus-associated cirrhosis: 2 years of entecavir treatment
  Shin SK1, Kim JH2, Park H1, Kwon OS1, Lee HJ3, Yeon JE3, Byun KS3, Suh SJ4, Yim HJ4, Kim YS1, Kim JH1. J Gastroenterol Hepatol. 2015 Jun 11. doi: 10.1111/jgh.13020. [Epub ahead of print]
 
505.Hepatitis B screening and prevalence among resettled refugees - United States, 2006-2011
  Scott KC, Taylor EM, Mamo B, Herr ND, Cronkright PJ, Yun K, Altshuler M, Shetty S. MMWR Morb Mortal Wkly Rep. 2015 Jun 5;64(21):570-3.
 
506.Medical training fails to prepare providers to care for patients with chronic hepatitis B infection
  Chao SD1, Wang BM1, Chang ET1, Ma L1, So SK1. World J Gastroenterol. 2015 Jun 14;21(22):6914-23. doi: 10.3748/wjg.v21.i22.6914.
 
507.Role of antiviral therapy in the natural history of hepatitis B virus-related chronic liver disease
  Russo FP1, Rodríguez-Castro K1, Scribano L1, Gottardo G1, Vanin V1, Farinati F1. World J Hepatol. 2015 May 18;7(8):1097-104. doi: 10.4254/wjh.v7.i8.1097.
 
508.Similar efficacy and safety of tenofovir in Asians and non-Asians with chronic hepatitis B
  Pan CQ1, Chan S1, Trinh H1, Yao A1, Bae H1, Lou L1. World J Gastroenterol. 2015 May 14;21(18):5524-31. doi: 10.3748/wjg.v21.i18.5524.
 
509.Long-term safety of oral nucleos(t)ide analogues for patients with chronic hepatitis B - a cohort study of 53,500 subjects
  Wong GL1,2,3, Tse YK1,2, Wong VW1,2,3, Fung TY4, Choi KK5, Chan HL1,2,3. Hepatology. 2015 May 14. doi: 10.1002/hep.27894. [Epub ahead of print]
 
510.Thyroid function is associated with non-alcoholic fatty liver disease in chronic hepatitis B infected subjects
  Ding WJ1, Wang MM2, Wang GS1, Fen S1, Qin JJ1, Fan JG1. J Gastroenterol Hepatol. 2015 May 14. doi: 10.1111/jgh.12998. [Epub ahead of print]
 
511.Tenofovir-based rescue therapy for chronic hepatitis B patients who had failed treatment with lamivudine, adefovir, and entecavir
  Kim BG1, Jung SW1, Kim EH1, Kim JH1, Park JH1, Sung SJ1, Park BR2, Kim MH2, Kim CJ2, Lee BU1, Park JH1, Jeong ID1, Bang SJ1, Shin JW1, Park NH1,2. J Gastroenterol Hepatol. 2015 May 14. doi: 10.1111/jgh.12993. [Epub ahead of print]
 
512.Hepatitis B Virus Screening for Patients With Cancer Before Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update
  Hwang JP1, Somerfield MR1, Alston-Johnson DE1, Cryer DR1, Feld JJ1, Kramer BS1, Sabichi AL1, Wong SL1, Artz AS1. J Clin Oncol. 2015 May 11. pii: JCO.2015.61.3745. [Epub ahead of print]
 
513.High Risk of Hepatitis B Reactivation among Patients with Acute Myeloid Leukemia
  Chen CY1, Huang SY1, Cheng A2, Chou WC3, Yao M1, Tang JL4, Tsay W1, Sheng WH2, Tien HF1. PLoS One. 2015 May 14;10(5):e0126037. doi: 10.1371/journal.pone.0126037. eCollection 2015.
 
514.Screening for human immunodeficiency virus and other sexually transmitted diseases among u.s. Women with prenatal care
  Ross CE1, Tao G, Patton M, Hoover KW. Obstet Gynecol. 2015 May;125(5):1211-6. doi: 10.1097/AOG.0000000000000756.
 
515.Hepatitis B reactivation in the setting of chemotherapy and immunosuppression - prevention is better than cure
  Pattullo V1. World J Hepatol. 2015 May 8;7(7):954-67. doi: 10.4254/wjh.v7.i7.954.
 
516.Hepatocellular carcinoma risk in chronic hepatitis B virus-infected compensated cirrhosis patients with low viral load
  Sinn DH1, Lee J1, Goo J2, Kim K2, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Yoo BC1, Paik SW1. Hepatology. 2015 May 11. doi: 10.1002/hep.27889. [Epub ahead of print]
 
517.Strategies to control hepatitis B: Public policy, epidemiology, vaccine and drugs
  Locarnini S1, Hatzakis A2, Chen DS3, Lok A4. J Hepatol. 2015 Apr;62(1S):S76-S86. doi: 10.1016/j.jhep.2015.01.018.
 
518.Tenofovir monotherapy after achieving complete viral suppression on entecavir plus tenofovir combination therapy
  Kim LH1, Chaung KT, Ha NB, Kin KC, Vu VD, Trinh HN, Nguyen HA, Nguyen MH. Eur J Gastroenterol Hepatol. 2015 Apr 21. [Epub ahead of print]
 
519.Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine
  Bowden S1, Locarnini S1, Chang TT1, Chao YC1, Han KH1, Gish RG1, de Man RA1, Yu M1, Llamoso C1, Tang H1. World J Gastroenterol. 2015 Apr 21;21(15):4644-51. doi: 10.3748/wjg.v21.i15.4644.
 
520.Acute-on-chronic liver failure: A new syndrome that will re-classify cirrhosis
  Arroyo V1, Moreau R2, Jalan R3, Ginès P4; EASL-CLIF Consortium CANONIC Study. J Hepatol. 2015 Apr;62(1S):S131-S143. doi: 10.1016/j.jhep.2014.11.045.
 
521.Outcomes of Infants Born to Women Infected With Hepatitis B
  Schillie S1, Walker T2, Veselsky S3, Crowley S4, Dusek C5, Lazaroff J6, Morris SA7, Onye K8, Ko S3, Fenlon N9, Nelson NP3, Murphy TV3. Pediatrics. 2015 Apr 20. pii: peds.2014-3213. [Epub ahead of print]
 
522.The Epidemiology of Acute Hepatitis B in the United States from Population-Based Surveillance, 2006-2011
  Iqbal K1, Klevens RM1, Kainer MA2, Baumgartner J3, Gerard K4, Poissant T5, Sweet K6, Vonderwahl C7, Knickerbocker T8, Khudyakov Y1, Xia GL1, Roberts H1, Teshale E1. Clin Infect Dis. 2015 Apr 22. pii: civ332. [Epub ahead of print]
 
523.Poor Recognition of Risk Factors for Hepatitis B by Physicians Prescribing Immunosuppressive Therapy: A Call for Universal Rather than Risk-Based Screening
  Visram A1, Chan KK2, McGee P3, Boro J2, Hicks LK4, Feld JJ1. PLoS One. 2015 Apr 15;10(4):e0120749. doi: 10.1371/journal.pone.0120749.
 
524.Intended and unintended effects of large-scale adverse event disclosure: a controlled before-after analysis of five large-scale notifications
  Wagner TH1, Taylor T2, Cowgill E2, Asch SM3, Su P2, Bokhour B4, Durfee J5, Martinello RA6, Maguire E7, Elwy AR4. BMJ Qual Saf. 2015 May;24(5):295-302. doi: 10.1136/bmjqs-2014-003800.
 
525.A retrospective study of administration of vaccination for hepatitis B among newborn infants prior to hospital discharge at a midwestern tertiary care center
  Myers HI1, Spracklen CN2, Ryckman KK3, Murray JC4. Vaccine. 2015 Mar 31. pii: S0264-410X(15)00361-8. doi: 10.1016/j.vaccine.2015.03.053. [Epub ahead of print]
 
526.A Comparison of Patients With Hepatitis B- or Hepatitis C-Based Advanced-Stage Hepatocellular Carcinoma
  Carr BI1, Guerra V2, Steel JL3, Lu SN4. Semin Oncol. 2015 Apr;42(2):309-315. doi: 10.1053/j.seminoncol.2014.12.019. Epub 2015 Jan 28.
 
527.Risk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment: Extending perspective from old to newer drugs
  Nard FD1, Todoerti M1, Grosso V1, Monti S1, Breda S1, Rossi S1, Montecucco C1, Caporali R1. World J Hepatol. 2015 Mar 27;7(3):344-61. doi: 10.4254/wjh.v7.i3.344.
 
528.Genotypes and viral variants in chronic hepatitis B: A review of epidemiology and clinical relevance
  Croagh CM1, Desmond PV1, Bell SJ1. World J Hepatol. 2015 Mar 27;7(3):289-303. doi: 10.4254/wjh.v7.i3.289.
 
529.Personalized treatment of hepatitis B
  Lok AS1. Clin Mol Hepatol. 2015 Mar;21(1):1-6. Epub 2015 Mar 25.
 
530.New insights in the management of chronic hepatitis B
  Gill US1, Kennedy PT2. Clin Med. 2015 Apr;15(2):191-6. doi: 10.7861/clinmedicine.15-2-191.
 
531.Association between adefovir dipivoxil treatment and the risk of renal insufficiency in patients with chronic hepatitis B: A meta-analysis
  Yang Q1, Shi YU2, Yang Y2, Lou G2, Lv F1. Biomed Rep. 2015 Mar;3(2):269-275. Epub 2015 Jan 7.
 
532.Hepatitis B e Antigen Status and Hepatitis B DNA Levels in Women of Childbearing Age with Chronic Hepatitis B Infection Screening for Clinical Trials
  Tran TT1, Gordon SC2, Fung S3, Dinh P4, Yee L4, Martins EB4, Buti M5, Marcellin P6. PLoS One. 2015 Mar 19;10(3):e0121632. doi: 10.1371/journal.pone.0121632. eCollection 2015.
 
533.T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance
  Ye B1, Liu X1, Li X1, Kong H1, Tian L1, Chen Y1. Cell Death Dis. 2015 Mar 19;6:e1694. doi: 10.1038/cddis.2015.42.
 
534.Recent advances in use of gene therapy to treat hepatitis B virus infection
  Bloom K1, Ely A, Arbuthnot P. Adv Exp Med Biol. 2015;848:31-49. doi: 10.1007/978-1-4939-2432-5_2.
 
535.Prospective study of hepatitis B virus reactivation in patients with hematological malignancies
  Pompili M1, Basso M1, Hohaus S2, Bosco G1, Nosotti L3, D'Andrea M3, Fenu S4, Grieco A1, Laure Ann Hepatol. 2015 Mar-Apr;14(2):168-74.
 
536.Sharp truth: health care workers remain at risk of bloodborne infection
  Rice BD1, Tomkins SE2, Ncube FM2. Occup Med (Lond). 2015 Feb 6. pii: kqu206. [Epub ahead of print]
 
537.Prognosis in liver transplantation recipients after hepatitis B virus recurrence
  Sun LY, Zhu ZJ, Qu W, Sun XY, Rao W, Liu Y. Hepatogastroenterology. 2014 Oct;61(135):2047-51.
 
538.Prospective study of hepatitis B virus reactivation in patients with hematological malignancies
  Linke R1, Ulrich F1, Bechstein WO1, Schnitzbauer AA1. Ann Hepatol. 2015 Mar-Apr;14(2):161-7.
 
539.Comparison of the efficacies of entecavir 0.5 and 1.0?mg combined with adefovir in patients with chronic hepatitis B who had failed on prior nucleos(t)ide analogue treatments
  Cho Y1, Lee JH, Yu SJ, Yoon JH, Lee HS, Kim YJ. J Med Virol. 2015 Feb 24. doi: 10.1002/jmv.24150. [Epub ahead of print]
 
540.Sharp truth: health care workers remain at risk of bloodborne infection
  Rice BD1, Tomkins SE2, Ncube FM2. Occup Med (Lond). 2015 Feb 6. pii: kqu206. [Epub ahead of print]
 
541.Effect of Entecavir and Tenofovir Treatment on Noninvasive Fibrosis Scores: Which One Is Better?
  Koksal AR1, Alkim H, Boga S, Ergun M, Bayram M, Ozguven BY, Alkim C. Am J Ther. 2015 Feb 2. [Epub ahead of print]
 
542.Cancer risk in HBV patients with statin and metformin use: a population-based cohort study
  Chen CI1, Kuan CF, Fang YA, Liu SH, Liu JC, Wu LL, Chang CJ, Yang HC, Hwang J, Miser JS, Wu SY. Medicine (Baltimore). 2015 Feb;94(6):e462. doi: 10.1097/MD.0000000000000462.
 
543.Efficacy of antiviral therapy with nucleotide/nucleoside analogs after curative treatment for patients with hepatitis B virus-related hepatocellular carcinoma: A systematic review and meta-analysis
  Xia BW1, Zhang YC1, Wang J2, Ding FH2, He XD3.
 
544.Acoustic radiation force impulse elastography, FibroScan®, Forns' index and their combination in the assessment of liver fibrosis in patients with chronic hepatitis B, and the impact of inflammatory activity and steatosis on these diagnostic methods
  Dong DR1, Hao MN2, Li C2, Peng Z3, Liu X4, Wang GP1, Ma AL1. Mol Med Rep. 2015 Feb 4. doi: 10.3892/mmr.2015.3299. [Epub ahead of print]
 
545.Quantitative hepatitis B core antibody levels in the natural history of hepatitis B virus infection
  Song LW1, Liu PG2, Liu CJ3, Zhang TY1, Cheng XD4, Wu HL3, Yang HC3, Hao XK4, Yuan Q5, Zhang J6, Kao JH3, Chen DS3, Chen PJ7, Xia NS8. Clin Microbiol Infect. 2014 Oct 29. pii: S1198-743X(14)00063-9. doi: 10.1016/j.cmi.2014.10.002. [Epub ahead of print]
 
546.The compliance of doctors with viral hepatitis B screening and antiviral prophylaxis in cancer patients receiving cytotoxic chemotherapy using a hospital-based screening reminder system
  Sun WC1, Hsu PI1, Yu HC2, Lin KH1, Tsay FW1, Wang HM1, Tsai TJ1, Chen WC1, Lai KH1, Cheng JS1. PLoS One. 2015 Feb 6;10(2):e0116978. doi: 10.1371/journal.pone.0116978. eCollection 2015.
 
547.The efficacy and safety of entecavir in patients with chronic hepatitis B- associated liver failure: a meta-analysis
  Zhang X1, Liu L2, Zhang M1, Gao S1, Du Y1, An Y3, Chen S1. Ann Hepatol. 2015 Mar-Apr;14(2):150-60.
 
548.Towards an HBV cure: state-of-the-art and unresolved questions-report of the ANRS workshop on HBV cure
  Zeisel MB1, Lucifora J2, Mason WS3, Sureau C4, Beck J5, Levrero M6, Kann M7, Knolle PA8, Benkirane M9, Durantel D2, Michel ML10, Autran B11, Cosset FL12, Strick-Marchand H13, Trépo C14, Kao JH15, Carrat F16, Lacombe K16, Schinazi RF17, Barré-Sinoussi F18, Delfraissy JF19, Zoulim F14. Gut. 2015 Feb 10. pii: gutjnl-2014-308943. doi: 10.1136/gutjnl-2014-308943. [Epub ahead of print]
 
549.Vaccination coverage among adults, excluding influenza vaccination - United States, 2013
  Williams WW, Lu PJ, O'Halloran A, Bridges CB, Kim DK, Pilishvili T, Hales CM, Markowitz LE. MMWR Morb Mortal Wkly Rep. 2015 Feb 6;64(4):95-102.
 
550.Hepatitis B virus infection status and risk of type 2 diabetes mellitus: A meta-analysis
  Zhang J1, Shen Y, Cai H, Liu YM, Qin G. Hepatol Res. 2015 Jan 19. doi: 10.1111/hepr.12481. [Epub ahead of print]
 
551.Compared efficacy of preservation solutions in liver transplantation: a long-term graft outcome study from the European liver transplant registry
  Adam R1, Delvart V, Karam V, Ducerf C, Navarro F, Letoublon C, Belghiti J, Pezet D, Castaing D, Le Treut YP, Gugenheim J, Bachellier P, Pirenne J, Muiesan P; all the ELTR contributing centres, the European Liver, Intestine Transplant Association (ELITA). Am J Transplant. 2015 Feb;15(2):395-406. doi: 10.1111/ajt.13060.
 
552.Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues
  Fan R1, Sun J1, Yuan Q2, Xie Q3, Bai X4, Ning Q5, Cheng J6, Yu Y7, Niu J8, Shi G9, Wang H10, Tan D11, Wan M12, Chen S13, Xu M14, Chen X15, Tang H16, Sheng J17, Lu F18, Jia J19, Zhuang H18, Xia N2, Hou J20; Chronic Hepatitis B Study Consortium; Chronic Hepatitis B Study Consortium. Gut. 2015 Jan 13. pii: gutjnl-2014-308546. doi: 10.1136/gutjnl-2014-308546. [Epub ahead of print]
 
553.Efficacy of Neonatal HBV Vaccination on Liver Cancer and Other Liver Diseases over 30-Year Follow-up of the Qidong Hepatitis B Intervention Study: A Cluster Randomized Controlled Trial
  Qu C1, Chen T2, Fan C2, Zhan Q1, Wang Y1, Lu J2, Lu LL2, Ni Z2, Huang F2, Yao H2, Zhu J2, Fan J2, Zhu Y2, Wu Z1, Liu G1, Gao W1, Zang M1, Wang D1, Dai M3, Hsia CC1, Zhang Y4, Sun Z1. PLoS Med. 2014 Dec 30;11(12):e1001774. doi: 10.1371/journal.pmed.1001774. eCollection 2014.
 
554.Antiviral Treatment among Pregnant Women with Chronic Hepatitis B
  Fan L1, Owusu-Edusei K Jr1, Schillie SF1, Murphy TV1. Infect Dis Obstet Gynecol. 2014;2014:546165. doi: 10.1155/2014/546165. Epub 2014 Dec 7.
 
555.Suppression of hepatitis B virus DNA accumulation in chronically infected cells using a bacterial CRISPR/Cas RNA-guided DNA endonuclease
  Kennedy EM1, Bassit LC2, Mueller H3, Kornepati AV1, Bogerd HP1, Nie T2, Chatterjee P2, Javanbakht H3, Schinazi RF4, Cullen BR5. Virology. 2014 Dec 29;476C:196-205. doi: 10.1016/j.virol.2014.12.001. [Epub ahead of print]
 
556.Natural history of chronic hepatitis B virus infection
  Busch K1, Thimme R. Med Microbiol Immunol. 2014 Dec 25. [Epub ahead of print]
 
557.Discontinuation of antiviral prophylaxis correlates with high prevalence of hepatitis B virus (HBV) reactivation in rheumatoid arthritis patients with HBV carrier state: a real-world clinical practice
  Mo Y, Liang A, Ma J, Chen L, Zheng D, Schumacher HR, Dai L. BMC Musculoskelet Disord. 2014 Dec 22;15(1):449. [Epub ahead of print]
 
558.Serum Levels of Hepatitis B Surface Antigen Predict Severity of Fibrosis in Patients with E Antigen-positive Chronic Hepatitis B
  Marcellin P1, Martinot-Peignoux M2, Asselah T2, Batrla R3, Messinger D4, Rothe V4, Lau G5, Liaw Y6. Clin Gastroenterol Hepatol. 2014 Dec 23. pii: S1542-3565(14)01829-1. doi: 10.1016/j.cgh.2014.12.017. [Epub ahead of print]
 
559.Optimal therapy of chronic hepatitis B: how do I treat my HBeAg-negative patients?
  Viganò M1, Invernizzi F, Lampertico P. Liver Int. 2015 Jan;35 Suppl 1:107-13. doi: 10.1111/liv.12717.
 
560.Early to Phase II drugs currently under investigation for the treatment of liver fibrosis
  Hauff P1, Gottwald U, Ocker M. Expert Opin Investig Drugs. 2014 Dec 30:1-19. [Epub ahead of print]
 
561.Recent FDA warnings on hepatitis B reactivation with immune-suppressing and anti-cancer drugs: Just the tip of the iceberg?
  Di Bisceglie AM1, Lok AS, Martin P, Terrault N, Perrillo RP, Hoofnagle JH. Hepatology. 2014 Nov 21. doi: 10.1002/hep.27609. [Epub ahead of print]
 
562.Incidence of Hepatocellular Carcinoma after HBsAg Seroclearance in Chronic Hepatitis B Patients: a Need for Surveillance
  Kim GA1, Lee HC2, Kim MJ3, Ha Y1, Park EJ1, An J1, Lee D1, Shim JH1, Kim KM1, Lim YS1. J Hepatol. 2014 Nov 28. pii: S0168-8278(14)00880-0. doi: 10.1016/j.jhep.2014.11.031. [Epub ahead of print]
 
563.Combination therapy of interferon and nucleotide/nucleoside analogues for chronic hepatitis B
  Wong GL1, Wong VW, Chan HL. J Viral Hepat. 2014 Dec;21(12):825-34. doi: 10.1111/jvh.12341.
 
564.Combination versus sequential monotherapy in chronic HBV infection: a mathematical approach
  Bertacchi D1, Zucca F2, Foresti S3, Mangioni D3, Gori A3. Math Med Biol. 2014 Nov 13. pii: dqu022. [Epub ahead of print]
 
565.Combination therapy of interferon and nucleotide/nucleoside analogues for chronic hepatitis B
  Wong GL1, Wong VW, Chan HL. J Viral Hepat. 2014 Dec;21(12):825-34. doi: 10.1111/jvh.12341.
 
566.Non-invasive assessment of liver fibrosis in chronic hepatitis B
  Branchi F, Conti CB, Baccarin A, Lampertico P, Conte D, Fraquelli M. World J Gastroenterol. 2014 Oct 28;20(40):14568-14580.
 
567.Hepatitis A and B immunity and vaccination in chronic hepatitis B and C patients in a large United States cohort
  Henkle E, Lu M, Rupp LB, Boscarino JA, Vijayadeva V, Schmidt MA, Gordon SC; for the Chronic Hepatitis Cohort Study (CHeCS) Investigators. Clin Infect Dis. 2014 Nov 3. pii: ciu879. [Epub ahead of print]
 
568.Long-term prognosis of patients with hepatitis B infection: causes of death and utility of nucleos(t)ide analogue therapy
  Tada T1, Kumada T, Toyoda H, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, Kitabtake S, Ito T. J Gastroenterol. 2014 Nov 7. [Epub ahead of print]
 
569.Comparison of Clinical Manifestations and Outcomes between Hepatitis B Virus- and Hepatitis C Virus-Related Hepatocellular Carcinoma: Analysis of a Nationwide Cohort
  Sinn DH1, Gwak GY1, Cho J2, Paik SW1, Yoo BC1. PLoS One. 2014 Nov 5;9(11):e112184. doi: 10.1371/journal.pone.0112184. eCollection 2014.
 
570.Chemotherapy-related reactivation of hepatitis B infection: Updates in 2013
  Kim HY, Kim W. World J Gastroenterol. 2014 Oct 28;20(40):14581-14588.
 
571.Community-based hepatitis B screening: what works?
  Robotin MC1, George J2. Hepatol Int. 2014 Aug 1;8(4):478-492. eCollection 2014.
 
572.Tenofovir Disoproxil Fumarate in Asian or Pacific Islander Chronic Hepatitis B Patients With High Viral Load (? 9 log10 copies/mL)
  Fung S1, Gordon SC, Krastev Z, Horban A, Petersen J, Sperl J, Gane E, Jacobson IM, Yee LJ, Dinh P, Martins EB, Flaherty JF, Kitrinos KM, Dusheiko G, Trinh H, Flisiak R, Rustgi VK, Buti M, Marcellin P. Liver Int. 2014 Oct 2. doi: 10.1111/liv.12694. [Epub ahead of print]
 
573.The global burden of liver disease: a challenge for methods and for public health
  Byass P. BMC Med. 2014 Sep 18;12:159. doi: 10.1186/s12916-014-0159-5.
 
574.Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine
  Zhang L1, Gui XE2, Teter C3, Zhong H4, Pang Z5, Ding L6, Li F7, Zhou Y8, Zhang L9. Vaccine. 2014 Sep 18. pii: S0264-410X(14)01242-0. doi: 10.1016/j.vaccine.2014.08.078. [Epub ahead of print]
 
575.Type 2 diabetes: a risk factor for liver mortality and complications in hepatitis B cirrhosis patients
  Hsiang JC1, Gane EJ, Bai WW, Gerred SJ. J Gastroenterol Hepatol. 2014 Sep 22. doi: 10.1111/jgh.12790. [Epub ahead of print]
 
576.Maternal transmission risk and antibody levels against hepatitis B virus e antigen in pregnant women
  Lu LL1, Chen BX2, Wang J3, Wang D4, Ji Y4, Yi HG4, Chen T4, Zhang Y5, Petersen E6, Li Q7, Qu C8. Int J Infect Dis. 2014 Sep 19. pii: S1201-9712(14)01613-0. doi: 10.1016/j.ijid.2014.07.028. [Epub ahead of print]
 
577.Tenofovir disoproxil fumarate vs adefovir dipivoxil in Chinese patients with chronic hepatitis B after 48 weeks: a randomized controlled trial
  Hou JL1, Gao ZL, Xie Q, Zhang JM, Sheng JF, Cheng J, Chen CW, Mao Q, Zhao W, Ren H, Tan DM, Niu JQ, Chen SJ, Pan C, Tang H, Wang H, Mao YM, Jia JD, Ning Q, Xu M, Wu SM, Li J, Zhang XX, Ji Y, Dong J, Li J. J Viral Hepat. 2014 Sep 22. doi: 10.1111/jvh.12313. [Epub ahead of print]
 
578.Hepatitis B reactivation during cancer chemotherapy: an international survey of the membership of the American Association for the Study of Liver Diseases
  Hwang JP1, Barbo AG, Perrillo RP. J Viral Hepat. 2014 Sep 15. doi: 10.1111/jvh.12305. [Epub ahead of print]
 
579.Risk for hepatitis B and C virus transmission in nail salons and barbershops and state regulatory requirements to prevent such transmission in the United States
  Yang J1, Hall K, Nuriddin A, Woolard D. J Public Health Manag Pract. 2014 Nov-Dec;20(6):E20-30. doi: 10.1097/PHH.0000000000000042.
 
580.Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis
  Mokdad AA1, Lopez AD, Shahraz S, Lozano R, Mokdad AH, Stanaway J, Murray CJ, Naghavi M. BMC Med. 2014 Sep 18;12(1):145. [Epub ahead of print]
 
581.Effect of hepatitis B virus genotypes on the efficacy of adefovir dipivoxil antiviral therapy
  Wen Z1, Zhang H1, Zhang M2, Tan D3, Li Q4, Zhang H1, Wu P1, Deng L1. Hepat Mon. 2014 Aug 17;14(8):e10813. doi: 10.5812/hepatmon.10813. eCollection 2014.
 
582.Hepatitis B and C in pregnancy: a review and recommendations for care
  Dunkelberg JC1, Berkley EM2, Thiel KW3, Leslie KK3. J Perinatol. 2014 Sep 18. doi: 10.1038/jp.2014.167. [Epub ahead of print]
 
583.Scoring systems for predicting mortality after liver transplantation
  Pan HC1, Jenq CC2, Lee WC3, Tsai MH4, Fan PC1, Chang CH1, Chang MY2, Tian YC2, Hung CC2, Fang JT2, Yang CW2, Chen YC2. PLoS One. 2014 Sep 12;9(9):e107138. doi: 10.1371/journal.pone.0107138. eCollection 2014.
 
584.Long-Term Treatment with Tenofovir in Asian-American Chronic Hepatitis B Patients Is Associated with Abnormal Renal Phosphate Handling
  Tien C1, Xu JJ, Chan LS, Chang M, Lim C, Lee S, Huh B, Shinada S, Bae HS, Fong TL. Dig Dis Sci. 2014 Sep 20. [Epub ahead of print]
 
585.Individualized management of pregnant women with high hepatitis B virus DNA levels
  Zhang Z, Chen C, Li Z, Wu YH, Xiao XM. World J Gastroenterol. 2014 Sep 14;20(34):12056-12061.
 
586.Hepatitis B viral load affects prognosis of hepatocellular carcinoma
  Yu SJ, Kim YJ. World J Gastroenterol. 2014 Sep 14;20(34):12039-12044.
 
587.Interleukin 28B genetic polymorphism and hepatitis B virus infection
  Takahashi T. World J Gastroenterol. 2014 Sep 14;20(34):12026-12030.
 
588.Noninvasive assessment of liver fibrosis in patients with chronic hepatitis B
  Enomoto M, Morikawa H, Tamori A, Kawada N. World J Gastroenterol. 2014 Sep 14;20(34):12031-12038.
 
589.A Randomized, Open-Label Clinical Study of Combined Peginterferon Alfa-2a (40KD) and Entecavir Treatment for HBeAg-Positive Chronic Hepatitis B
  Xie Q1, Zhou H1, Bai X2, Wu S3, Chen JJ4, Sheng J5, Xie Y6, Chen C7, Chan HL8, Zhao M9. Clin Infect Dis. 2014 Sep 4. pii: ciu702. [Epub ahead of print]
 
590.Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single north american center
  Franssen B1, Alshebeeb K, Tabrizian P, Marti J, Pierobon ES, Lubezky N, Roayaie S, Florman S, Schwartz ME. Ann Surg. 2014 Oct;260(4):650-8. doi: 10.1097/SLA.0000000000000917.
 
591.Chronic hepatitis B in 2014: Great therapeutic progress, large diagnostic deficit
  Niederau C. World J Gastroenterol. 2014 Sep 7;20(33):11595-11617.
 
592.Association between maternal HBsAg carrier status and neonatal adverse outcomes: meta-analysis
  Luo L1, Wu J, Qu Y, Li J, Pan L, Li D, Wang H, Mu D. J Matern Fetal Neonatal Med. 2014 Sep 18:1-10. [Epub ahead of print]
 
593.Caesarean section to prevent transmission of hepatitis B: A meta-analysis
  Chang MS, Gavini S, Andrade PC, McNabb-Baltar J. Can J Gastroenterol Hepatol. 2014 Sep;28(8):439-44.
 
594.Recent Population Expansions of Hepatitis B Virus in the United States
  Ramachandran S1, Purdy MA2, Xia GL2, Campo DS2, Dimitrova ZE2, Teshale EH2, Teo CG2, Khudyakov YE2. J Virol. 2014 Sep 3. pii: JVI.01594-14. [Epub ahead of print]
 
595.Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice
  Zhang H, Pan CQ, Pang Q, Tian R, Yan M, Liu X. Hepatology. 2014 Aug;60(2):468-76.
 
596.Hepatitis B flares in chronic hepatitis B: pathogenesis, natural course and management
  Chang ML1, Liaw YF2. J Hepatol. 2014 Aug 29. pii: S0168-8278(14)00620-5. doi: 10.1016/j.jhep.2014.08.033. [Epub ahead of print]
 
597.Prognostic value of the combined use of transient elastography and FibroTest in patients with chronic hepatitis B
  Park MS1, Kim SU, Kim BK, Park JY, Kim DY, Ahn SH, Shin SH, Kang W, Moon C, Han KH. Liver Int. 2014 Sep 2. doi: 10.1111/liv.12678. [Epub ahead of print]
 
598.The immune tolerant phase of chronic HBV infection: new perspectives on an old concept
  Bertoletti A1, Kennedy PT2. Cell Mol Immunol. 2014 Sep 1. doi: 10.1038/cmi.2014.79. [Epub ahead of print]
 
599.Diagnostic usefulness of real-time elastography for liver fibrosis in chronic viral hepatitis B and C
  Kim YW1, Kwon JH1, Jang JW2, Kim MJ1, Oh BS1, Chung KW1, Park ES3, Nam SW1. Gastroenterol Res Pract. 2014;2014:210407. doi: 10.1155/2014/210407. Epub 2014 Aug 10.
 
600.Efficacy of Entecavir plus Tenofovir Combination Therapy for Chronic Hepatitis B Patients with Multi-Drug Resistant Strains
  Lee YB1, Lee JH2, Lee DH1, Cho H1, Ahn H1, Choi WM1, Cho YY1, Lee M1, Yoo JJ1, Cho Y1, Cho EJ1, Yu SJ1, Kim YJ1, Yoon JH1, Kim CY1, Lee HS1. Antimicrob Agents Chemother. 2014 Aug 25. pii: AAC.03845-14. [Epub ahead of print]
 
601.Entecavir Is Safe and Effective in Patients Previously Treated with Adefovir, including Those with Adefovir-Resistance
  Nguyen NH1, Trinh HN, Nguyen TT, Do ST, Tran P, Nguyen HA, Nguyen KK, Garcia RT, Lutchman GA, Nguyen MH. J Gastroenterol Hepatol. 2014 Aug 28. doi: 10.1111/jgh.12728. [Epub ahead of print]
 
602.Assessment of Bone Mineral Density in Tenofovir treated Chronic Hepatitis B patients: Can FRAX identify those at greatest risk?
  Gill US1, Zissimopoulos A2, Al-Shamma S2, Burke K2, McPhail MJ3, Barr DA4, Kallis YN2, Marley RT2, Kooner P2, Foster GR1, Kennedy PT1. J Infect Dis. 2014 Aug 25. pii: jiu471. [Epub ahead of print]
 
603.Immunogenicity of hepatitis B vaccine in patients with inflammatory bowel disease and the benefits of revaccination
  Yolima CG1, Xavier MG, Magda CM, José Ángel RP, Natalia BS, Francisco RF, Francesc CJ. J Gastroenterol Hepatol. 2014 Aug 26. doi: 10.1111/jgh.12712. [Epub ahead of print]
 
604.Quantification of HBsAg in nucleos(t)ide-naïve patients treated for chronic hepatitis B with entecavir with or without tenofovir in the BE-LOW study
  Zoulim F1, Carosi G2, Greenbloom S3, Mazur W4, Nguyen T5, Jeffers L6, Brunetto M7, Yu S8, Llamoso C8. J Hepatol. 2014 Aug 28. pii: S0168-8278(14)00618-7. doi: 10.1016/j.jhep.2014.08.031. [Epub ahead of print]
 
605.Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B was associated with unexpected high rate of peripheral neuropathy
  Marcellin P1, Wursthorn K2, Wedemeyer H2, Chuang WL3, Lau G4, Avila C5, Peng CY6, Gane E7, Gee Lim S8, Fainboim H9, Foster GR10, Safadi R11, Rizzetto M12, Manns M2, Bao W13, Naoumov N5. J Hepatol. 2014 Aug 21. pii: S0168-8278(14)00607-2. doi: 10.1016/j.jhep.2014.08.021. [Epub ahead of print]
 
606.Survey of health status, nutrition and geography of food selection of chronic liver disease patients
  Leslie T1, Pawloski L2, Kallman-Price J3, Escheik C4, Hossain N3, Fang Y3, Gerber LH5, Younossi ZM3. Ann Hepatol. 2014 Sep-Oct;13(5):533-40.
 
607.Human Immunodeficiency Virus and Coinfection with Hepatitis B and C
  Petty LA1, Steinbeck JL2, Pursell K2, Jensen DM3. Infect Dis Clin North Am. 2014 Sep;28(3):477-499. doi: 10.1016/j.idc.2014.05.005.
 
608.Knowledge, Awareness and Medical Practice of Asian Americans/Pacific Islanders on Chronic Hepatitis B Infection: Review of Current Psychosocial Evidence
  Do TN, Nam SG. Pogon Sahoe Yongu. 2011;31(3):341-364.
 
609.Temporal Trends of Non-alcoholic Fatty Liver Disease-related Hepatocellular Carcinoma in the Veteran Affairs Population
  Mittal S1, Sada YH2, El-Serag HB3, Kanwal F3, Duan Z2, Temple S2, May SB2, Kramer JR2, Richardson PA2, Davila JA2. Clin Gastroenterol Hepatol. 2014 Aug 19. pii: S1542-3565(14)01228-2. doi: 10.1016/j.cgh.2014.08.013. [Epub ahead of print]
 
610.Risk assessment of clinical outcomes in asian patients with chronic hepatitis B using enhanced liver fibrosis test
  Kim BK1, Kim HS, Yoo EJ, Oh EJ, Park JY, Kim DY, Ahn SH, Han KH, Kim SU, Park YN. Hepatology. 2014 Aug 20. doi: 10.1002/hep.27389. [Epub ahead of print]
 
611.Antenatal hepatitis B in a large teaching NHS Trust - Implications for future care
  White HA1, Wiselka MJ2, Wilson DJ3. J Infect. 2014 Aug 16. pii: S0163-4453(14)00245-X. doi: 10.1016/j.jinf.2014.07.028. [Epub ahead of print]
 
612.Hepatitis B vaccine by intradermal route in non responder patients: An update
  Filippelli M, Lionetti E, Gennaro A, Lanzafame A, Arrigo T, Salpietro C, La Rosa M, Leonardi S. World J Gastroenterol. 2014 Aug 14;20(30):10383-10394.
 
613.Natural history of chronic hepatitis B: Phases in a complex relationship
  Croagh CM, Lubel JS. World J Gastroenterol. 2014 Aug 14;20(30):10395-10404.
 
614.APRI and FIB-4 are good predictors of the stage of liver fibrosis in chronic hepatitis B: the Chronic Hepatitis Cohort Study (CHeCS)
  Teshale E1, Lu M, Rupp LB, Holmberg SD, Moorman AC, Spradling P, Vijayadeva V, Boscarino JA, Schmidt MA, Gordon SC; the CHeCS Investigators. J Viral Hepat. 2014 Aug 1. doi: 10.1111/jvh.12279. [Epub ahead of print]
 
615.Clinicopathological features of hepatitis B virus recurrence after liver transplantation: eleven-year experience
  Zhang D, Jiao Z, Han J, Cao H. Int J Clin Exp Pathol. 2014 Jun 15;7(7):4057-66. eCollection 2014.
 
616.Comparison of Diagnostic accuracy of APRI and FIB-4 for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: A systemic review and meta-analysis
  Xiao G1, Yang J, Yan L. Hepatology. 2014 Aug 18. doi: 10.1002/hep.27382. [Epub ahead of print]
 
617.Alpha-fetoprotein level as a biomarker of liver fibrosis status: a cross-sectional study of 619 consecutive patients with chronic hepatitis B
  Liu YR, Lin BB, Zeng DW, Zhu YY, Chen J, Zheng Q, Dong J1, Jiang JJ. BMC Gastroenterol. 2014 Aug 16;14:145. doi: 10.1186/1471-230X-14-145.
 
618.Polymorphisms of HLA-DP are associated with response to peginterferon in Caucasian patients with chronic hepatitis B
  Brouwer WP1, Sonneveld MJ, Tabak F, Simon K, Cakaloglu Y, Akarca US, Zeuzem S, Ferenci P, Heathcote JE, de Knegt RJ, Boonstra A, Hansen BE, Janssen HL. Aliment Pharmacol Ther. 2014 Aug 11. doi: 10.1111/apt.12910. [Epub ahead of print]
 
619.Hepatitis B virus infection correlates with poor prognosis of extranodal natural killer/T cell lymphoma
  Wang L, Wu-Xiao ZJ, Chen XQ, Zhang YJ, Lu Y, Xia ZJ. Leuk Lymphoma. 2014 Aug 11:1-20. [Epub ahead of print]
 
620.Treatment cessation in noncirrhotic, e-antigen negative chronic hepatitis B is safe and effective following prolonged anti-viral suppression with nucleosides/nucleotides
  Patwardhan VR1, Sengupta N, Bonder A, Lau D, Afdhal NH. Aliment Pharmacol Ther. 2014 Aug 11. doi: 10.1111/apt.12908. [Epub ahead of print]
 
621.A new model for predicting liver cirrhosis in chronic hepatitis B virus carriers with low serum alanine transaminase activity
  Zeng DW1, Zhang JM2, Liu YR1, Dong J1, Wu YL1, Lin S1, Jiang JJ1, Zhu YY3. Clin Res Hepatol Gastroenterol. 2014 Jul 18. pii: S2210-7401(14)00152-1. doi: 10.1016/j.clinre.2014.06.007. [Epub ahead of print]
 
622.Re-appraisal of old and new diagnostic tools in the current management of chronic hepatitis B
  Bessone F. Liver Int. 2014 Aug;34(7):991-1000. doi: 10.1111/liv.12499. Epub 2014 Mar 12.
 
623.Understanding early serum hepatitis D virus and HBsAg kinetics during pegylated interferon-alfa therapy via mathematical modeling
  Guedj J1, Rotman Y, Cotler SJ, Koh C, Schmid P, Albrecht J, Haynes-Williams V, Liang JT, Hoofnagle JH, Heller T, Dahari H. Hepatology. 2014 Aug 7. doi: 10.1002/hep.27357. [Epub ahead of print]
 
624.A Randomized Study to Evaluate the Immunogenicity and Safety of a Heptavalent Diphtheria, Tetanus, Pertussis, Hepatitis B, Poliomyelitis, Haemophilus influenzae b, and Meningococcal Serogroup C Combination Vaccine Administered to Infants at 2, 4, and 12 Months of Age
  Thollot F1, Scheifele D, Pankow-Culot H, Cheuvart B, Leyssen M, Ulianov L, Miller JM. Pediatr Infect Dis J. 2014 Jul 16. [Epub ahead of print]
 
625.Outcomes of Patients with Chronic Hepatitis B Who do not Meet Criteria for Antiviral Treatment at Presentation
  Yapali S1, Talaat N1, Fontana RJ1, Oberhelman K1, Lok AS2. Clin Gastroenterol Hepatol. 2014 Jul 17. pii: S1542-3565(14)01048-9. doi: 10.1016/j.cgh.2014.07.019. [Epub ahead of print]
 
626.Kinetics of hepatitis B surface antigen loss in patients with HBeAg-positive chronic hepatitis B treated with tenofovir disoproxil fumarate
  Marcellin P1, Buti M2, Krastev Z3, de Man RA4, Zeuzem S5, Lou L6, Gaggar A6, Flaherty JF6, Massetto B6, Lin L6, Dinh P6, Mani Subramanian G6, McHutchison JG6, Flisiak R7, Gurel S8, Dusheiko GM9, Jenny Heathcote E10. J Hepatol. 2014 Jul 18. pii: S0168-8278(14)00518-2. doi: 10.1016/j.jhep.2014.07.019. [Epub ahead of print]
 
627.Platelets promote liver immunopathology contributing to hepatitis B virus-mediated hepatocarcinogenesis
  Sitia G. Semin Oncol. 2014 Jun;41(3):402-5. doi: 10.1053/j.seminoncol.2014.04.013. Epub 2014 Apr 24.
 
628.A new model for predicting liver cirrhosis in chronic hepatitis B virus carriers with low serum alanine transaminase activity
  Zeng DW1, Zhang JM2, Liu YR1, Dong J1, Wu YL1, Lin S1, Jiang JJ1, Zhu YY3. Clin Res Hepatol Gastroenterol. 2014 Jul 18. pii: S2210-7401(14)00152-1. doi: 10.1016/j.clinre.2014.06.007. [Epub ahead of print]
 
629.Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections
  Rehermann B1, Bertoletti A. Hepatology. 2014 Jul 21. doi: 10.1002/hep.27323. [Epub ahead of print]
 
630.Prevention of hepatitis B virus reinfection in liver transplant recipients
  Roche B1, Samuel D. Intervirology. 2014;57(3-4):196-201. doi: 10.1159/000360944. Epub 2014 Jul 15.
 
631.Chronic hepatitis B virus in young adults: the need for new approaches to management
  Gill US1, Kennedy PT. Expert Rev Anti Infect Ther. 2014 Jul 23:1-9. [Epub ahead of print]
 
632.Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C
  Institute of Medicine (US) Committee on the Prevention and Control of Viral Hepatitis Infection; Colvin HM, Mitchell AE, editors.
 
633.The impact of type 2 diabetes and obesity on the long-term outcomes of more than 85 000 liver transplant recipients in the US
  Younossi ZM1, Stepanova M, Saab S, Kalwaney S, Clement S, Henry L, Frost S, Hunt S. Aliment Pharmacol Ther. 2014 Jul 16. doi: 10.1111/apt.12881. [Epub ahead of print]
 
634.Therapy of acute and fulminant hepatitis B
  Tillmann HL1, Patel K. Intervirology. 2014;57(3-4):181-8. doi: 10.1159/000360939. Epub 2014 Jul 15.
 
635.Chronic Hepatitis B Treatment Eligibility and Actual Treatment Rates in Patients in Community Gastroenterology and Primary Care Settings
  Nguyen VG1, Wan K, Trinh HN, Li J, Zhang JQ, Nguyen MH. J Clin Gastroenterol. 2014 Jul 10. [Epub ahead of print]
 
636.Hepatitis Viruses and Liver Transplantation: Evolving Trends in Antiviral Management
  Verna EC. Clin Liver Dis. 2014 Aug;18(3):575-601. doi: 10.1016/j.cld.2014.05.002.
 
637.Practice Patterns and Attitudes of Primary Care Providers and Barriers to Surveillance of Hepatocellular Carcinoma in Patients with Cirrhosis
  Dalton-Fitzgerald E1, Tiro J2, Kandunoori P1, Halm EA3, Yopp A4, Singal AG5. Clin Gastroenterol Hepatol. 2014 Jul 11. pii: S1542-3565(14)00987-2. doi: 10.1016/j.cgh.2014.06.031. [Epub ahead of print]
 
638.Residual Amount of HBV DNA in Serum is Related to Relapse in Chronic Hepatitis B Patients After Cessation of Nucleos(t)ide Analogs
  Jiang JN1, Huang ZL, He LX, Huang YH, Su MH, Xie R, Liang YX, Fu WD, Huang XH, Guo WW, Zhong SH, Liu ZH, Li SH, Zhu TF, Gao ZL. J Clin Gastroenterol. 2014 Jul 10. [Epub ahead of print]
 
639.Clinical impact of occult hepatitis B virus infection in immunosuppressed patients
  Sagnelli E, Pisaturo M, Martini S, Filippini P, Sagnelli C, Coppola N. World J Hepatol. 2014 Jun 27;6(6):384-93. doi: 10.4254/wjh.v6.i6.384.
 
640.Effect of Menarche Onset on the Clinical Course in Females with Chronic Hepatitis B Virus Infection
  Wu JF1, Tsai WY1, Tung YC1, Chen HL2, Ni YH3, Hsu HY1, Chang MH4. J Pediatr. 2014 Jun 24. pii: S0022-3476(14)00499-5. doi: 10.1016/j.jpeds.2014.05.049. [Epub ahead of print]
 
641.Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest) and elastography (FibroScan)
  Poynard T1, Vergniol J2, Ngo Y3, Foucher J2, Thibault V4, Munteanu M3, Merrouche W2, Lebray P5, Rudler M5, Deckmyn O3, Perazzo H5, Thabut D5, Ratziu V5, de Ledinghen V2. J Hepatol. 2014 Jul 9. pii: S0168-8278(14)00457-7. doi: 10.1016/j.jhep.2014.06.027. [Epub ahead of print]
 
642.Chronic hepatitis B infection and risk of preterm labor: A meta-analysis of observational studies
  Huang QT1, Wei SS2, Zhong M3, Hang LL2, Xu YY2, Cai GX2, Liu Q4, Yu YH2. J Clin Virol. 2014 Jun 16. pii: S1386-6532(14)00222-4. doi: 10.1016/j.jcv.2014.06.006. [Epub ahead of print]
 
643.Association between infection of hepatitis B virus and onset risk of B-cell non-Hodgkin's lymphoma: a systematic review and a meta-analysis
  Yi HZ1, Chen JJ, Cen H, Yan W, Tan XH. Med Oncol. 2014 Aug;31(8):84. doi: 10.1007/s12032-014-0084-7. Epub 2014 Jun 28.
 
644.Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians
  Arends P1, Sonneveld MJ1, Zoutendijk R1, Carey I2, Brown A3, Fasano M4, Mutimer D5, Deterding K6, Reijnders JG1, Oo Y5, Petersen J7, van Bömmel F8, de Knegt RJ1, Santantonio T4, Berg T8, Welzel TM9, Wedemeyer H6, Buti M10, Pradat P11, Zoulim F11, Hansen B1, Janssen HL12; for the VIRGIL Surveillance Study Group. Gut. 2014 Jul 10. pii: gutjnl-2014-307023. doi: 10.1136/gutjnl-2014-307023. [Epub ahead of print]
 
645.Vertical transmission of hepatitis B virus: challenges and solutions
  Gentile I, Borgia G. Int J Womens Health. 2014 Jun 10;6:605-11. doi: 10.2147/IJWH.S51138. eCollection 2014.
 
646.The bloodborne pathogen standard in private practice
  Davis D1, Carlton A, Wisch JS. Community Support Oncol. 2014 Mar;12(3):82-3.
 
647.Prediction of Development of Liver-Related Events by Transient Elastography in Hepatitis B Patients With Complete Virological Response on Antiviral Therapy
  Lee HW1, Yoo EJ1, Kim BK2, Kim SU2, Park JY2, Kim DY2, Ahn SH3, Han KH3. Am J Gastroenterol. 2014 Jun 24. doi: 10.1038/ajg.2014.157. [Epub ahead of print]
 
648.The impact of oral antiviral therapy on long-term survival of hepatitis B surface antigen-positive patients on haemodialysis
  Ow MM1, de Zoysa JR, Gane EJ. N Z Med J. 2014 Jun 20;127(1396):34-42.
 
649.Hepatitis B virus reactivation in patients with hepatocellular carcinoma undergoing anti-cancer therapy
  Jang JW. World J Gastroenterol. 2014 Jun 28;20(24):7675-7685.
 
650.Incidence of hepatitis in patients with evidence of past or current hepatitis B or C during chemotherapy for early breast cancer
  Levaggi A1, DE Maria A2, Dozin B3, Iacono G4, Bighin C5, Giraudi S4, Lambertini M5, D'Alonzo A4, Poggio F5, Pronzato P5, Del Mastro L4. Anticancer Res. 2014 Jul;34(7):3715-20.
 
651.Screening, detecting and enhancing the yield of previously undiagnosed hepatitis B and C in patients with acute medical admissions to hospital: A pilot project undertaken at the Vancouver General Hospital
  Kapeluto J, Kadatz M, Wormsbecker A, Sidhu K, Yoshida EM. Can J Gastroenterol Hepatol. 2014 Jun;28(6):315-8.
 
652.Hepatitis B in Pregnancy
  Whittaker G, Herrera JL. South Med J. 2014 Mar;107(3):195-200.
 
653.Screening for Hepatitis B Virus Infection in Nonpregnant Adolescents and Adults: U.S. Preventive Services Task Force Recommendation Statement
  LeFevre ML. Ann Intern Med. 2014 May 27. doi: 10.7326/M14-1018. [Epub ahead of print]
 
654.Hepatitis B virus DNA quantification with the three-in-one (3io) method allows accurate single-step differentiation of total HBV DNA and cccDNA in biopsy-size liver samples
  Taranta A1, Tien Sy B2, Zacher BJ1, Rogalska-Taranta M3, Manns MP1, Bock CT4, Wursthorn K5. J Clin Virol. 2014 May 2. pii: S1386-6532(14)00148-6. doi: 10.1016/j.jcv.2014.04.015. [Epub ahead of print]
 
655.Management of chronic hepatitis B in children: an unresolved issue
  Della Corte C1, Nobili V, Comparcola D, Cainelli F, Vento S. J Gastroenterol Hepatol. 2014 May;29(5):912-9. doi: 10.1111/jgh.12550.
 
656.Current recommendations of managing HBV infection in preconception or pregnancy
  Park JS1, Pan C. Front Med. 2014 Jun;8(2):158-65. doi: 10.1007/s11684-014-0340-4. Epub 2014 May 29.
 
657.Cirrhosis Regression in Patients With Viral Hepatitis B and C: A Systematic Review
  Manne V1, Akhtar E, Saab S. J Clin Gastroenterol. 2014 Jun 11. [Epub ahead of print]
 
658.Prevalence and causes of elevated serum aminotransferase levels in a population-based cohort of persons with chronic hepatitis B virus infection
  Spradling PR1, Bulkow L2, Teshale EH3, Negus S4, Homan C4, Simons B4, McMahon BJ5. J Hepatol. 2014 Jun 6. pii: S0168-8278(14)00393-6. doi: 10.1016/j.jhep.2014.05.045. [Epub ahead of print]
 
659.Bridging Basic Science and Clinical Research - The EASL Monothematic Conference on Translational Research in Viral Hepatitis
  Boettler T1, Moradpour D2, Thimme R1, Zoulim F3. J Hepatol. 2014 May 15. pii: S0168-8278(14)00357-2. doi: 10.1016/j.jhep.2014.05.016. [Epub ahead of print]
 
660.Hepatic Steatosis Is Highly Prevalent in Hepatitis B Patients and Negatively Associated with Virological Factors
  Wang MM1, Wang GS, Shen F, Chen GY, Pan Q, Fan JG. Dig Dis Sci. 2014 May 18. [Epub ahead of print]
 
661.Current Treatment Guidelines for Chronic Hepatitis B and Their Application.
  Uribe LA1, O'Brien CG, Wong RJ, Gish RR, Tsai N, Nguyen MH. J Clin Gastroenterol. 2014 May 22. [Epub ahead of print]
 
662.Effect of Antiviral Prophylaxis Strategy for Chemotherapy-Associated Hepatitis B Reactivation in Non-Hodgkin's Lymphoma Patients with Hepatitis B Virus Infection: A Retrospective Cohort Study
  Yang F1, Zhu HL2, He C2, Li JJ2, Xiang B2, Cui X2, Huang J2, Ji J2, Ma HB2, Liu T2. Indian J Hematol Blood Transfus. 2014 Jun;30(2):97-104. doi: 10.1007/s12288-012-0195-2. Epub 2012 Oct 30.
 
663.Prevention of Liver Cancer Through the Early Detection of Risk-Related Behavior Among Hepatitis B or C Carriers
  Fan JY1, Huang TJ, Jane SW, Chen MY. Cancer Nurs. 2014 May 15. [Epub ahead of print]
 
664.Strategies for the prevention of recurrent hepatitis B virus infection after liver transplantation
  Manne V, Allen RM, Saab S. Gastroenterol Hepatol (N Y). 2014 Mar;10(3):175-9.
 
665.Hepatitis B virus genotypes: Global distribution and clinical importance
  Sunbul M. World J Gastroenterol. 2014 May 14;20(18):5427-5434.
 
666.A drug safety evaluation of rituximab and risk of hepatitis B
  Riedell P1, Carson KR. Expert Opin Drug Saf. 2014 May 12:1-11. [Epub ahead of print]
 
667.Treatment cessation of entecavir in Asian patients with hepatitis B e antigen negative chronic hepatitis B: a multicentre prospective study
  Seto WK1, Hui AJ2, Wong VW3, Wong GL3, Liu KS1, Lai CL1, Yuen MF1, Chan HL3. Gut. 2014 May 15. pii: gutjnl-2014-307237. doi: 10.1136/gutjnl-2014-307237. [Epub ahead of print]
 
668.Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of Hepatitis B Virus
  Greenup AJ1, Tan PK1, Nguyen V1, Glass A1, Davison S1, Chatterjee U2, Holdaway S3, Samarasinghe D3, Jackson K4, Locarnini S4, Levy MT5. J Hepatol. 2014 May 3. pii: S0168-8278(14)00301-8. doi: 10.1016/j.jhep.2014.04.038. [Epub ahead of print]
 
669.Impact of Viral Hepatitis on Outcomes after Liver Resection for Hepatocellular Carcinoma: Results from a North American Center
  Lee JJ1, Kim PT, Fischer S, Fung S, Gallinger S, McGilvray I, Moulton CA, Wei AC, Greig PD, Cleary SP. Ann Surg Oncol. 2014 May 8. [Epub ahead of print]
 
670.Early identification and linkage to care of persons with chronic hepatitis B virus infection - three u.s. Sites, 2012-2014
  Beckett GA, Ramirez G, Vanderhoff A, Nichols K, Chute SM, Wyles DL, Schoenbachler BT, Bedell DT, Cabra R, Ward JW; Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC. MMWR Morb Mortal Wkly Rep. 2014 May 9;63(18):399-401.
 
671.Telbivudine during the second and third trimester of pregnancy interrupts HBV intrauterine transmission: a systematic review and meta-analysis
  Lu YP, Liang XJ, Xiao XM, Huang SM, Liu ZW, Li J, Hocher B, Chen YP. Clin Lab. 2014;60(4):571-86.
 
672.Cost-Effectiveness of Testing Hepatitis B-Positive Pregnant Women for Hepatitis B e Antigen or Viral Load
  Fan L1, Owusu-Edusei K Jr, Schillie SF, Murphy TV. Obstet Gynecol. 2014 May;123(5):929-37. doi: 10.1097/AOG.0000000000000124.
 
673.Notes from the field: investigation of infectious disease risks associated with a nontransplant anatomical donation center - Arizona, 2014
  de Perio MA, Bernard BP, Delaney LJ, Pesik N, Cohen NJ; National Institute for Occupational Safety and Health, CDC. MMWR Morb Mortal Wkly Rep. 2014 May 2;63(17):384-5.
 
674.Prognostic Evaluation of Patients Undergoing Living-Donor Liver Transplant By APACHE II and MELD Scores
  Zhang ZY1, Chen R, Zhou ZQ, Peng CH, Zhou GW. Exp Clin Transplant. 2014 Apr 28. doi: 10.6002/ect.2013.0289. [Epub ahead of print]
 
675.A simple and inexpensive point-of-care test for hepatitis B surface antigen detection: serological and molecular evaluation
  Gish RG1, Gutierrez JA, Navarro-Cazarez N, Giang K, Adler D, Tran B, Locarnini S, Hammond R, Bowden S. J Viral Hepat. 2014 Apr 30. doi: 10.1111/jvh.12257. [Epub ahead of print]
 
676.Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection
  Sagnelli E1, Pisaturo M, Martini S, Sagnelli C, Filippini P, Coppola N.
 
677.Strategies to Inhibit Entry of HBV and HDV into Hepatocytes
  Urban S1, Bartenschlager R2, Kubitz R3, Zoulim F4. Gastroenterology. 2014 Apr 24. pii: S0016-5085(14)00556-3. doi: 10.1053/j.gastro.2014.04.030. [Epub ahead of print]
 
678.Liver stiffness by transient elastography predicts liver-related complications and mortality in patients with chronic liver disease
  Pang JX1, Zimmer S2, Niu S2, Crotty P3, Tracey J3, Pradhan F3, Shaheen AA3, Coffin CS3, Heitman SJ1, Kaplan GG1, Swain MG3, Myers RP1. PLoS One. 2014 Apr 22;9(4):e95776. doi: 10.1371/journal.pone.0095776. eCollection 2014.
 
679.Scoring systems predict the prognosis of acute-on-chronic hepatitis B liver failure: an evidence-based review
  Wu FL1, Shi KQ, Chen YP, Braddock M, Zou H, Zheng MH. Expert Rev Gastroenterol Hepatol. 2014 Apr 24. [Epub ahead of print]
 
680.Viral infections in pregnancy: advice for healthcare workers
  Chin TL1, Macgowan AP2, Jacobson SK2, Donati M3. J Hosp Infect. 2014 Mar 12. pii: S0195-6701(14)00066-8. doi: 10.1016/j.jhin.2013.12.011. [Epub ahead of print]
 
681.The impact of hepatitis B on heart transplantation: 19 years of national experience in Korea
  Shin HS1, Cho HJ1, Jeon ES2, Hwang HY3, Kim JJ4, Kim KB3, Oh BH1, Lee HY1. Ann Transplant. 2014 Apr 23;19:182-7. doi: 10.12659/AOT.889680.
 
682.Performance of Enhanced Liver Fibrosis test and comparison with transient elastography in the identification of liver fibrosis in patients with chronic hepatitis B infection
  Trembling PM1, Lampertico P, Parkes J, Tanwar S, Viganò M, Facchetti F, Colombo M, Rosenberg WM. J Viral Hepat. 2013 Aug 15. doi: 10.1111/jvh.12161. [Epub ahead of print]
 
683.Hepatitis B vaccination and screening awareness in primary care practitioners
  Said A1, Jou JH2. Hepat Res Treat2014;2014:373212. doi: 10.1155/2014/373212. Epub. 2014 Mar 6.
 
684.Characteristics and Management of Patients with Chronic Hepatitis B in an Integrated Care Setting
  Sarkar M1, Shvachko VA, Ready JB, Pauly MP, Terrault NA, Peters MG, Manos MM. Dig Dis Sci. 2014 Apr 12. [Epub ahead of print]
 
685.The impact of hepatitis screening on diagnosis and treatment in rheumatoid arthritis
  Conway R1, Doran MF, O'Shea FD, Crowley B, Cunnane G. Clin Rheumatol. 2014 Apr 13. [Epub ahead of print]
 
686.The clinical significance of occult HBV infection
  Squadrito G, Spinella R, Raimondo G. Ann Gastroenterol. 2014;27(1):15-19.
 
687.A prospective long-term study of hepatitis B virus reactivation in patients with hematologic malignancy
  Tamori A1, Hino M, Kawamura E, Fujii H, Uchida-Kobayashi S, Morikawa H, Nakamae H, Enomoto M, Murakami Y, Kawada N. J Gastroenterol Hepatol. 2014 Apr 14. doi: 10.1111/jgh.12604. [Epub ahead of print]
 
688.Characterization of Chronic Hepatitis B Cases Among Foreign-Born Persons in Six Population-Based Surveillance Sites, United States 2001-2010
  Liu SJ1, Iqbal K, Shallow S, Speers S, Rizzo E, Gerard K, Poissant T, Klevens RM. J Immigr Minor Health. 2014 Apr 5. [Epub ahead of print]
 
689.Distinct Seromarkers Predict Different Milestones of Chronic Hepatitis B Progression
  Liu J1, Yang HI, Lee MH, Batrla-Utermann R, Jen CL, Lu SN, Wang LY, You SL, Hsiao CK, Chen CJ; for the R.E.V.E.A.L.-HBV Study Group. Hepatology. 2014 Feb 20. doi: 10.1002/hep.27083. [Epub ahead of print]
 
690.Prevalence of diagnosed chronic hepatitis B infection among U.S. Medicaid enrollees, 2000-2007
  Byrne DD1, Newcomb CW2, Carbonari DM3, Nezamzadeh MS3, Leidl KB2, Herlim M2, Yang YX4, Hennessy S3, Kostman JR5, Leonard MB6, Localio R2, Lo Re V 3rd7. Ann Epidemiol. 2014 Mar 5. pii: S1047-2797(14)00075-1. doi: 10.1016/j.annepidem.2014.02.013. [Epub ahead of print]
 
691.Risk of Hip Fracture Associated with Untreated and Treated Chronic Hepatitis B Virus Infection
  Byrne DD1, Newcomb CW2, Carbonari DM3, Nezamzadeh MS3, Leidl KB2, Herlim M2, Yang YX1, Hennessy S3, Kostman JR4, Leonard MB5, Russell Localio A2, Lo Re V 3rd6. J Hepatol. 2014 Apr 5. pii: S0168-8278(14)00218-9. doi: 10.1016/j.jhep.2014.04.001. [Epub ahead of print]
 
692.Association of Nucleos(t)ide Analogue Therapy with Reduced Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B-a Nationwide Cohort Study
  Wu CY1, Lin JT2, Ho HJ3, Su CW4, Lee TY5, Wang SY6, Wu C6, Wu JC7. Gastroenterology. 2014 Apr 1. pii: S0016-5085(14)00445-4. doi: 10.1053/j.gastro.2014.03.048. [Epub ahead of print]
 
693.Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis
  Singal AG1, Pillai A2, Tiro J3. PLoS Med. 2014 Apr 1;11(4):e1001624. doi: 10.1371/journal.pmed.1001624. eCollection 2014.
 
694.Hepatitis B in pregnancy
  Dyson JK1, Waller J2, Turley A3, Michael E3, Moses S4, Valappil M4, Hudson M5, Bassendine M5, McPherson S5. Frontline Gastroenterol. 2014 Apr;5(2):111-117. Epub 2013 Oct 17.
 
695.Management of hepatitis B during pregnancy
  Patton H1, Tran TT2. Nat Rev Gastroenterol Hepatol. 2014 Apr 1. doi: 10.1038/nrgastro.2014.30. [Epub ahead of print]
 
696.Prevention of Neonatal Hepatitis B Virus Transmission
  Bleich LM1, Swenson ES. J Clin Gastroenterol. 2014 Mar 24. [Epub ahead of print]
 
697.Efficacy and resistance in de novo combination lamivudine and adefovir dipivoxil therapy versus entecavir monotherapy for the treatment-naive patients with chronic hepatitis B: a meta-analysis
  Liu F, Wang X, Wei F, Hu H, Zhang D, Hu P1, Ren H. Virol J. 2014 Mar 28;11(1):59. doi: 10.1186/1743-422X-11-59.
 
698.Current state of and needs for hepatitis B screening: results of a large screening study in a low-prevalent, metropolitan region
  Bottero J1, Boyd A2, Lemoine M3, Carrat F4, Gozlan J5, Collignon A6, Boo N7, Dhotte P8, Varsat B9, Muller G10, Cha O11, Valin N12, Nau J13, Campa P12, Silbermann B14, Bary M15, Girard PM1, Lacombe K1. PLoS One. 2014 Mar 24;9(3):e92266. doi: 10.1371/journal.pone.0092266. eCollection 2014.
 
699.Immune response to hepatitis B vaccination in drug using populations: A systematic review and meta-regression analysis
  Kamath G1, Shah DP1, Hwang LY2. Vaccine. 2014 Mar 11. pii: S0264-410X(14)00299-0. doi: 10.1016/j.vaccine.2014.02.072. [Epub ahead of print]
 
700.The importance of baseline viral load when assessing relative efficacy in treatment-naive HBeAg-positive chronic hepatitis B: a systematic review and network meta-analysis
  Mealing S, Ghement I, Hawkins N, Scott DA, Lescrauwaet B, Watt M, Thursz M, Lampertico P, Mantovani L, Morais E, Bregman B, Cucherat M. Syst Rev. 2014 Mar 7;3(1):21. [Epub ahead of print]
 
701.Student vaccination requirements of u.s. Health professional schools: a national survey
  Libby TE1, Lindley MC, Ahmed F, Stevenson J, Grabowsky M, Strikas RA. J Allied Health. 2014 Spring;43(1):12-21.
 
702.Efficacy and safety of tenofovir disoproxil fumarate in asian-americans with chronic hepatitis B in community settings
  Pan CQ1, Trinh H2, Yao A3, Bae H4, Lou L5, Chan S6; Study 123 Group. PLoS One. 2014 Mar 4;9(3):e89789. doi: 10.1371/journal.pone.0089789. eCollection 2014.
 
703.Hepatitis B Reactivation and Rituximab: A New Boxed Warning and Considerations for Solid Organ Transplantation
  Martin ST1, Cardwell SM, Nailor MD, Gabardi S. Am J Transplant. 2014 Mar 4. doi: 10.1111/ajt.12649. [Epub ahead of print]
 
704.Economic Evaluation of the Routine Childhood Immunization Program in the United States, 2009
  Zhou F1, Shefer A, Wenger J, Messonnier M, Wang LY, Lopez A, Moore M, Murphy TV, Cortese M, Rodewald L. Pediatrics. 2014 Mar 3. [Epub ahead of print]
 
705.Efficacy of entecavir in chronic hepatitis B patients with persistently normal alanine aminotransferase: randomized, double-blind, placebo-controlled study
  Tseng KC, Chen CY, Tsai HW, Chang TT, Chuang WL, Hsu PI, Liu WC, Cheng PN. Antivir Ther. 2014 Feb 28. doi: 10.3851/IMP2754. [Epub ahead of print]
 
706.Reported reasons for testing among hepatitis B virus infected patients, - Chronic Hepatitis Cohort Study (CHeCS), United States, 2006-2010
  Gerbi GB1, Rupp LB, Ko SC, Moorman A, Holmberg SD, Xu F; The CHeCS Investigators. Liver Int. 2014 Mar 3. doi: 10.1111/liv.12509. [Epub ahead of print]
 
707.An update on hepatitis B, d, and e viruses
  Price J. Top Antivir Med. 2013 Dec;21(5):157-63.
 
708.The pharmaceuticalization of sexual risk: Vaccine development and the new politics of cancer prevention
  Mamo L1, Epstein S2. Soc Sci Med. 2014 Jan;101:155-65. doi: 10.1016/j.socscimed.2013.11.028. Epub 2013 Nov 21.
 
709.WHO guidance on the prevention of viral hepatitis B and C among people who inject drugs
  Walsh N1, Verster A2, Rodolph M2, Akl EA3. Int J Drug Policy. 2014 Jan 26. pii: S0955-3959(14)00012-7. doi: 10.1016/j.drugpo.2014.01.009. [Epub ahead of print]
 
710.Prognostic Benefit of the Addition of a Quantitative Index of Hepatic Encephalopathy to the MELD score: the MELD-EEG
  Montagnese S, De Rui M, Schiff S, Ceranto E, Valenti P, Angeli P, Cillo U, Zanus G, Gatta A, Amodio P, Merkel C. Liver Int. 2014 Feb 12. doi: 10.1111/liv.12490. [Epub ahead of print]
 
711.Incomplete Hepatitis B Immunization, Maternal Carrier Status and Increased Risk of Liver Diseases: A 20-year Cohort Study of 3.8 Million Vaccinees
  Chien YC, Jan CF, Chiang CJ, Kuo HS, You SL, Chen CJ. Hepatology. 2014 Feb 4. doi: 10.1002/hep.27048. [Epub ahead of print]
 
712.Effect of a liver cancer education program on hepatitis B screening among asian americans in the Baltimore-washington metropolitan area, 2009-2010
  Juon HS1, Lee S2, Strong C3, Rimal R4, Kirk GD5, Bowie J5. Prev Chronic Dis. 2014 Feb 6;11:E18. doi: 10.5888/pcd11.130258.
 
713.Effects of Tenofovir Disoproxil Fumarate in Hepatitis B e Antigen-Positive Patients with Normal Levels of Alanine Aminotransferase and High Levels of HBV DNA
  Chan HL1, Chan CK2, Hui AJ3, Chan S4, Poordad F5, Chang TT6, Mathurin P7, Flaherty JF8, Lin L8, Corsa A8, Gaggar A8, Subramanian GM8, McHutchison JG8, Lee S9, Gane EJ10. Gastroenterology. 2014 Jan 23. pii: S0016-5085(14)00103-6. doi: 10.1053/j.gastro.2014.01.044. [Epub ahead of print]
 
714.The validity of serum markers for fibrosis staging in chronic hepatitis B and C
  Li J, Gordon SC, Rupp LB, Zhang T, Boscarino JA, Vijayadeva V, Schmidt MA, Lu M; the Chronic Hepatitis Cohort Study (CHeCS) Investigators. J Viral Hepat. 2014 Jan 29. doi: 10.1111/jvh.12224. [Epub ahead of print]
 
715.Lamivudine Compared With Newer Antivirals for Prophylaxis of Hepatitis B Core Antibody Positive Livers: A Cost-Effectiveness Analysis
  Wright AJ, Fishman JA, Chung RT. Am J Transplant. 2014 Jan 24. doi: 10.1111/ajt.12598. [Epub ahead of print]
 
716.Telbivudine protects renal function in patients with chronic hepatitis B infection in conjunction with adefovir-based combination therapy
  Lee M, Oh S, Lee HJ, Yeum TS, Lee JH, Yu SJ, Kim HY, Yoon JH, Lee HS, Kim YJ. J Viral Hepat. 2013 Dec 18. doi: 10.1111/jvh.12217. [Epub ahead of print]
 
717.Latent hepatitis B is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C
  Reddy A, May E, Ehrinpreis M, Mutchnick M. World J Gastroenterol. 2013 Dec 28;19(48):9328-33. doi: 10.3748/wjg.v19.i48.9328.
 
718.Risk of Hepatobiliary Cancer After Solid Organ Transplant in the United States
  Koshiol J1, Pawlish K2, Goodman MT3, McGlynn KA4, Engels EA5. Clin Gastroenterol Hepatol. 2013 Dec 19. pii: S1542-3565(13)01964-2. doi: 10.1016/j.cgh.2013.12.018. [Epub ahead of print]
 
719.Extra-hepatic Effects of Nucleoside and Nucleotide Analogues in Chronic Hepatitis B Treatment
  Fung J, Seto WK, Lai CL, Yuen MF. J Gastroenterol Hepatol. 2013 Dec 27. doi: 10.1111/jgh.12499. [Epub ahead of print]
 
720.Biomarkers of liver cell deat.
  Eguchi A1, Wree A2, Feldstein AE2. J Hepatol. 2014 Jan 8. pii: S0168-8278(14)00006-3. doi: 10.1016/j.jhep.2013.12.026. [Epub ahead of print]
 
721.Durability of efficacy after telbivudine off-treatment in chronic hepatitis B patients
  Chen DB1, Chen YM1, Liu J1, Xie DY1, Lu CR1, Huang ZL1, Zhu RH1, Gao ZL2. J Clin Virol. 2014 Jan;59(1):50-4. doi: 10.1016/j.jcv.2013.11.002. Epub 2013 Nov 13.
 
722.Sexual transmission of viral hepatitis
  Gorgos L. Infect Dis Clin North Am. 2013 Dec;27(4):811-36. doi: 10.1016/j.idc.2013.08.002. Epub 2013 Oct 31.
 
723.Slow response to entecavir treatment in treatment-naive HBV patients is conditioned by immune response rather than by the presence or selection of refractory variants
  Solmone M, Giombini E, Vincenti D, Rozera G, Testa A, Moscetti A, Catalano M, Abbate I, Capobianchi MR, Menzo S. Antivir Ther. 2013 Nov 25. doi: 10.3851/IMP2700. [Epub ahead of print]
 
724.A Rationalized Approach to the Treatment of Patients Infected with Hepatitis B
  Cox NR, Patel K, Tillmann HL. Mol Diagn Ther. 2013 Dec 3. [Epub ahead of print]
 
725.Management of hepatitis B in pregnant women and infants: a multicentre audit from four London hospitals
  Godbole G, Irish D, Basarab M, Mahungu T, Fox-Lewis A, Thorne C, Jacobs M, Dusheiko G, Rosenberg WM, Suri D, Millar AD, Nastouli E. BMC Pregnancy Childbirth. 2013 Dec 1;13:222. doi: 10.1186/1471-2393-13-222.
 
726.The impact of obesity and metabolic syndrome on chronic hepatitis B and drug-induced liver disease
  Pais R, Rusu E, Ratziu V. Clin Liver Dis. 2014 Feb;18(1):165-78. doi: 10.1016/j.cld.2013.09.015.
 
727.Hepatitis B Virus (HBV) Infection, Immunity and Susceptibility Among Men Who Have Sex with Men (MSM), Los Angeles County, USA
  Pitasi MA, Bingham TA, Sey EK, Smith AJ, Teshale EH. AIDS Behav. 2013 Nov 26. [Epub ahead of print]
 
728.Presence of anti-interferon antibodies is not associated with non-response to peginterferon treatment in chronic hepatitis B
  Arends P, van der Eijk AA, Sonneveld MJ, Hansen BE, Janssen HL, Haagmans BL. Antivir Ther. 2013 Dec 3. doi: 10.3851/IMP2711. [Epub ahead of print]
 
729.Long-term efficacy and safety of emtricitabine plus tenofovir DF vs tenofovir DF monotherapy in adefovir-experienced chronic hepatitis B patients
  Berg T, Zoulim F, Moeller B, Trinh H, Marcellin P, Chan S, Kitrinos KM, Dinh P, Flaherty Jr JF, McHutchison JG, Manns M. J Hepatol. 2013 Nov 29. pii: S0168-8278(13)00826-X. doi: 10.1016/j.jhep.2013.11.024. [Epub ahead of print]
 
730.Non-invasive assessment of liver fibrosis using real-time tissue elastography in patients with chronic hepatitis B
  Hu Q1, Zhu SY2, Kang LK1, Wang XY1, Lun HM3, Xu CM1. Clin Radiol. 2014 Feb;69(2):194-9. doi: 10.1016/j.crad.2013.10.003. Epub 2013 Nov 26.
 
731.Similar Response to Entecavir 0.5 and 1.0 Mg in Treatment-Naïve Chronic Hepatitis B Patients: A Case-Control Study
  Ha NB, Ha NB, Chaung KT, Trinh HN, Nguyen HA, Nguyen KK, Nguyen MH. Dig Dis Sci. 2013 Nov 19. [Epub ahead of print]
 
732.Antiviral therapy delays esophageal variceal bleeding in hepatitis B virus-related cirrhosis
  Li CZ, Cheng LF, Li QS, Wang ZQ, Yan JH. World J Gastroenterol. 2013 Oct 28;19(40):6849-56. doi: 10.3748/wjg.v19.i40.6849.
 
733.Hepatitis B vaccination coverage among health-care personnel in the United States
  Byrd KK, Lu PJ, Murphy TV. Public Health Rep. 2013 Nov-Dec;128(6):498-509.
 
734.The ratios of Treg/Th17 and TGF-?1/IL-17 are associated with the development of HBV-associated liver cirrhosis
  Yu X, Guo R, Ming D, Su M, Lin C, Deng Y, Lin Z, Su Z. J Gastroenterol Hepatol. 2013 Nov 15. doi: 10.1111/jgh.12459. [Epub ahead of print]
 
735.HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability
  Kim GA, Lim YS, An J, Lee D, Shim JH, Kim KM, Lee HC, Chung YH, Lee YS, Suh DJ. Gut. 2013 Oct 25. doi: 10.1136/gutjnl-2013-305517. [Epub ahead of print]
 
736.Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma
  Liu J, Yang HI, Lee MH, Lu SN, Jen CL, Batrla-Utermann R, Wang LY, You SL, Hsiao CK, Chen PJ, Chen CJ; for the R.E.V.E.A.L.-HBV Study Group. Gut. 2013 Nov 13. doi: 10.1136/gutjnl-2013-305785. [Epub ahead of print]
 
737.Risk factors for hepatocellular carcinoma in patients with drug-resistant chronic hepatitis B
  Jun CH, Hong HJ, Chung MW, Park SY, Cho SB, Park CH, Joo YE, Kim HS, Choi SK, Rew JS. World J Gastroenterol. 2013 Oct 28;19(40):6834-41. doi: 10.3748/wjg.v19.i40.6834.
 
738.HBV- and HCV-related infections and risk of pancreatic cancer
  Fiorino S, Cuppini A, Castellani G, Bacchi-Reggiani ML, Jovine E. JOP. 2013 Nov 10;14(6):603-9. doi: 10.6092/1590-8577/1948.
 
739.Measures to Reduce Mother-to-Child Transmission of Hepatitis B Virus in China: A Meta-Analysis
  Xu H, Zeng T, Liu JY, Lei Y, Zhong S, Sheng YJ, Zhou Z, Ren H. Dig Dis Sci. 2013 Nov 6. [Epub ahead of print]
 
740.Efficient identification of low-income Asian American women at high risk for hepatitis B
  Joseph G, Nguyen K, Nguyen T, Stewart S, Davis S, Kevany S, Marquez T, Pasick R. J Health Care Poor Underserved. 2013 Nov;24(4):1701-16. doi: 10.1353/hpu.2013.0159.
 
741.Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: Resolved and unresolved issues
  Liu CJ. J Gastroenterol Hepatol. 2014 Jan;29(1):26-30. doi: 10.1111/jgh.12421
 
742.Entecavir-associated myopathy: a case report and literature review
  Yuan K, Wang G, Huang Z, Lin B, Zhou H, Lu X. Muscle Nerve. 2013 Nov 12. doi: 10.1002/mus.24118. [Epub ahead of print]
 
743.Antiviral efficacy of entecavir in nucleos(t)ide-naïve patients of Black/African descent with chronic hepatitis B
  Jeffers L, Van Rensburg CJ, Banks A, Schechter M, Schmidt SJ, Hu W, Llamoso C, Parana R. J Viral Hepat. 2014 Jan;21(1):74-6. doi: 10.1111/jvh.12144. Epub 2013 Sep 24.
 
744.Hepatitis B: global scientific development from a critical point of view
  Schmidt S, Bundschuh M, Scutaru C, Klingelhoefer D, Groneberg DA, Gerber A. J Viral Hepat. 2013 Nov 10. doi: 10.1111/jvh.12205. [Epub ahead of print]
 
745.Chronic hepatitis B virus infection
  McMahon BJ. Med Clin North Am. 2014 Jan;98(1):39-54. doi: 10.1016/j.mcna.2013.08.004. Epub 2013 Oct 20.
 
746.Risk of vertical transmission of hepatitis B after amniocentesis in HBs antigen-positive mothers
  Yi W, Pan CQ, Hao J, Hu Y, Liu M, Li L, Liang D. J Hepatol. 2013 Nov 19. pii: S0168-8278(13)00801-5. doi: 10.1016/j.jhep.2013.11.008. [Epub ahead of print]
 
747.Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio
  Harimoto N, Shirabe K, Nakagawara H, Toshima T, Yamashita Y, Ikegami T, Yoshizumi T, Soejima Y, Ikeda T, Maehara Y. Transplantation. 2013 Dec 15;96(11):1008-12. doi: 10.1097/TP.0b013e3182a53f2b.
 
748.Knowledge of HBV and HCV and individuals' attitudes toward HBV- and HCV-infected colleagues: a national cross-sectional study among a working population in Japan
  Eguchi H, Wada K. PLoS One. 2013 Sep 26;8(9):e76921. doi: 10.1371/journal.pone.0076921.
 
749.Hepatitis B virus gene mutations and hepatocarcinogenesis
  Liang T, Chen EQ, Tang H. Asian Pac J Cancer Prev. 2013;14(8):4509-13.
 
750.Trends in the knowledge, attitudes and practices of travel risk groups toward prevention of hepatitis B: Results from the repeated cross-sectional Dutch Schiphol Airport Survey 2002-2009
  van Genderen PJ, van Thiel PP, Mulder PG, Overbosch D; Dutch Schiphol Airport Study Group. Travel Med Infect Dis. 2013 Sep 29. pii: S1477-8939(13)00140-3. doi: 10.1016/j.tmaid.2013.09.002. [Epub ahead of print]
 
751.Anti-TNF therapy in patients with HBV infection-analysis of 87 patients with inflammatory arthritis
  Ye H, Zhang XW, Mu R, Fang LK, Gu JR, Lin J, Du JF, Chen JW, Chen YJ, Wu LJ, Pang XF, Li ZG. Clin Rheumatol. 2013 Sep 29. [Epub ahead of print]
 
752.Quality of life, depression, and anxiety among hepatitis B patients
  Keskin G, Gümüs AB, Orgun F. Gastroenterol Nurs. 2013 Sep-Oct;36(5):346-56. doi: 10.1097/SGA.0b013e3182a788cc.
 
753.Comparison of hepatitis B prophylactic outcomes in living donor liver transplantation recipients who meet the Milan or UCSF criteria
  Jiang L, Yan LN, Wen TF, Li B, Yang JY. Hepatobiliary Pancreat Dis Int. 2013 Oct;12(5):494-9.
 
754.Prevention of recurrent hepatitis B infection after liver transplantation
  Wong TC, Fung JY, Lo CM. Hepatobiliary Pancreat Dis Int. 2013 Oct;12(5):465-72.
 
755.Efficacy of lamivudine combined with adefovir dipivoxil versus entecavir monotherapy in patients with hepatitis B-associated decompensated cirrhosis: A meta-analysis
  Peng H, Liu J, Yang M, Tong S, Yin W, Tang H, Hu P, Hu H, Ren H. J Clin Pharmacol. 2013 Sep 16. doi: 10.1002/jcph.181. [Epub ahead of print]
 
756.High hepatitis B virus surface antigen levels and favorable interleukin 28B genotype predict spontaneous hepatitis C virus clearance in uremic patients
  Yu ML, Dai CY, Huang CF, Lee JJ, Yeh ML, Yeh SM, Kuo HT, Huang JF, Chang JM, Chen HC, Juo SH, Hwang SJ, Chuang WL; FORMOSA-LIKE group. J Hepatol. 2013 Oct 2. pii: S0168-8278(13)00683-1. doi: 10.1016/j.jhep.2013.09.023. [Epub ahead of print]
 
757.Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection
  Coppola N, Marrone A, Pisaturo M, Starace M, Signoriello G, Gentile I, Adinolfi LE, Sagnelli E, Zampino R. Eur J Clin Microbiol Infect Dis. 2013 Oct 1. [Epub ahead of print]
 
758.Antiviral Therapy for Chronic Hepatitis B Virus Infection and Development of Hepatocellular Carcinoma in a US Population
  Gordon SC, Lamerato LE, Rupp LB, Li J, Holmberg SD, Moorman AC, Spradling PR, Teshale EH, Vijayadeva V, Boscarino JA, Henkle EM, Oja-Tebbe N, Lu M; Checs Investigators. Clin Gastroenterol Hepatol. 2013 Oct 6. pii: S1542-3565(13)01511-5. doi: 10.1016/j.cgh.2013.09.062. [Epub ahead of print]
 
759.Hepatitis B virus gene mutations and hepatocarcinogenesis
  Liang T, Chen EQ, Tang H. Asian Pac J Cancer Prev. 2013;14(8):4509-13.
 
760.Efficacy of adefovir-based combination therapy for patients with Lamivudine- and entecavir-resistant chronic hepatitis B virus infection
  Lee YB, Lee JH, Choi WM, Cho YY, Yoo JJ, Lee M, Lee DH, Cho Y, Yu SJ, Kim YJ, Yoon JH, Kim CY, Lee HS. Antimicrob Agents Chemother. 2013 Dec;57(12):6325-32. doi: 10.1128/AAC.01742-13. Epub 2013 Oct 7.
 
761.Hepatitis B and C in the armed forces
  Freshwater DA. J R Army Med Corps. 2013 Sep;159(3):169-74. doi: 10.1136/jramc-2013-000096. Epub 2013 Jun 3.
 
762.Hepatitis B vaccination with or without hepatitis B immunoglobulin at birth to babies born of HBsAg-positive mothers prevents overt HBV transmission but may not prevent occult HBV infection in babies: a randomized controlled trial
  Pande C, Sarin SK, Patra S, Kumar A, Mishra S, Srivastava S, Bhutia K, Gupta E, Mukhopadhyay CK, Dutta AK, Trivedi SS. J Viral Hepat. 2013 Nov;20(11):801-10. doi: 10.1111/jvh.12102. Epub 2013 Apr 23.
 
763.Analysis of rheumatoid factor according to various hepatitis B virus infectious statuses
  Choi ST, Lee HW, Song JS, Lee SK, Park YB.
 
764.Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade
  Yim HJ, Hwang SG. Clin Mol Hepatol. 2013 Sep;19(3):195-209. doi: 10.3350/cmh.2013.19.3.195. Epub 2013 Sep 30.
 
765.De novo combination therapy adefovir plus lamivudine as a treatment for women of child-bearing age with HBeAg-positive chronic hepatitis B Before Pregnancy
  Li-Na M, Xiang-Chun D, Xiao-Yan L, Chun-Qiong X, Liu SW, Yan X. J Med Virol. 2013 Oct 25. doi: 10.1002/jmv.23828. [Epub ahead of print]
 
<
766.Compromised Function of Natural Killer Cells in Acute and Chronic Viral Hepatitis